The Contribution of Psychological Intervention to the Management of Epilepsy by Gillham, Ruth Alison
 
 
 
 
 
 
 
https://theses.gla.ac.uk/ 
 
 
 
 
Theses Digitisation: 
https://www.gla.ac.uk/myglasgow/research/enlighten/theses/digitisation/ 
This is a digitised version of the original print thesis. 
 
 
 
 
 
 
 
 
Copyright and moral rights for this work are retained by the author 
 
A copy can be downloaded for personal non-commercial research or study, 
without prior permission or charge 
 
This work cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the author 
 
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the author 
 
When referring to this work, full bibliographic details including the author, 
title, awarding institution and date of the thesis must be given 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enlighten: Theses 
https://theses.gla.ac.uk/ 
research-enlighten@glasgow.ac.uk 
XHE_CQNIBIBHHOH_QE-P£Y£HQLQG ICAL INTERVENT ION TO THE
mmagemeni_qf EPILEPSY,.
Ruth Alison GiIlham M.A. , M.App.Sci
A thesis submitted to the University of Glasgow in 
fulfilment of the requirements for the degree of Doctor of
Philosophy.
Departments of Neurology and Psychological Medicine, 
University of Glasgow.
April 1988.
© R u t h  A. Gillham 1988.
ProQuest Number: 10998185
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 10998185
Published by ProQuest LLC(2018). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLC.
ProQuest LLC.
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106- 1346
TABLE OF CONTENTS.
LIST OF FIGURES 1
ACKNOWLEDGEMENTS 2
SUMMARY 3
CHAPTER 1: Limitations of Conventional 6
Management of Epilepsy.
CHAPTER 2: Psychiatric, Psychological and 15
Social Aspects of Epilepsy.
CHAPTER 3: Non-pharmacological Methods of 35
Seizure Control.
CHAPTER 4: Preliminary Study: Characteristics 57
of an Out-Patient Population of 
People with Epilepsy.
CHAPTER 5: Treatment Study: Design and Methods. 85
CHAPTER 6: Treatment Study: Evaluation of 115
Treatment Effects.
CHAPTER 7: The Concept of Severity. 155
CHAPTER 8: Factors Potentially Advantageous 167
for Treatment.
CHAPTER 9: Demographic Variables as Predictors 189 
of Treatment Response.
CHAPTER 10: Combining Predictors. 196
CHAPTER 11: Limitations, Conclusions and Final 203
Evaluation.
APPENDICES. 223
REFERENCES. 230
-1-
LIST OF FIGURES.
FIGURE 1
FIGURE 2
FIGURE 3
FIGURE 4
FIGURE 5
Numbers of subjects in each of 8 Bands of 
monthly seizure frequency.
Diagrammatic Representation of the 
Experimental Design.
Mean Weekly Seizure Rate for each Group in 
each of the 42 weeks of the study.
Mean Weekly seizure Rate for each Group at 
the beginning and end of each phase.
Relationships between percentage improvement 
in Weekly Seizure Rate, (WSR) final follow-up 
WSR and final control ratings.
-2-
ACKNOWLEDGMENTS.
The author would like to thank the following for their 
assistance with the work reported here:
Professor J.A. Simpson, Department of Neurology, and 
Professor D.N. Brooks, Department of Psychological 
Medicine, for their patient supervision of this work; 
The Consultants in Neurology, Institute of Neurological 
Sciences, for access to patients in their care;
Mrs Janet Wilson, Paisley College, and Dr Adrian Bowman 
University of Glasgow, for Statistical advice;
Mr Charles Palliser, Department of English Studies, 
Strathclyde University, for help with spelling and 
punctuation.
-3-
SUMMARY.
The conventional treatment of epilepsy is pharmacological, 
but anticonvulsant drugs are not effective in every case
V
and their use may be limited by side-effects. There are. a 
wide range of psychiatric, psychological and social 
problems associated with epilepsy and it is argued that 
they frequently require intervention in their own right. 
There are many examples of psychological methods applied 
to seizure control in the literature, but unfortunately 
not all have adequate operational definitions and the 
application of such treatments has yet to be established.
A standarised interview schedule was presented to 105 
consecutive patients with epilepsy attending neurology 
review clinics. The prevalence of psychological 
disturbance, in terms of standard scales, and poor seizure 
control, was measured. The proportion of patients 
experiencing various seizure related phenomena which might 
be of use in seizure interruption strategies was recorded. 
It is concluded that there are sufficient numbers of 
patients with refractory epilepsy and significant 
psychological disorder in this population for a treatment 
study to be viable.
The design of the treatment study is described. Two types 
of treatment are evaluated in a form of cross-over design. 
Treatment A teaches patients seizure interruption and
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avoidance strategies. Treatment B focuses exclusively on 
alleviating anxiety and depression by standard 
psychological techniques. The main outcome measures are 
seizure frequency and scores on standard rating scales of 
anxiety and depression. The main purpose is to evaluate 
the effectiveness of these techniques in improving seizure 
control. The effect on psychological disorder will be also 
be assessed and an attempt will be made to identify 
factors predicting good and poor treatment outcomes.
Three groups of patients were studied. The first group (n 
= 19) had no significant psychopathology and received 
Treatment A only. The second and third groups, (n = 21, 
and n = 19) had both treatments administered 
consecutively. Group 2 had Treatment A then Treatment B 
and Group 3 B then A. Results showed a significant 
improvement in seizure frequency in all three groups after 
a stable baseline. Improvement was about 50% in 50% of 
cases and was maintained during six months follow-up.
There was no difference between the groups in terms of 
outcome, no difference between the treatments and no 
treatment order effect. Groups 2 and 3 showed significant 
improvement in measures of anxiety and depression and all 
three groups showed a reduction in the numbers of work 
related and social activities they felt barred from as 
result of their epilepsy. It is noted, however, that at 
the end of treatment the overall mean weekly seizure rate 
is still above 2 and that score on anxiety and depression
-5-
scales remaons above "normal’. Further analysis of the 
data shows evidence that anxiety, but probably not 
depression, may play a part in maintaining a high seizure 
frequency. It appears that depression is associated with 
lack of warning that a seizure is about to occur and with 
lack of independence, as defined in this study. 
Discriminant analysis showed that the best predictors of a 
good treatment outcome in terms of fall in seizure 
frequency, were presence of some form of warning of a 
seizure, and moderate pre-treatment levels of anxiety and 
depression.
The theoretical and practical implications of these 
results are discussed, with particular reference to 
possible treatment mechanisms. Some speculations which 
might explain the apparent relationship between anxiety 
and high seizure frequency are presented. It is concluded 
that psychological intervention has a potential 
application in the management of epilepsy but that future 
evaluations should use a longer follow-up period and 
should assess effectiveness of treatments when more than 
one therapist is employed.
CHAPTER 1
LIMITATIONS OF CONVENTIONAL MANAGEMENT OF EPILEPSY.
1. ANTI-EPILEPTIC DRUGS ARE SOMETIMES INEFFECTIVE.
2. ANTI-EPILEPTIC DRUGS HAVE SIDE-EFFECTS.
3. SEIZURES ARE NOT THE ONLY PROBLEM OF EPILEPSY.
The disorder of epilepsy is characterised by seizures. 
Conventional methods of treatment are directed at seizure 
elimination or reduction. The most effective anti-seizure 
treatments are pharmacological. Until the last decade the 
major emphasis of research in the area has been on the 
development of anti-epileptic drugs (AEDs), their optimal 
use with maximum effect and with the minimum of side 
effects. Epilepsy is not a single entity but rather a 
symptom of a great variety of underlying cerebral 
disorders. It is not therefore suprising that AEDs are 
more effective in some forms of the disorder than others. 
Generalised seizures, for example, can usually be 
controlled effectively by drug treatments, while temporal 
lobe seizures are quite frequently difficult to control. 
In many cases seizures can be virtually eliminated
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without troublesome drug side-effects and without 
significant effect on life-style. However there is a 
significant sub-group of people with epilepsy for whom 
treatment based purely on pharmocalogical intervention is 
less than adequate. The following discussion considers the 
reasons for this.
1) ANTI-EPILEPTIC DRUGS ARE SOMETIMES INEFFECTIVE.
There may be a number of reasons why anti-epileptic drugs 
(AEDs) are ineffective in any given patient. It has been 
suggested that poor compliance is a major cause of 
refractory epilepsy (1), and that this problem is 
particularly prevalent in children (2) and adolescents 
(3). The latter authors, Friedman et al., suggest that 
non-compliance is related to adolescent striving for 
independence, but it must be imagined that poor 
understanding of the purpose of medication, and 
forgetfulness also play a significant part. Much emphasis 
has been put on the importance of monitoring circulating 
blood levels in recent years (4) and the need to improve 
compliance figures prominently among the reasons for this.
Giordani et al.(5,6) investigated the effects of intensive 
diagnostic and therapeutic intervention on a
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series of patients with refractory epilepsy. 
Rationalisation of anticonvulsant therapy led to 
improvement in seizure frequency in 60% of their 
patients. It may be inferred from these studies that some 
cases of "refractory" epilepsy may be resolved by 
re-evaluation and improvement of clinical management.
However it has been asserted that 20 to 30% of all 
patients with epilepsy are refractory to anticonvulsant 
drug therapy, even when drugs are used in adequate doses 
and plasma levels are monitored (7). In simple terms 
epileptic seizures occur when the precipitating factors 
outweigh inhibiting factors. The mechanism of action of 
AEDs is generally that they increase seizure inhibition. 
There are a variety of ways in which this can occur and 
different drugs have different types of action.
Phenytoin, for example, has been shown to stimulate the 
Purkinje cells of the cerebellum and by this means exert 
an inhibitory influence on the cerebral cortex (8), while 
valproate prevents spread of seizure activity and raises 
the threshold for firing of a focus (9). It may be 
assumed that any given drug will act in the same way on 
all individuals although individual dosage requirements 
will be a function of a number of factors (body weight, 
metabolic rate etc.) (10).
On the other hand, precipitating factors may vary greatly 
in type and significance from one individual to another.
Several types of metabolic derangement can increase 
seizure susceptibility, but which once detected may be 
rectified. These include hypoxia, hypoglycaemia, 
hyponatraemia, hypernatraemia, hypocalcaemia, and 
magnesium deficiency (11). In addition there are a number 
of non-pathological physiological states which may 
increase the probability of having a seizure, such as 
over-hydration, drowsiness, sleep deprivation and alcohol 
use (12). Specific auditory, visual and somatosensory 
stimuli can provoke seizures in susceptible individuals. 
There are rare reports of seizures being triggered by 
highly specific sounds such as the voice of a particular 
newsreader, frogs croaking and machinery droning (13).
More commonly, light pattern changes caused by flashing 
lights, reading and moving grids have been shown to 
precipitate seizures (14). Cognitive events and emotional 
states have been frequently implicated but due to their 
subjective nature a direct association with seizures has 
been harder to prove (12, 15). Aird (12) concludes that 
there are over 40 known epileptogenic mechanisms, about 10 
of which vary from hour to hour depending upon habit 
factors and the daily activities of the patients. In any 
given individual the probability of a seizure occurring 
will be a product of their innate seizure threshold, and 
the presence and strength of various precipitating factors 
to which they may be sensitive, countered by natural and 
AED induced inhibition. Given the complexity of this 
equation, and the potential for inter and
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intra-individual variation, it is scarcely suprising that 
a significant proportion of patients is refractory to 
standard AED regimes.
2) ANTI-EPILEPTIC DRUGS HAVE SIDE EFFECTS.
Another important limitation of anticonvulsant therapy is 
that all AEDs in current use have significant 
side-effects (16). Consideration of haematological and 
hepatic disorders associated with these substances is 
beyond the scope of this text and they are, in any case, 
rare. However in an average epilepsy out-patient clinic 
there will be a minority of patients physically unable to 
tolerate AEDs in sufficient dosage to achieve 
satisfactory seizure control. Side -effects which are 
relatively harmless physically but psychologically 
distressing also occur. Phenytoin, one of the most 
commonly used AEDs, can cause unsightly facial hair 
growth, coursening of features and gum hypertrophy. (17) 
Sodium Valproate tends to cause weight increase (18). The 
psychosocial implications of these factors are apparent 
and may result in poor compliance.
There is increasing interest in cognitive side-effects 
associated with AEDs. Lennox and Lennox in 1960 (19) 
listed AEDs amongst the causes of mental impairment in 
patients with epilepsy, and suggested that phenobarbital
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was responsible for worsening intellectual status in 12% 
of cases. It is probably true to say, however, that it is 
only in the last 15 years that cognitive effects of AEDs 
have been a major area for research. Possibly the work 
of Reynolds and Travers in 1974 (20) was seminal in 
generating interest in the area. In a study of 57 
out-patients with epilepsy, they showed that after 
exclusion of cases with overt drug toxicity, patients 
with higher blood levels of phenobarbitone and phenytoin 
were more likely to show evidence of personality change, 
psychomotor slowing and intellectual deterioration and 
that this effect was independent of severity of the 
seizure disorder. At present the most commonly used AEDs 
are Phenytoin, Carbamasepine and Sodium Valproate. 
Phenobarbital, at one time ubiquitous, is used less 
commonly. There is evidence to suggest that all of these 
drugs can produce subtle cognitive impairment. 
Phenobarbital can impair short term memory and vigilance 
in normal volunteers (21) and reduce WAIS performance IQ 
in adult epileptic patients (22). Results of studies of 
the cognitive side-effects of phenytoin have been a 
little harder to interpret; some studies have shown that 
it can have a beneficial effect on some aspects of 
performance in non-epileptic subjects.(e.g Goldberg & 
Kurland 1970, (23) Smith and Lowry 1975, (24).) More
recent work has shown that performance on tracking tasks, 
(25) and on visual vigilance tasks (26) improves with 
increasing circulating blood concentrations in patients
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with epilepsy. However other studies have shown that 
there is an association between higher levels of 
phenytoin and poorer performance on tasks which have a 
strong motor element in epileptic patients (27). When 
Phenytoin has been compared to Carbamasepine it has been 
shown that it is associated with poorer performance on 
memory tasks (25). Carbamasepine has a relatively good 
track record compared to Phenobarbitone and Phenytoin, 
but MacPhee et al. have shown that it produces subtle 
psychomotor impairment in normal volunteers (28), in 
patients when it is administred in a single additional 
dose (29), and in patients on chronic Carbamazepine 
therapy (30). Sodium Valproate, the most modern of the 
major AEDs, appears to cause psychomotor impairment when 
high dose subjects are compared to low (31). There is 
also a single case report of "reversible" dementia where 
a patient with gross intellectual impairment improved 
following Sodium Valproate withdrawal (32). Clonazepam 
and Clobazam are benzodiazepines with anticonvulsant 
properties commonly used as an adjunct to other AEDs, but 
have been shown to produce impairment (33). The series of 
studies by Trimble and other authors has shown that 
multiple drug use is more harmful in terms of 
side-effects and probably not superior in terms of 
seizure conrol (34).
The point of listing these studies is to make clear the 
limitations of the use of AEDs; not only is there a risk
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of potentially dangerous physical side-effects, but the 
mental efficiency of the patient is increasingly likely 
to be impaired with increasing dosages (4). Better 
seizure control may be associated with poorer quality of 
life as a result of subtle intellectual impairment.
3) SEIZURES ARE NOT THE ONLY PROBLEM OF EPILEPSY.
Aird (7), in his chapter on common sources of failure in 
the therapeutic management of epilepsy, is very forceful 
in pointing out the importance of attending to 
non-seizure aspects of epilepsy, although he is not the 
only author to express this viewpoint (35). "Another 
aspect of this problem (therapeutic failure) concerns the 
relative dichotomy of neurologic and psychiatric 
specialization in dealing with the complex medical, 
social and psychologic problems of epileptic patients.
Too frequently, the neurologist tends to reduce the 
problem of diagnosis to seizure types, confirmation by 
EEG, and the prescription of appropriate drugs for the 
seizure types identified." Aird considers it essential 
that " the physician should have some understanding of 
the patient’s personality and of how he functions in his 
family and environment. Sociologic and psychologic 
factors may equal or even outweigh the medical problem in 
importance, and the inadequate management of such factors 
may bias the patient’s cooperation or response."
-14-
The literature dealing with the psychological and 
psychiatric problems associated with epilepsy is very 
extensive; having made the point that they are a major 
reason why management of epilepsy focused entirely on 
seizures is limited, a separate chapter will be devoted 
to their description.
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PSYCHIATRIC, .PSYCHOLOGICAL AND SOCIAL_ASPEdS_QE_EPILEPSY,
1. EPIDEMIOLOGY.
2. THE ROLE OF CEREBRAL PATHOLOGY.
3. PERSONALITY.
4. PSYCHOSIS.
5. DEPRESSION AND ANXIETY.
6. ATTITUDES AND PSYCHOSOCIAL PROBLEMS.
7. PSEUDOEPILEPTIC SEIZURES.
The literature dealing with each of these topics will be 
briefly reviewed. In each case there are implications for 
the present study and these will be noted.
1. EPIDEMIOLOGY.
Epidemiological studies of psychiatric disorders 
associated with epilepsy have given variable results,
-16-
depending on the operational definitions and the methods 
of data collection. Rutter, Graham and Yule (36), in their 
large survey of school children, found an incidence of 32% 
suffering from some form of psychiatric disorder amongst 
children with uncomplicated epilepsy. This was about 4 
times the rate of the normal population in their sample. 
The prevalence rises to about 50% in epilepsy complicated 
by other neurological disorders, mainly because of mental 
subnormality. Pond (37) suggests that there are only two 
useful community studies of the adult population (38, 39); 
others are based only on in-patient data. In summarising 
the results of these two studies he concludes that the 
prevalence of general neurotic disorder is about 15-20%; 
approximately the same as in any sample of subjects 
suffering from any chronic medical disability. There is a 
further 15-20% who, according to Pond's definitions, 
suffer from "problems peculiar to epilepsy resulting from 
the associated CNS damage, drug effects and ictal 
alterations of consciousness." Within this group there is 
an increased incidence of paranoid hallucinatory 
psychosis. In real terms this means that of every patient 
with epilepsy attending general hospital clinics, or their 
general practitioner, 1 in 3 may have some form of 
psychiatric disorder; mainly conduct disorders in children 
and adolescents, and mild affective disorders in adults 
(40). A more recent, although rather small scale study is 
reported be Toone (41). His group interviewed 103 patients 
with epilepsy using the Clinical Interview Schedule (CIS)
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(42), and found that the overall morbidity in terms of CIS 
scores was 48%, three-quarters of whom were diagnosed as 
having some form of affective neurosis.
These epidemiliogical studies serve to support the view 
expressed in the previous chapter; that psychological or 
psychiatric disorders are a very significant factor in 
epilepsy. This fact alone suggests that some form of 
psychotherapeutic intervention might contribute 
significantly to the management of the disorder as a 
whole.
2) THE ROLE OF CEREBRAL PATHOLOGY
One approach to quantifying and defining the relationship 
between epilepsy and psychiatric disorders is to attempt 
to relate the degree of psychiatric and psychological 
morbidity to variables which might give an indication of 
the severity of the seizure disorder. Some studies have 
shown that an early age of seizure onset is associated 
with intellectual deterioration (43,44), and Hermann et al 
(45) in a study using the MMPI, found that patients with 
adolescent onset of temporal lobe epilepsy (TLE) had a 
greater probability of developing psychological 
dysfunctions than patients with adult onset TLE. Seizure 
duration and absolute numbers of seizures have been shown
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to correlate with degree of cognitive impairment (46) but 
not with psychosis (47). Dodrill (48) showed that 
emotional and psychosocial adjustment were worst in 
persons having large numbers of single convulsions and 
that a history of status epilepticus was associated with 
decreased neuropsychological and psychosocial functioning. 
Hermann (49) concludes that these last two factors are 
interrelated but that "further research is necessary to 
define the relationship." Despite the positive findings in 
this body of research Lesser, in his review of the 
evidence (50), points out that causal links between 
various seizure disorder severity factors, and 
psychological morbidity cannot necessarily be inferred 
since all may be a result of the underlying cerebral 
pathology. This point is also made by Engel et al (51) who 
conclude that not all of the behaviour disturbances of 
epilepsy are due to psychosocial factors; some may be a 
result of anticonvulsant drug use, and some to specific 
structural lesions. Beran and Flanagan (52), in a recent 
study comparing patients with and without structural 
lesions, concluded that the presence of such lesions was 
the key factor in producing psychosocial disability in a 
proportion of people with epilepsy.
A review of the literature leads one to the view that the 
causal relationships between the neurological, 
psychological, social and psychiatric aspects of epilepsy
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defy disentanglement. Most discussion centres on the 
extent to which the various neurological factors directly 
produce psychological morbidity. Although some authors 
(48, 50, 53) briefly alude to the reverse possibility; 
that some types of psychological disturbance may increase 
seizure frequency or severity, this has not been 
considered an important line of research. However this 
possibility has exciting implications for treatment; not 
only are the psychological problems of epilepsy worth 
treating in their own right, but doing so might improve 
seizure control.
3) PERSONALITY
There has been much discussion of the concept of 
"epileptic personality". Since the disorder of epilepsy 
was first described it was thought that deterioration of 
behaviour and personality were inevitable (54). Gowers, 
(55) and others of his period believed the deterioration 
to be a consequence of seizures, but the work of 
Kraepelin (56) influenced opinion towards the view that 
epilepsy was a disease entity in its own right, which, as 
in dementia praecox, was genetically determined and led 
inevitably to a degraded state. By the middle of this 
century it was recognised that epilepsy is not a disease 
but a symptom of a great variety of cerebral disorders, 
some of which cause mental changes and some of which do
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not. Epidemiological studies (37, 38, 39), were 
influential in moving epileptic personality research away 
from institutions, and the consensus of opinion of studies 
in the late 70"s (57, 58, 59) was that there is no 
specific personality disorder associated with epilepsy.
There is some evidence, however, that there are 
particular behaviour or personality changes associated 
with temporal lobe epilepsy (TLE). These have been 
described very fully by Geschwind (60). In simple terms he 
considers them to be a result of a combination of 
"viscosity" of thought, hyperemotionality and 
hyposexua1ity. Geschwind and Bear and Fedio (61) relate 
these characteristics convincingly to the functions of the 
limbic system, and suggest that hyperemotionality, for 
example, may be a result of electrical stimulation of the 
limbic system and the surrounding cortex. This 
stimulation, arising from the epileptic focus, might lead 
to enhanced affective association with previously neutral 
stimuli, events or concepts, depending on the area of 
cortex being stimulated. Brandt et al. (62), in a study 
more carefully controlled than that of Geschwind since 
they also studied patients with generalised epilepsy, 
found that people with right TLE were indistinguishable 
from normals, in terms of the personality measures they 
used, and that patients with left TLE and patients with 
generalised epilepsy were indistinguishable from each
-21-
other. The latter groups did, however, show some of the 
characteristics described by Geschwind. Dodrill and 
Batzel (63) reviewed this confusing area and concluded 
that persons with TLE do not have a greater incidence of 
emotional and psychiatric problems than people with other 
forms of epilepsy, but that there may be some 
"behavioural peculiarities" which appear in a small 
proportion of people with TLE.
In summary it would appear that there is little evidence 
for the existence of an "epileptic personality". Although 
the behavioural characteristics occurring in a few 
patients with TLE may influence their treatment reponse 
it seems doubtful that this effect would be sufficient to 
justify attempts to measure personality factors in this 
study.
4) PSYCHOSIS
It is widely accepted that there is an association 
between epilepsy and psychosis. At one time it was 
thought that the two disorders were antagonistic to each 
other (56), and this belief was most influential in the 
development of ECT. This notion has fallen out of fashion 
although there are recent reports of patients without 
previous psychiatric history who developed acute 
psychotic states on establishment of seizure control and
-22-
EEG normalisation (64, 65). Reviews of the area (66, 67, 
68) agree on the diversity of type of psychotic reaction 
in epilepsy. Psychotic symptoms may be directly related to 
seizure activity as in temporal lobe status, or may occur 
interictally. The clinical presentation of interictal 
psychosis is subtly different from non-epileptic psychoses 
(69) and much attention has been paid to the relationship 
between site of cerebral pathology and psychotic 
symptomatology (70, 71).
Detailed exploration of this area would be of little 
relevance to the present study for two reasons. Firstly, 
as will be demonstrated in subsequent chapters, overt 
psychosis is very rare in the population under study. 
Secondly patients with significant psychotic symptoms will 
almost invariably be receiving some form of psychiatric 
treatment. This treatment will not be standardised and so 
would confound the evaluation of a further psychological 
intervention. Patients with epilepsy and interictal 
psychoses might benefit from psychological intervention 
but would have to be studied independently from 
non-psychotic patients with careful control of their 
pharmacological and non-pharmacological psychiatric 
treatment. Given the relative scarcity of such patients 
this would have to form the subject of a separate 
investigation.
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5) DEPRESSION AND ANXIETY
Depression and anxiety are very commonly reported by 
patients with epilepsy. At the University of Washington 
regional Epilepsy Centre, for example, over 40% of 211 
adult patients stated that depression was frequently a 
problem "during the past month." (72), and in a community 
study carried out in London, 36% of the sample were 
diagnosed as having some form of affective neurosis (47). 
Yet Betts (73) comments that of all conditions associated 
with epilepsy, anxiety and depression are the least well 
recognised or described in the literature. As recently as 
1985 Robertson and Trimble (74) claimed that theirs was 
the first therapeutic trial of the treatment of depression 
in patients with epilepsy. This is particularly surprising 
because since 1976 (57) it has been known that tricyclics 
and related classes of drugs tend to lower seizure 
threshold. In fact their claim was not quite valid; Davis 
et al (72) published some preliminary results of a study 
evaluating a cognitive behavioural treatment of depression 
in epilepsy in 1984, but the few authors who comment on 
anxiety and depression agree there is a need for further 
research into the nature and treatment of the 
non-psychotic psychological disturbances of epilepsy.
Betts (73) gives a useful descriptive classification of 
the ways in which depression and anxiety may be related
to epilepsy. They may occur as a reaction to the 
diagnosis of epilepsy and the psychosocial problems which 
frequently accompany that diagnosis. They may occur as a 
prodromal emotional change before a seizure. They may be 
experienced, in the case of TLE, as part of the aura or 
seizure itself. Both may occur in association with some 
form of interictal psychosis. Depression may occur as a 
result of a decrease in seizure frequency. Anxiety may 
present as a true phobic state, with seizures 
(collectively) as the unconditioned stimulus. There is 
also some evidence that panic attacks may share some 
underlying cerebral pathology with seizures; a case of 
panic attacks associated with a right temporal lobe 
arteriovenous malformation has been reported (75) and 
also folowing right temporal lobectomy (76). An 
investigative study by Coyle and Sterman (77) led them to 
conclude that a neurophysiological association between 
panic and seizures was at best very rare, but their study 
has been criticised on the grounds that not all their 
patients had EEGs and so seizures could not be absolutely 
ruled out (78). If underlying cerebral pathology is only 
rarely the cause of both seizures and psychological 
disorders another more direct causal link may exist 
between the two factors. Dowds et al. (79) observed that
72% of 300 unselected primary care patients with epilepsy 
reported that emotional upset was accompanied by an 
exacerbation in seizure frequency. It seems possible that 
emotional upset may lower seizure threshold. Although
-25-
this possibility has favourable implications for the 
usefulness of psychological intervention in seizure 
control other explanations for Dowds' observation exist. 
Patients undergoing some personal crisis are more likely 
to forget their medication and patients whose seizure 
control is deteriorating are more likely to become 
emotionally upset.
It is apparent from Betts classification, and the other 
evidence presented, that the types of anxiety and 
depression in epilepsy are varied, and the 
inter-relationships between the factors complex. Deciding 
if a patient is describing a surge of fear occurring as 
part of his seizure or in anticipation of having a seizure 
requires highly developed interviewing skills and clinical 
acumen. Similarly time and careful history taking are 
needed to distinguish a depressive illness requiring 
pharmacological treatment from feelings of helplessness 
and misery resulting from loss of social functioning. It 
is obvious that these disorders are of great importance 
among patients with epilepsy, and that some may well be 
amenable to standard, non-pharmacological psychological 
therapies. This, therefore is an indication of the type of 
therapeutic intervention which would be most worth 
evaluating.
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6) ATTITUDES AND PSYCHOSOCIAL PROBLEMS
The psychosocial problems of epilepsy are very frequently 
referred to in the literature, but rarely defined. It is 
accepted that they are an important component of the 
disorder and that they require management in their own 
right (7), but little information is available on exactly 
how this should be done. However there is agreement that a 
major cause of the psychosocial problems is public 
attitude to epilepsy. Rutter, Graham and Yule (36) in 
their neuropsychiatric survey, concluded that "the 
widespread community prejudice against epilepsy was 
probably an adverse factor in the child's development and 
it may be one reason for the high rate of psychiatric 
disorder in the epilepsy group." A Gallup poll organised 
by Chanon in 1980 and quoted by Gunn (80) seemed to 
suggest that public attitude towards the disorder is 
becoming more tolerant. In 1979 5% of the sample felt that 
they would not let their child associate with an epileptic 
child; in 1969 the response rate to this question had been 
15%. Burden, however, in a review of the social problems 
of epilepsy (81), states the opinion that this is an 
under-estimate of the likelihood of a negative reaction in 
a real life situation. He goes on to delineate the 
psychological effects of negative public attitude, namely 
a sense of inadequacy leading to social withdrawal or 
anti-social aggression, and the practical effects, namely 
difficulty in making friends and finding employment.
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It is worth digressing to note that the origins of present 
day attitude to epilepsy are based firmly in our culture. 
Historically there has been a tendency to regard epilepsy 
as a disorder or disease which is in some sense visited 
upon the sufferer by an external agency. To the ancient 
Greeks, prior to Hippocrates, seizures were a 
manifestation of direct, divine intervention. Although in 
the fifth century B.C.E. Hippocrates ascribed epilepsy to 
a disorder of the brain, for many centuries the belief 
that epilepsy was caused, or at least regulated, by gods, 
demons or the movement of celestial bodies, persisted. 
Possibly the suddenness of onset of seizures, their 
dramatic and alarming nature and the fact that they 
frequently occur in individuals who are otherwise normal, 
combine to create an impression in the mind of the 
observer that something supernatural has occurred. In the 
thirteenth century Thomas Aquinas classified epilepsy 
among conditions of "natural" as opposed to "supernatural" 
origin, but even to the present day seizures provoke a 
sense of fear and people with epilepsy are frequently made 
to feel rejected by society (82). The importance of public 
education in dispelling the cultural myths which surround 
epilepsy has often been emphasised (82, 83, 7, 81, 84, 85, 
86), but results of public opinion polls (94) and 
employment studies (87) suggest that this goal has yet to 
be ach i eved.
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Pond (84), and more recently GiIlham (85), draw attention 
to the importance of attitude to chronic medical disorder 
within the family. This may be distinguished from public 
attitude but may equally result in psychosocial 
difficulties. Parents may experience guilt if they believe 
epilepsy to be genetically determined, and also if they 
believe it to be a result of some trivial childhood 
accident for which they feel responsible. They may respond 
with rejection or denial of the disorder, or with 
over-protectiveness thereby fostering dependence and the 
sick role.
Attempts have been made to quantify the psychosocial 
aspects of epilepsy, most notably by Dodrill et al. (88), 
in the development of the Washington Psychosocial Seizure 
Inventory (WPSI). This 132 item questionnaire attempts to 
assess family background, emotional adjustment, 
interpersonal adjustment, vocational adjustment, financial 
status, adjustment to seizues and overall psychosocial 
functioning. The scale was correlated with professional 
ratings within each of the above sections. Validation of 
the scale (89), showed it to be, at the least, a reliable 
indicator of probable employment status. There are few 
references made to the WPSI in the literature subsequent 
to its inception in 1980, and so it might appear that it 
has limited practical application.
In summary there is agreement in the literature that one
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of the major causes of psychosocial problems is the 
attitude of society, families and possibly patients, to 
epilepsy. Evaluation of some form of educative program in 
a clinical setting, aimed at dispelling misunderstandings 
about the disorder, would be useful.
7) PSEUDOEPILEPTIC SEIZURES.
Pseudoepileptic seizures are sometimes referred to as 
pseudoseizures, or psychogenic seizures, but in the view 
of Fenton (90) neither of these terms is adequate. The 
term "pseudoseizure" conveys the impression that the event 
is not really a seizure, while although it may not be 
aetiologically epileptic, it is undoubtedly a seizure. The 
term "psychogenic" leads to even more confusion but a 
useful definition is given by Fenwick (15). He defines 
primary psychogenic seizures as epileptic events triggered 
by an act of will on the part of the patient. It is not 
uncommon for patients to be able to induce seizures by 
attention to sensory stimulation (e.g. patterns of light) 
to which they are sensitive. Some patients report feeling 
that to have a seizure brings a sense of relief, and also 
security that the subsequent priod is likely to be seizure 
free. It is not uncommon to find patients who feel 
generally physically and psychologically better if they 
have an occasional seizure than if they have none. 
Obviously attention must be paid to these motivating
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factors when attempting to eliminate primary psychogenic 
seizures. Fenwick defines secondary psychogenic seizures 
as those which are precipitated by a specific function of 
the mind without deliberate intent. By way of example he 
draws attention to the work of Ingram and Ryman (91) who 
described a patient whose seizures were precipitated by 
simple calculation. Both primary and secondary psychogenic 
seizures are epileptic in this definition. However Gumnit 
and Gates (92) the term "psychogenic” as though it were 
synonymous with "pseudoepileptic".
If the two disorders, epilepsy and pseudoepilepsy, were 
mutually exclusive then the management of both would be 
more simple. Riley and Roy (93), however, estimate that 
26% of patients with epilepsy also suffer from 
pseudoepileptic seizures. It is not clear from their 
account how they arrived at this figure; Gumnit quotes 
estimates varying between 5% and 50% but points out that 
even the lowest estimate means that 350,000 Americans will 
experience pseudoepileptic seizures at some time in their 
life and that therefore the problem must be considered 
significant. Fenton (90) suggests that the reason for this 
frequency of the association between epileptic and 
pseudoseizures is that patients whose seizures come under 
pharmacological control have lost a valuable source of 
reinforcement. During the time that their seizures were 
not under control, particularly if onset was in 
adolescence, they may have missed opportunities for
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developing socially acceptable sources of reinforcement 
and for acquiring stress coping mechanisms.
The reason for the large variance in prevalence estimates 
is that pseudoepileptic seizures are frequently very 
difficult to diagnose. Roy (94) found a personal or family 
history of epilepsy, or an experience of working in a 
medical environment, in about one third of a series of 
patients with hysteria, most of whom had hysterical 
convulsions. Thus simulated seizures may be very 
convincing in this population. Various authors have 
produced guidelines to aid discrimination between the two 
types of attack (90, 95, 92, 96, 97). The last three of 
these are based on studies carried out at the Minnesota 
Comprehensive Epilepsy Program. Gumnit (92) in reporting 
and reviewing the results shows that using multivariate 
discriminant analysis on certain clinical characteristics 
gives a classification rate of 4% false positive and 4% 
false negative.
Two recent developments have also proven useful in 
elucidating this diagnostic problem. Firstly EEG 
telemetry, allowing continuous monitoring of patients, has 
enabled seizures not accompanied by the expected EEG 
changes to be designated pseudoepileptic with some 
confidence. However a study by King et al. (98) highlights 
the limitations of this technique. In their study only 55% 
of the sample had seizures during prolonged monitoring,
-32-
leaving doubt as to the diagnosis in the remainder. In any 
case muscle artifact makes reading of the record difficult 
and the possibility that some patients may have had 
partial seizures causing electrical changes not detectable 
by scalp electrodes can not be completely ruled out. 
Secondly post-ictal rises in prolactin level have been 
demonstrated (99). This occurs reliably after generalised 
seizures and complex partial seizures, but not after 
pseudoepileptic seizures or simple partial seizures. It 
will be seen that a clinician who is able to put these 
diagnostic techniques together has a reasonable chance of 
being correct for most cases, particularly if the seizures 
are real or simulated generalised attacks. However it will 
also be seen that a possibility of mis-diagnosis remains 
particularly in patients with a combination of real and 
pseudo partial seizures. There are striking examples of 
misdiagnosis in the literature, Titelbaum (100) recently 
reported a case of pseudo-epilepsy who had had numerous 
admissions to hospital with presumed status epilepticus, 
and who eventually died of what appeared to be a 
miscalculated parasuicide attempt. On the other hand 
Herskowitz and Rosman (101) reported a case of "pseudo 
pseudo seizures" in a patient who reported faking seizures 
and who eventually proved to be suffering from genuine 
epilepsy.
The diagnostic problem is further complicated by the 
possibility of a neurophysiological or aetiological link
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between hysteria and epilepsy. Trimble (102), in reviewing 
the evidence for such a link, concludes that "there is 
little doubt that patients diagnosed as hysteria very 
often have accompanying underlying neurological disease." 
He goes on to say that it appears possible that 
neurological disorder might predispose one to the 
development of hysterical symptoms and draws attention to 
the evidence that excessive AED use in epileptic patients 
can cause pseudoepileptic seizures, possibly by some 
disinhibiting process (103).
Once diagnosis of pseudoepilepsy has been made, and 
unecessary AEDs have been withdrawn leaving sufficient to 
control genuine seizures should there be any, there is 
still a formidable task ahead of the clinician. Fenton 
(90) receommends a minimum of 10 and a maximum of 30 one 
hour psychotherapy sessions. He appears to envisage this 
taking place in an in-patient setting alongside a 
behavioural management or group therapy programme. He 
comments that work with the patient's spouse or parents is 
always required, and that after discharge from hospital 
contact with the therapist should be maintained at regular 
intervals gradually getting further apart for a minimum of 
two years. He also notes that the long-term outcome is 
unknown and quotes estimates of improvement rates which 
vary between 30 and 80%.
It will be seen from the foregoing discussion that the
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incidence of pseudoseizures in an epileptic population is 
almost certainly too high to be a factor which can simply 
be ignored in a study of the effectiveness of 
psychological intervention in seizure control. It will 
also be seen, however, that diagnostic and therapeutic 
techniques would need to be elaborate and expensive if 
patients with pseudoepileptic seizures were to be excluded 
or treated.
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CHAPTER 3
NQN-PHARMACQLQG.IGAL_ME_THOB£_QF__SEIZURE CONTROL.
1. METHODS BASED ON LEARNING THEORY.
2. BIOFEEDBACK AND INHIBITION.
3. PSYCHOLOGICAL DISTURBANCE AND RELAXATION TRAINING.
A great variety of non-pharmacological methods of seizure 
control have been reported. For the purpose of this review 
they have been divided into three main categories but in 
almost every case the treatment in question could have been 
included in two or more categories. This is a major reason 
why the evaluation of these reports is difficult; in 
general it could be said that while their scope and variety 
is impressive, the elegance of their experimental designs 
is not. A general critique of the methodology of the 
studies discussed will be given in the final section, 
followed by a review of recent studies which overcome the 
methodological problems of earlier work.
1. METHODS BASED ON LEARNING THEORY
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One approach to the management of seizures is to treat them 
as though they were simply undesirable behaviours. To do 
this would be to suggest that seizures are in some sense 
learned behaviours and that as such they can be 
extinguished. On this premise the whole range of 
contingency management techniques becomes available. It is 
hardly surprising that both patients, who experience 
seizures as an entirely involuntary event, and clinicians 
with understanding of the neurophysiology of seizures, 
regard this approach with scepticism. There are, however, 
many accounts in the literature of the effective use of 
contingency management techniques of seizure control. 
Mostofsky and Balaschak (104) in reviewing this area, quote 
studies in four categories according to the rationale 
behind the treatment. An example of the first of these, 
"denial of reward”, in which the occurence of a seizure is 
not followed by a display of concern but is ignored, is 
found in a report by Gardner (105). He presents a case of a 
ten year old girl, who was having frequent seizures. 
"Frequent" is not defined, and the ambiguous term 
"psychogenic" is used to classify the type of epilepsy. The 
girl’s parents were instructed to ignore seizures and to 
reinforce acceptable playing behaviour. Medication was 
withdrawn and in two weeks seizures ceased without further 
recurrence over a twenty-six week period. There is no 
information in this report which would lead one to suppose 
that this girl’s seizures were not pseudoepileptic. However 
if only effective against pseudoepileptic seizures the
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technique would be well worth developing.
Another type of contingency menagement programme is a 
"penalty programme". The paradigm for this is that the 
patient is made to enter a "time - out" room when having, 
or having had, a seizure. By describing this regime as a 
"penalty programme" Mostofsky and Balaschak carefully 
circumvent arguments about whether time-out rooms are 
punishment or merely denial of reward. They quote a sample 
case of a thirty-four year old male patient who had been 
hospitalised for fifteen years because of his low level of 
intellectual functioning and high seizure frequency. At 
base-line he was having twenty seizures per week. The 
time-out procedure was adopted and the number of seizures 
dropped to zero by the end of the first week. The programme 
was run for a further eleven weeks. During the subsequent 
five months he had only one seizure. Again there is 
insufficient information given to allow distinction between 
pseudo and genuine seizures.
Thirdly there are reports of techniques which might be 
described as relief avoidance programmes. In general an 
aversive stimulus, such as a shock or a foul tasting 
medicine, is given until the patient demonstrates reduction 
in the clinical or electrical manifestation of the seizure. 
Ounstead et al. (106), for example, administered a burst of 
subjectively unpleasant photic stimulation to a six year 
old boy when his EEG began to show pre-seizure changes. The
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subject could terminate the unpleasant stimulation if his 
spike and wave activity stopped within five seconds of 
onset, and learnt to do so within a few trials. In this 
case it seems clear that the seizures were epileptic since 
EEG monitoring was used. The treatment mechanism, however, 
is less clear; the report might equally be an example of 
the use of biofeedback or of a seizure interruption 
technique. Both of these types of treatment are discussed 
in subsequent sections.
Wright (107) uses a punishment paradigm in the treatment of 
a 14 year old boy whose seizures were of "organic" origin. 
This method differs from relief avoidance. Instead of the 
subject being given the noxious stimulus until he learns to 
control his seizures to avoid the stimulus, the stimulus is 
given as an immediate consequence of the seizure. Under EEG 
monitoring this child was given an electric shock every 
time his record showed evidence of seizure activity. A 
reduction in frequency of 75% is reported.
Successful outcome single case studies where seizure free 
periods have been rewarded have been reported (108, 109, 
110). A study of relatively superior design was carried out 
by Lavender (111). He carried out a series of four single 
case studies with adequate baselines and with a well 
defined treatment, the most important component of which 
was rewarding progressively longer seizure free periods.
Two of his four mentally handicapped patients showed
-39-
significant improvement during the treatment phase of the 
experiment with reversal of the effect during withdrawal of 
reinforcement. It is not clear why treatment was not 
successful in the other two cases but this simple 
behavioural intervention certainly appears worth further 
investigation.
Systematic desensitisation is a treatment based on learning 
theory, widely used for treatment of phobic anxiety, in 
which the link between the stimulus and the phobic reaction 
is broken by systematic presentation of feared situations 
in a hierarchical order. Desensitisation has also been used 
to treat reflex epilepsy. As early as 1874 Dunsmore (112) 
described a patient in whom seizures could be triggered by 
pats on the head, but no attempts were made to habituate 
patients to seizure provocative stimuli until the work of 
Forster in the 60s and early 70s. Forster (113) described 
in detail the case of a 53 year old women who developed 
epilepsy two years after a head injury. She experienced 
brief focal seizures only while listening to the radio. 
Clinical tests showed definitive EEG changes in reponse to 
the voices of three radio announcers. Tapes of their voices 
were obtained and they were played to the patient for brief 
periods initially, and then for progressively longer 
periods until the threshold at which seizure activity began 
was determined. With repeated sub-threshold exposures the 
patient became desensitised to the stimulus and ceased to
-40-
have seizures. Forster has used this approach successfully 
to treat other forms of reflex epilepsy, such as reading 
epilepsy, and musicogenic epilepsy (114).
It is not necessarily clear from accounts of reflex 
epilepsy whether the stimulus is unconditioned or 
conditioned. In the former case underlying idiopathic 
neural susceptibility to the stimulus must be assumed. 
Photic stimulation is almost certainly an unconditioned 
stimulus to patients susceptible to its effects, although 
the mechanisms of epileptogenesis in photosensitive 
epilepsy are not completely understood (115). On the other 
hand an operant model may be applied to some sensorily 
triggered seizures. Chance association between a sensory 
stimulus and a seizure could conceivably increase the 
probability of a seizure occurring at the next presentation 
of the stimulus, perhaps as a result of the patient’s 
expectations or apprehension. Although it is agreed that 
stress may precipitate seizures (116) the underlying 
mechanism is rarely discussed. Stress, or some of the 
physiological changes accompanying it, may be a primary 
unconditioned seizure trigger in some individuals, but the 
possibility that a learned association has occurred cannot 
be entirely discounted. Systematic desensitisation to 
stress provoking factors has been attempted in patients 
with epilepsy and is discussed in the final section which 
deals with psychological disturbance. However the fact that 
these treatments can improve seizure control adds little to
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the understanding of the link between anxiety or stress and 
seizures.
2. BIOFEEDBACK AND INHIBITION.
These two techniques have been placed together because both 
require the subject to carry out some activity designed to 
inhibit seizure activity.
The principles which underly biofeedback have been 
succinctly defined by Lubar and Deering (117). "Biofeedback
......  is a methodology for acquiring control over internal
processes based upon operant conditioning of 
electrophysiological, neuromuscular and autonomic activity. 
Procedurally, biofeedback requires that an exteroceptive 
stimulus is made contingent upon targeted biological 
activity. Ultimately control of targeted biological 
responses is acquired. The process may occur with or 
without awareness on the part of the subject as to exactly 
which manipulations must be done in order to bring about 
this control."
It is widely accepted that human and animal subjects can 
increase production of basic EEG rhythms if they are 
rewarded for doing so. The standard technique in human 
subjects is to transduce a selected frequencing band from 
conventional EEG output into an auditory or visual signal.
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The subject is told to keep the signal on as long as 
possible. Subjects appear to be able to use this "feedback" 
to increase the period of time during which the selected 
frequency band is produced.
There is some evidence that this type of EEG biofeedback 
can improve seizure control. Cabral and Scott (118) trained 
three patients to enhance alpha rhythm and over a six month 
period observed a mean seizure frequency decrease of 92%, 
but they also used relaxation training and so it is not 
possible to identify the effective treatment component. 
Studies using direct feedback of seizure activity have not 
been promising (119, 120), but the use of feedback of the 
band of activity between 12 and 15 Hz, usually termed 
sensorimotor rhythm (SMR), seems to have some potential. 
This rhythm is found over the rolandic cortex when there is 
inhibitory activity in subcortical motor pathways. It is 
thought that SMR is generated by one particular pathway 
leading from the cerebellum to the ventral lateral and 
ventral anterior thalamus and thence to the sensory and 
motor cortex. SMR presents some technical difficulties for 
measurement because it can ride on a much slower "carrier" 
wave. Lubar has managed to overcome this difficulty and the 
subsequent studies use his technique. Sterman and his group 
first showed that cats could increase SMR if food rewards 
were made contingent upon it (121). They then showed, by 
administering Monomethylhydrazine that SMR trained animals 
had a higher threshold for seizures than control animals
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(122). In a subsequent human study (123) they trained four 
patients to enhance SMR activity in response to visual 
feedback and reported, without statistical analyses, a 66% 
reduction in seizure frequency. They concluded that SMR 
must inhibit seizure activity. Following this Lubar and 
others devised sophisticated apparatus that reinforced SMR 
unless slow activity of 3 to 8 Hz was present because they 
believed that there was antagonistic action between these 
two rhythms. They used this apparatus in a series of 
systematic single-case studies (124, 125) and later in 
studies employing double-blind designs (126) comparing 
different reinforcement schedules and feedback frequencies 
ranging from 8Hz to 15 Hz. Total numbers of patients in 
this series are small; the most recent (126) used 4 males 
and 4 females, but the success rate appears to be 
unequivocal seizure frequency reduction in about 60% of 
cases during treatment and showing reversal during 
non-contingent feedback. In reviewing the series (117)
Lubar concludes that training should take at least a year 
and that booster sessions will be necessary indefinitely.
He reccomends that training should be carried out only by 
highly trained personel and preferably with relatively 
intelligent subjects.
Possibly the amount of time and sophistication of apparatus 
required has put researchers off because there are only two 
reports of the use of EEG biofeedback in seizure control in 
the literature after 1981. Tansey (127) reports a single
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case study where SMR biofeedback was used in the treatment 
of petit mal epilepsy. The patient, a 14 year old girl, was 
given 33 sessions of SMR training and an increase in 
amplitude of 14Hz rhythm was observed. This was accompanied 
by a total cessation of seizures which had previously 
occurred at
a frequency of 4 to 5 per hour. A study using a new concept 
in biofeedback, ”non-volitional" biofeedback, is reported 
by Ramamurthi (128). He and his co-author translated a 
range of basic EEG rhythms (usually alpha and theta), into 
visual analogues and fed them back to 58 patients with 
epilepsy so that they were made aware of when they were 
producing the particular rhythms. No instruction or 
reinforcement was given for producing any particular 
frequency. They report a reduction in severity and 
frequency of attacks of more than 80% in about a third of 
the cases, but the information given is too scanty for 
proper evaluation of the usefulness of the technique. It 
must be suspected that the complexity of the apparatus and 
the experimental situation led to a placebo effect in these 
subjects.
Per-cent end-tidal C02 biofeedback has been successfully 
used in the management of epilepsy associated with 
hyperventilation (129). This training had a rapid 
corrective effect on respiration in a series of eleven 
women and seven men all with idiopathic epilepsy and 
chronic hyperventilation. For some reason data are
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presented for only 10 subjects, but these showed EEG 
normalisation and a mean seizure frequency decrease of 48 
per month. The authors suggest that treatment works simply 
by eliminating a seizure precipitating factor so 
significant in this group of patients that they were 
refractory to AEDs.
In summary there is evidence that EEG biofeedback can be 
used to train subjects to alter basic cerebral EEG rhythms 
and that this may increase seizure threshold or inhibit 
seizure propagation. Alerting subjects to EEG changes at 
seizure onset by sonding a tone or flashing a light may 
also be useful, but there is less support for this. 
Biofeedback has also been used effectively as a treatment 
for hyperventilation induced seizures. The main drawback of 
these methods is that they require much time, expertise and 
expensive equipment with the result that most evaluative 
studies have very small numbers of subjects.
"Conditioned Inhibition" is a term first used by Efron in 
1957 (130), but he is not the first to describe a 
conditioned inhibition treatment. Gowers in 1881 (131) 
wrote about a patient in whom Jacksonian fits could be 
arrested by application of a ligature. The seizure began 
with a sensation in the foot which then passed up the leg. 
If a ligature was applied to the leg above the path of the 
sensation, the seizure terminated instead of progressing to
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a generalised convulsion. After a few months the seizures 
spontaneously arrested at the spot where the ligature had 
been. Efron suggests that the ligature arrested seizure 
activity by "building up cortical inhibition", that is by 
causing a burst of cortical activity ahead of the path of 
the seizure. Thirty years later this explanation appears 
very simplistic, and indeed evidence has come to light 
which suggests that activity in an area of the cortex 
regularly involved in seizure discharges can actually 
trigger bursts of seizure activity (12, 15). Nevertheless
there is nothing as striking in the literature as the case 
which Efron describes in two papers (130, 132) in support 
of his theory. His patient was a forty one year old female 
black American singer, with a seizure frequency of seven to 
eighteen per month over twenty six years. In the 
terminology of the time her seizures were classified as 
uncinate; more recent systems would term them temporal lobe 
seizures but they were invariably accompanied by secondary 
generalisation and were completely refractory to 
Phenobarbitone and Phenytoin. Diagnosis was confirmed by 
electroencephalography. All seizures followed an identical 
pattern; they began with a feeling of depersonalisation and 
frantic activity with excessive concern about time. This 
worsened until she experienced a "forced expectation of a 
strong smell", which eventually arrived "like an explosion" 
and which was "disgustingly sweet and penetrating". After 
about ten minutes she would feel compelled to turn to the 
right and a tonic-clonic seizure would ensue. It was
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discovered that sniffing hydrogen sulphide before the 
actual olfactory hallucination, and during the "forced 
expectation" phase, invariably aborted the attack. If the 
gas was presented after this phase then bizarre fragments 
of the seizure still occurred. The number of occurrences of 
the initial phase of the aura was equivalent to the 
pre-treatment seizure frequency. Efron and his patient then 
experimented with different odours and discovered that 
provided it was strong and subjectively unpleasant any 
scent was effective. EEG monitoring confirmed that seizure 
activity began shortly after the patient reported a feeling 
of depersonalisation, and ended shortly after the 
administration of a strong scent. All anticonvulsant 
medication was withdrawn without effect. At this stage the 
patient was using a primary, unconditioned stimulus - the 
strong scent - to abort her attacks. The following year
(132) Efron paired presentations of the scent with 
presentations of a silver bracelet. Eventually the sight of 
the bracelet alone was sufficient to terminate attacks, and 
so conditioned inhibition had been achieved. This was 
effective even during a continuous infusion of Metrazol. 
Until this point in the treatment seizure frequency had 
remained unchanged; there was no reduction in the number of 
auras although none progressed beyond the initial phase. 
After this point seizure frequency fell so that at the time 
of reporting the study the patient had been seizure free 
for 14 months.
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Unfortunately, although Efron's studies cannot be faulted 
on methodological grounds and most be assumed to 
represent a real phenomenon, there have been no 
subsequent reports of a true "conditioned inhibition" 
treatment, or even of use of spontaneous unconditioned 
inhibition. This is surprising because patients 
experiencing olfactory hallucinations immediately before 
a temporal lobe seizure are uncommon but not rare. It 
should be perfectly possible at a large centre to
evaluate a treatment similar to Efron's systematically.
The only other report of an attempt to interrupt the 
progress of seizures comes from Zlutnick and Mayville
(133), but although their treatment was successful in 4
cases, they did not distinguish between behaviours which
led up to the seizure and behaviours, or alterations in 
concious level, which were part of the seizure itself. 
Thus it is not clear whether their treatment inhibited 
seizures or eliminated precipitating factors.
Treatments using relaxation training may make use of some 
unconditioned inhibitory process but since other 
principles are involved they are discussed in a 
subsequent section.
3. PSYCHOLOGICAL DISTURBANCE AND RELAXATION TRAINING.
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The relationship between anxiety and depression and 
epilepsy has already been discussed and it has been noted 
that many patients claim that these disorders can 
increase their seizure frequency, or bring about a 
breakdown of seizure control. (See Chapter 2 section 5). 
Treatment of these disorders, therefore, may be expected 
to improve seizure control in individuals who claim this 
association. Williams et al. (134) demonstrated the 
potential of psychiatric and psychological treatments in 
the management of epilepsy. In their series of 37 
patients with refractory seizures 70% showed substantial 
improvement in seizure control after non-pharmacological 
psychiatric treatment and maintained this improvement 
during follow-up of 2 to 36 months. There are many rather 
serious methodological problems in this study; it is 
uncontrolled, treatments were not standardised, and some 
unknown proportion of the sample had pseudoepileptic 
seizures and not epilepsy. It is, however, most 
interesting to note in the light of Fenton's 
reccomendations (90) that treatment for pseudoepilepsy 
should take at least two years, that Williams achieved 
his results in only two sessions in some cases.
Other studies are better controlled, but are single case 
studies of highly selected patients and so 
generalisations about the potential application of the 
methods cannot be made. Standage (135), for example, 
presented the case of a 29 year old women with a seven
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year history of both complex partial seizures and tonic 
clonic seizures, occurring at a rate of one per month, 
and according to her own account triggered by "tension". 
Her EEG was consistent with a diagnosis of epilepsy, but 
she had also been liable to panic attacks when left alone 
and had experienced extreme anxiety at the thought of 
going out. Initially relaxation was promoted with 
Diazepam and then relaxation training was substituted for 
the drug. A standard imaginal desensitisation procedure 
was carried out in seven weekly sessions and at the same 
time graded practice in leaving the house was 
implemented. The patient had only two seizures in the 
following year. The use of Diazepam spoils the design of 
the experiment because it has anticonvulsant properties, 
but the fact that the improvement was maintained after 
the drug was withdrawn certainly suggests that anxiety 
was a seizure precipitating factor and that its 
elimination was responsible for the improvement.
Other single case studies have been carried out by 
Parrino (136), and Ince (137). Parrino brought about a 
reduction in seizure frequency from 58 per day to none 
for 5 months in a 36 year old male with a putative 
diagnosis of Creutzfeldt-Jakob's disease. The main 
treatment component was deep muscle relaxation and this 
was used specifically to help the patient cope with 
anxiety provoking situations. Ince used a combination of 
relaxation training and desensitisation to treat an
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anxious 12 year old boy with a combination of partial and 
generalised seizures. Again there was a striking 
reduction in seizure frequency - a fall from about 35 per 
week to none for 6 months after a 30 week treatment 
period.
Relaxation training has also been used in combibation 
with biofeedback by Cabral and Scott (118). The study is 
described in the previous section. Indeed it may be that 
relaxation and biofeedback are the same treatment. Lubar 
(117) suggests that relaxation enhances "idling" cerebral 
rhythms, such as SMR, and so may simply and cheaply 
achieve the same result as complex biofeedback 
programmes.
All the studies in this section, and indeed most of the 
single case studies in previous sections, can be faulted. 
Kraft and Poling (138) review all studies using any type 
of psychological treatment prior to 1982 and draw 
attention to the methodological problems. They point out 
that seizure frequency is always the main dependent 
variable, but that observational procedures are almost 
never adequately defined. Of the eleven studies examined 
only three employed an exprimental design adequate to 
demonstrate a functional relationship between treatment 
and changes in seizure frequency. They note that 
treatments are often poorly described and almost 
invariably cross the boundaries between theoretical
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models. They conclude that "more carefully controlled 
research is necessary to demonstrate the power and 
generality of such teatments".
Since 1982 a number of researchers have taken Kraft and 
Polings comments seriously and produced larger controlled 
experiments. All of these can be included in this section 
since they use either relaxation training or some other 
treatment aimed at the alleviation of psychological 
disturbance. Chronologically the first of these 
investigates the effect on seizure control of relaxation 
treatment of stress (139). Rousseau et al. had a small 
sample, 8 subjects, but used a sham treatment to control 
for placebo effect. All subjects had at least six 
seizures during a three week baseline and were then 
assigned to a sham treatment condition or to relaxation 
training for three weeks. After this the sham treatment 
group had three weeks of treatment. Both groups showed a 
very significant reduction in seizure frequency during 
treatment but one subject showed an improvement during 
sham treatment and a reversal during real treatment. 
Although this study suggests that relaxation training can 
bring about a reduction in seizure frequency the baseline 
may be too short to rule out absolutely chance cyclical 
variations. The lack of follow-up does not allow comment 
on treatment effect maintenance. However, unlike most 
earlier studies, the treatment method is properly 
described and clear cut, and there is control for
non-specific effects.
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The experimental design of Dahl et al. (140) improves on 
this; the baseline is longer (10 weeks) and there was a 
one year follow-up. Their subjects were 18 children, aged 
between 7 and 17 years, with refractory epilepsy, the 
treatment was composite, using contingency management, 
seizure interruption techniques and relaxation, and there 
was random allocation to "attention" control, and to no 
treatment control groups. The main dependent variable was 
the product of seizure frequency and seizure duration, 
termed "seizure index". Results showed a clear reduction 
in seizure index during treatment, maintained at 
follow-up and not reproduced by the attention control 
group. The authors conclude that their treatment 
programme may be effective for children with refractory 
epilepsy. The main limitations of this study are its 
small sample size (there were only six children in each 
group), and the composite nature of the treatment which 
prevents analysis of effective components. It must be 
imagined that when parents and teachers record seizure 
duration there must be considerable measurement error and 
possibly some bias. This factor may cast some doubt on 
the validity of the results.
Tan and Bruni (141) attempted to compare the 
effectiveness of a cognitive behavioural group therapy 
package with group supportive counselling. Their sample
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contained 30 adults attending a specialist epilepsy 
centre. The study was well controlled with random 
allocation to the two treatment groups and to a third 
waiting list control group. Outcome measure included a 
range of psychological and psychosocial self report 
scales and ratings as well as seizure frequency. Results 
were disappointing; no significant differences were found 
between the three groups on any of the outcome measures 
except for therapist's global rating of psychological 
adjustment. Both treatment groups improved significantly 
on this but the control group did not. Since the ratings 
were not blind this result is not encouraging. Possibly 
group therapy is not suitable for this population where 
there are large individual differences in both seizure 
variables and type of psychological difficulty.
The most recent study, at the time of writing, was 
carried out by Dahl et al. (142). This study is broadly
similar to the one carried out by the same authors in 
1985 (139), but in this case their subjects are 18 adults 
instead of children and they effectively increase the 
sample size by giving some subjects two treatment 
conditions in consecutive phases. They simplified their 
treatment package to two main components; relaxation and 
ability to identify high seizure risk situations so that 
relaxation training could be applied appropriately. 
"Seizure index" scores were rejected in favour of a 
simple seizure frequency count. Results showed a mean
improvement, of 66% during treatment which was maintained 
at 30 week follow-up. One suprising finding which the 
authors do not explain was an increase in seizure 
frequency of 68% in the group undergoing the "attention 
control" condition immediately after baseline. Although 
this study suggests that this type of treatment is 
promising, the authors point out that the sizes of the 
groups were minimal for statistical analysis, and that 
seizure frequency count is a rather limited outcome 
measure because it gives no indicaton of whether the 
patient is finding his seizures less troublesome, or if 
his level of psychological adjustment has improved. 
Although relaxation training is used invariably as a 
component of anxiety management programmes and although 
high seizure risk situations identified by Dahl's 
patients must provoke anxiety, the authors do not comment 
on possible relationships between anxiety levels and 
seizure precipitation.
At the end of this review it will be seen that the next 
logical step is to conduct a study using as large a 
sample as possible, prehaps more representative of the 
population of people with epilepsy as a whole. In most 
previous studies patients seem to be selected on the 
grounds that all else has failed.
All types of treatment discussed appear to have potential
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but with the exception of Williams et al. (134) little 
attention has been paid to the possibility that 
psychological distress may maintain a high seizure 
frequency and that treatments aimed at alleviating it may 
improve seizure control. Possibly the recent work using 
relaxation training achieves its good results indirectly 
by improving psychological state. Use of a wider range of 
outcome measures might elucidate this.
The content of Chapter 2 was intended to drive home the 
point that there is more to managing epilepsy than 
reducing seizure frequency. The research reviewed in this 
chapter, with very few exceptions (134, 141) has focused 
exclusively on seizure reduction, thus falling into the 
trap so succinctly described by Aird (Chapter 1 section
3), when he points out the limitations of this approach. 
Future research should not only attempt to measure pre 
and post treatment psychological disturbance but should 
evaluate treatments designed to alleviate it.
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CHAPTER 4
PRELIMINARY_STUDY_: .CHARACTERISTICS OF AN QUT-PATTENT 
POPULATION OF PEOPLE WITH EPILEPSY.
1. INTRODUCTION
2. AIMS
3. METHOD
4. RESULTS
5. SUMMARY AND CONCLUSIONS
1. INTRODUCTION.
The literature review justifies the conclusion that there 
is a need for further evaluation of psychological 
treatments of epilepsy but the studies reviewed are very 
diverse both in terms of the treatments employed and in 
terms of the type of patient treated. Before any detailed 
plan of a treatment study can be made the target 
population must be selected and enough information 
gathered about it to allow a rational selection of an 
appropriate treatment.
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The prevalence of epilepsy is estimated at 3 to 6 per 1000 
population (143). The vast majority of people with 
epilepsy live at home; some attend specialist clinics; 
some are managed by their general practitioner; and 
presumably there is some unknown proportion who do not 
receive any medical attention. Although there is a higher 
incidence of epilepsy among people in institutions, 
relatively few people are institutionalised because of 
their epilepsy.
It is not proposed to make any attempt to evaluate 
psychological treatments as an alternative to 
pharmacological treatments; we are not therefore 
interested in patients with epilepsy whose seizures are 
well controlled on anticonvulsant medication. It is likely 
that most poorly controlled patients will either be 
institutionalised or will be attending specialist clinics. 
One possible study would be to evaluate systematically the 
effect of psychological teatments in an institutional 
setting and another in an out-patient population. In the 
light of the relative numbers of patients, and of current 
trends away from institutional care towards community care 
it seemed more appropriate to attempt to improve 
out-patient management of epilepsy.
It cannot necessarily be assumed, however, that patients 
attending specialist clinics for the management of their 
epilepsy require any treatment additional to that which
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they receive as part of normal clinic routine. It may be 
that the combination of anticonvulsant medication and 
medical attention is sufficient to bring about a trend 
towards better seizure control in this population.
Patients in regular attendance at specialist neurology 
clinics will already be receiving psychological support 
and possibly specific advice about psychological problems. 
Before embarking on a treatment study it is necessary to 
find out if there is any need for additional standardised 
psychological intervention in the target population.
Some knowledge of the type of problems and disabilities 
and characteristics of this population would make 
treatment selection more rational and efficient. If, for 
example, it was shown that most poorly controlled patients 
tend to be dependent on a relative, then it may be 
possible to make use of this fact to design treatment 
programmes which could be administered by relatives. If 
many patients have significant psychological disorders 
potentially treatable by psychological methods then it 
would be worth evaluating the effect of such methods on 
seizure frequency. If knowledge of seizure provoking 
factors and the use of natural seizure avoiding strategies 
are common, then evaluation of the effect of these 
features on seizure control must form part of the study.
2. AIMS
2. AIMS
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The purpose of the preliminary study is to define and 
measure certain characteristics in the target population, 
as follows:
A. Measure seizure control.
i) Define "poor control" from the point of view of the 
clinician and of the patient. This will allow an 
operational definition for the purpose of subject 
selection in the subsequent treatment study.
If patients and clinicians are asked to rate seizure 
control, say on a three point scale from poor to good, 
then some measure of the severity of the disorder may be 
obtained. Severity and seizure frequency are not 
necessarily the same. Severity is a value judgement based 
on many factors probably differing in importance from 
individual to individual. Perceived control is a 
distillation of all these factors, unknown, guessed at and 
known. It may not be necessary to use both clinician and 
patient control ratings when selecting patients for the 
treatment study but it is worth establishing reliability 
by comparing ratings from two sources.
ii) Identify the proportion of patients attending 
neurology out-patient clinics whose seizures are poorly 
controlled in terms of the above definition.
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B. Establish some measure of chronicity.
If poor control tends to be a temporary state rapidly 
alleviated by a change in medication, then psychological 
treatments have little to offer.
C. Define and measure the incidence of any co-existing 
psychological problems.
If it is shown that poorly controlled patients have an 
increased incidence of psychological disorders treatable 
by psychological techniques then it would be worth 
evaluating a treatment based on these techniques. The 
evidence that such treatments may improve seizure control 
has been presented in the literature review. In a 
carefully designed experiment it may be possible to 
generate and test hypotheses about the direction of 
causality between seizure frequency and psychological 
disorder, although it is unlikely, given the complexity of 
the relationship, that any definite conclusions will be 
able to be drawn.
D. Measure the proportion of patients who know of 
environmental or psychological factors which tend to
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provoke seizures, and compare the incidence of these 
patients amongst those who are poorly controlled and those 
who are well controlled.
If it is shown that patients commonly know of seizure 
provoking factors, or can predict when they are going to 
have a seizure, it would suggest that it is possible to 
evaluate a treatment based on seizure interruption 
strategies.
If it is shown that poorly controlled patients know of 
seizure provoking factors less commonly than well 
controlled patients, this might be an indication that such 
knowledge is advantageous.
E. Measure compliance with anticonvulsant drug treatments.
Psychological intervention may be effective in some 
patients only because they respond to an increased amount 
of therapist time by increased compliance with drug 
treatments. It is therefore important to measure 
compliance before, during, and after psychological 
treatment.
F. Describe the demographic features of the population i.e 
age, sex, marital status, years since diagnosis, incidence
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of medical and psychiatric problems, employment status.
These factors are of secondary importance and are unlikely 
to be of specific relevance. However since there is so 
little published information about patients with poorly 
controlled seizures it is necessary to eliminate the 
possibility that these factors are related to seizure 
control. Some information of practical use for treatment 
planning may emerge. Even with these variables included 
there are still others left out, for example, genetic and 
family history, educational history and drug history. It 
was decided that these would be so unlikely to be of 
relevance to the subsequent treatment study, or that it 
would be so difficult to obtain accurate records relating 
to them, that it would not be cost-effective to collect 
information about them.
3. SUBJECTS.
Subjects were drawn from attenders at Neurology review 
clinics covering two geographical areas. All patients had, 
in the view of the neurologist who interviewed them as 
part of the normal clinic routine, a firm diagnosis of 
epilepsy. The number of cases interviewed was 160. The 
schedule was completed by 105 patients; the remaining 55 
were unable to supply all the required information. In 
some cases this was because a co—existing disability made 
sections of the interview irrelevant or inappropriate. In
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some cases this was because patients did not know the 
answers to questions relating to their seizure type or 
frequency. This may have introduced a degree of sample 
bias since subjects who could not describe their seizures 
and did not know the frequency might have a less severe 
disorder. Since the main purpose of this preliminary study 
is to see if a treatment study is feasible, this type of 
sample bias, if it exists, does not pose any particular 
problem.
N = 160
Complete data on 105 subjects.
4. METHOD
Data were collected by means of a standardised interview 
and questionnaires (see appendix A). These were 
administered to consecutive patients in neurology 
out-patient clinics if they had a firm diagnosis of 
epilepsy in the view of the neurologist who reviewed them. 
This diagnosis was made from a combination of EEG and 
clinical evidence. Then the following variables were used 
in data analysis to meet the requirements of the aims of 
the study listed above.
A. DEMOGRAPHIC VARIABLES
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A. DEMOGRAPHIC VARIABLES
i) Age.
ii) Sex.
iii) Marital Status, 
i v ) Emp1oyment.
This was assessed in terms of three categories:
1 = employed, 2 = unemployed for any reason 
except 3, 3 = lost job as a direct result of 
having epilepsy, 
v) Medical History.
Patients were asked to list medical problems 
other than epilepsy for which they had received 
specialist treatment during the past year.
B. CLINICAL VARIABLES
i) Seizure Type.
Where possible this was obtained from the case file. Five 
categories were identified:
1 = major generalised
2 = partial seizures
3 = combination of 1 and 2
4 = 'Absences'
5 = Unknown
ii) Frequency.
Almost all subjects with frequent seizures had 
kept a written record of them from a period
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varying from about a month to five years (one 
case). Patients with no written record were 
asked to estimate the average monthly 
frequency. A relative was asked to estimate 
seizure frequency independently. If agreement 
was obtained, and if this was consistent with 
reports in the case file, the estimate was 
accepted. If there was no such agreement the 
patient was asked to keep a written record over 
the next two months. It was not possible to 
obtain seizure frequency estimates by any of 
these methods for 9 out of the 160 subjects 
interviewed.
iii)s Control N'
The neurologist interviewing the patient rated 
seizure control on a three point scale:
1 = adequate
2 = inadequate but improved in last two months.
3 = inadequate
iv)'Control P*
As above but rated by the patient.
v) Chronicity.
Subjects rated as inadequately controlled were 
asked to estimate the number of months/years 
since they were well controlled. They were
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asked to estimate the number of changes in 
medication in the last six months. The number 
of clinic visits in the last six months was 
obtained from the records.
vi) "Years"
Number of years since diagnosis of epilepsy.
vii) "Warning"
A yes/no response to the question of whether 
the subject experiences an aura or "warning" 
that he is about to have a seizure.
vi i i)"Provocation"
A yes/no response to the question of whether or 
not the subject knows of anything which tends 
to provoke, trigger or bring on an attack. 
Subjects were also asked to list such factors.
ix) "Repression"
A yes/no response to the question of whether or 
not the subject can ever put off or avoid 
having a seizure.
C. MENTAL HEALTH
i) "GHQ 30"
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The 30 item General Health Questionnaire was 
administered. This was selected as the 
quickest, most reliable and valid measure of 
significant psychological disorder.
ii) "FSSI"
The Foulds Sign Symptom Inventory was 
administered to patients scoring above the 
criterion of 4 on the GHQ to enable some form 
of categorisation of psychological disorder. 
This scale was selected because it contains 
groups of questions designed to identify 
psychotic symptoms not included in the GHQ.
5. RESULTS
FREQUENCY AND CONTROL (AIM A. )
Figure 1. shows the distribution of seizure frequency per 
month over the sample of 151 patients from whom it was 
possible to get an acceptably accurate estimate, (see 
variable B ii). Fifty per cent of the sample had 5 or 
fewer seizures per month and the rest had from 5 to 160 
seizures per month. The curve approximates to a Poisson 
rather than a Normal distribution, so that the lower the 
seizure frequency the larger the proportion of individuals 
suffering from that frequency.
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[ NOTE — Five patients had 50 or more seizures per month 
and these were excluded from further statistical analysis 
because of the unacceptable skew they imposed on the 
distribution. These 5 patients were similar in that they 
all suffered from very frequent ' absences’ or ’petit mal' 
seizures. They were rated as poorly controlled but because 
their seizures were so brief and slight they did not 
appear greatly handicapped on any of the other measures. ]
Table 1 shows the proportion of subjects in each of the 
three categories of control as rated by the neurologist 
(see variable B iii above), and the mean monthly seizure 
frequency in each of the categories.
Table 1
Neurologist J s Seizure Control Rating (Control *N M .
11
11
1
Adequate
2
Improving
3
Inadequate
1 N 42 39 65
1
i Percentage 28.8 26. 7 46. 1
1
!Mean Seiz.Freq. 
1 per month.
i
4. 23 7. 61 20. 53
Table 2 shows the proportion of subjects in each of the 
three categories of control as rated by the patient
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himself (see variable B iv above), and the mean monthly 
seizure frequency in each of the categories.
Table_2L_
_£atientls_Rating_of_Seizure_Control ( Control -'PM.
11
11
1
1
Adequate
2
Improving
3
Inadequate
: n
i
63 29 56
i
J Percentage
i
43.2 19. 9 38. 3
i
[Mean Seiz.freq. 
! per month.
ii
3.91 3. 14 25. 10
A chi-squared test comparing categorisation by the 
neurologist with categorisation by the patient gives a 
of 8.82, significant at the 2.5% level, thus demonstrating 
that the two measures are differently distributed.
T-tests comparing the mean seizure frequency in 
neurologist's categories with the mean seizure frequency 
in patient's categories, showed no significant 
differences.
It will be seen that either there is a very large amount 
of error in the Control measures or that patients and 
neurologists take factors other than absolute seizure 
frequency into consideration when rating control. Possibly 
neurologists and patients give different emphasis to the
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various factors involved in making a control rating, but 
the result is that some patients believe themeselves to be 
adequately controlled when the clinician reviewing them 
does not. This serves to show the subjective nature of 
seizure control assessment, and that it does not depend 
simply on a frequency count.
CHRONICITY (Aim B.)
Fifty one patients were classified as poorly controlled by 
both the clinician and by their own rating. Amongst 28 of 
these the mean time since control had last been adequate 
wsa 2.1 years with a range of 8 months to 10 years. The 
remaining 23 patients said that control had never been 
adequate since they first began to have seizures.
The number of changes in anticonvulsant drug in the 
previous six months amongst the 51 poorly controlled 
patients ranged from of 0 to 4.
The mean number of changes in dosage was 5.3 with a range 
of 0 to 10. The upper limit of this range is rather 
approximate because most patients who had had more than 2 
or 3 changes in dosage were unsure as to how many. Case 
records were not helpful because some changes had been 
instituted by the patient's G.P.
The mean number of times poorly controlled patients had
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been reviewed during the previous six months was 2.1 with 
a range of 0 to 8.
Twenty patients had had no change in medication and had 
not been reviewed during the previous six months.
There are a number of implications from these data 
concerning frequency, control and chronicity for the 
proposed treatment study:
1) It will be possible to obtain a sufficiently large 
number of subjects who have seizures frequently enough to 
make treatment evaluation possible over a matter of months 
rather than years.
2) There is a large enough sample of patients with high 
seizure frequency who are rated as poorly controlled.
3) Control ratings and seizure frequency appear to measure 
different aspects of control. A measure of frequency and a 
control rating should be used in selecting patients for 
the treatment study.
4) Poor control appears to be a relatively stable state. 
These data tend to support the suggestion in the 
literature that there is a distinct sub-group of patients
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for whom conventional treatment is not effective.
5) Changes in medication in this population are not 
infrequent and the effect of this will have to taken into 
consideration in an evaluation of the impact of 
psychological treatments. However should this prove to be 
too complex there would probably be enough patients whose 
medication would not be changed during the course of the 
study to allow the exclusion of those whose medication was 
changed.
The importance of these implications is apparent; the 
treatment study would be less tenable if, for example, 
seizure frequencies were so low that the study would have 
to take place over a period of time which was longer than 
the average period during which seizures stayed poorly 
controlled without psychological treatment. It is 
essential that control should be rated as poor, as well as 
that seizure frequency should be 'high'". 'High* is an 
arbitrary term. A patient with 20 seizures per month who 
rates his control as adequate and whose neurologist agrees 
with him, does not require intervention. A patient with 10 
seizures per month may be considered very poorly 
controlled and be a good candidate for treatment.
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PSYCHOLOG ICAL MORBIDITY (Aim C.)
The measure of 'psychological morbidity' in this part of 
the study is the GHQ 30. This measure is not an aid to 
diagnosis of the specific psychological problem, but is an 
indicator of severity. As a research tool it is ideal for 
the present purpose which is simply to identify 
psychological morbidity in the target population.
Mean GHQ score was 6.81 with a range of 25 and standard 
deviation of 6 .52.
When using the GHQ 30, a score greater than or equal to 4 
is generally taken as an indicator of significant 
psychopathology. In this sample (N = 105) 56.6% scored 
above the cut-off point. In Goldberg's sample of 4067 
primary care attenders 38.8% scored above the cut off 
point. It would appear that compared to Goldberg's sample 
this sample experiences significantly more symptoms of 
anxiety and depression. However such a comparison is not 
really possible because certain items in the GHQ confound 
the feelings associated with seizures with those 
associated with anxiety. Thus the GHQ score may be 
slightly artificially raised. Comparisons within the 
sample might also be affected by this problem, an 
individual with an improving seizure frequency could score 
lower on the GHQ simply because he has less somatic 
disturbance with the decrease in seizures. The effect of
this artefact would, be small and does not invalidate use 
of the GHQ but it should be borne in mind to add a degree 
of caution to any conclusions drawn.
The Foulds Sign Symptom Inventory was administered to give 
some indication of diagnostic type in terms of 
psychological disorder. It was administered to the first 
20 consecutive patients and then to patients who scored 
above the cut-off point on the GHQ. Among the first 20, 12
scored below the GHQ cut-off. Of these, 7 checked no items 
at all on the FSSI and the remainder not more than 2 
items. Of the 80 who completed the FSSI only 5 patients 
checked more than 2 items on the 'psychotic' scales. The 
rest all checked at least 3 items on scale A (anxiety) and 
scale B (neurotic depression). The high correspondence of 
significant GHQ score with the A and B sections of the 
FSSI supports current thinking that anxiety and depression 
form a significant part of the psychopathology measured by 
the GHQ.
The nnrrftTfltinn nnefficient (Pearsonls rj bet we en___jGHQ_l
and ' seizure frequency' is 0. 34 with p _<_Q^.0QQ1^-
Thus in statistical terms there is a very highly 
significant relationship between psychopathology and 
seizure frequency. The clinical significance of this 
relationship is less impressive. Even if we assume that 
there is no measurement error and that there is a direct
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causal relationship between GHQ and seizure frequency 
thus:
GHQ score — > seizure frequency
then the best that a total zeroing of GHQ could achieve 
would be an 11.8% reduction in seizure frequency. It must 
also be borne in mind that since GHQ is not an interval 
scale a Pearson's correlation is not a precise measure. It 
may fail to identify distinct sub-groups. However the plot 
of GHQ against seizure frequency from which the 
^^correlation was calculated showed a relationship which, 
allowing for wide scatter, was approximately linear with 
no clusters at either end of the scale. Thus it may be 
assumed that there are no identifiable sub-groups.
The implications of an examination of psychological 
morbidity in this population are:
1) that there is significant psychopathology in this 
population,
2) that allowing for the limitations of the FSSI the 
psychopathology is non-psychotic and may be amenable to 
psychological treatment,
3) that treatment of psychopathology could not cause more
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than an 11.8% reduction in seizure frequency; indeed since 
this estimate is based on two rather gross assumptions the 
actual effect is likely to be far less.
"AURAS", "TRIGGERS' AND SELF-CONTROL (Aim D. )
Table 3 shows the proportion of subjects who experience 
some warning or ’aura' before a seizure, the proportion 
knowing of some psychological or environmental factor 
tending to provoke seizures and the proportion who feel 
that they can exert some self-control over seizures.
Table_3^
Proportions of Subjects Experiencing Seizure Related
Phenomena.
1
1
1
YES NO !
i
! AURAS
i
i
i
N = 6 6  
% = 62.9
N = 39 ! 
% = 37.1 !
i
! TRIGGERS
i
i
N = 69 
% - 65.7
CO
CD 
^
 
CO 
CO
II 
II
2 
«
111
! SELF-CONTROL
i
i
i
N = 16
% = 15.2
CO
05 
00 
00
II 
II
2
111
Of the 66 patients aware of J auras' 41 also claimed to 
know of provocatice factors, or "triggers’.
Of the 69 patients who claimed to know of factors 
triggering seizures 54 named "anxiety", "tension" or 
"worry". Other factors, with one or two unique exceptions,
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were excitement or rage, or were related to the menstrual 
cycle, sleep patterns or diet.
T- tests showed no significant differences in seizure 
frequency between the subjects experiencing these factors 
and those who do not.
It would appear then, that knowledge of provocative 
factors, presence of auras and belief in one's ability to 
exert some control over seizures confer no special 
advantages. However none of these patients had ever had 
any instruction concerning the use of these factors in 
^interruption strategies and the apparent lack of advantage 
should not deter systematic investigation of such 
strategies. It is promising that the most commonly 
encountered provocative factors are manipulable by 
psychological means.
COMPLIANCE (Aim E)
Sixty five patients claimed that they always took their 
took their medication exactly as prescribed. Twenty seven 
said that they occasionally missed a dose, nine said that 
they frequently forgot their medication and the remaining 
four said that they deliberately took less than the 
prescribed dose. An examination of the case records showed 
that eleven patients had drug levels below the therapeutic 
range when last tested.
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It will be beyond the scope of this study to monitor drug 
levels at regular intervals during psychological treatment 
and follow up. Some control over this problem may be 
achieved by excluding patients with a history of poor 
compliance and/or by giving patients firm advice to comply 
with medication well before the start of treatment, so 
that any improvement achieved by this can be measured 
independently from other treatment effects.
DEMOGRAPHIC VARIABLES (Aim F.)
,„^ GE Mean 33.01 yrs. Range 16
YEARS SINCE Mean 17.66 yrs. Range 0 
DIAGNOSIS
Sample contained 51 males and 54 females.
50 were married, 52 single and 3 divorced.
There was no significant correlation between Age or Years 
since diagnosis and seizure frequency.
T - tests showed that neither age nor sex is related to 
seizure frequency. It may be concluded that there will be 
no particular demographic sampling bias when selecting 
poorly controlled patients for the treatment study.
Age at onset might have been a more significant measure
- 62 S.D. 12.58
- 57 S.D. 12.35
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than years since diagnosis and patients were asked to give 
this (see Appendix). However such a large proportion of 
patients thought that they might possibly have been 
experiencing seizures for some years before diagnosis that 
this measure was rejected in favour of years since 
diagnosis since the latter was more certain.
SEIZURE TYPE 1. Major Generalised
2. Partial
3. Combination of 1 i
4. Absences 
. 5. Unknown
N = 14 13. 3%
N = 44 41. 9%
N = 26
CM 8%
N = 12 11. 4%
N = 9 8. 6%
Seizure type is biased towards categories 2 and 3 relative 
to estimates of seizure type in the general population. 
Category 2 includes all types of partial seizure and 
category 3, mixed partial and generalised. The bias will 
be due to the fact that partial seizures tend to be more 
difficult to control and thus patients suffering from them 
are more likely to be attending specialist clinics. This 
bias might have some implication for treatment selection - 
there is more prospect of using interruption strategies 
with patients suffering from partial seizures than with 
those suffering from generalised seizures because the 
former may experience auras.
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EMPLOYMENT
1. Employed 2. Unemployed 3. Unemployed as
a result of epilepsy. 
N = 34 N = 35 N = 36
32.4% 33.3% 34.3%
Unemployment rate is higher than in the general population 
(categories 2 and 3). An attempt was made to ascertain the 
importance of this factor by further analysis of the 
relationship between employment and seizure frequency. GHQ 
-was, included in the analysis because it is likely that 
unemployment may influence score on this measure; it has 
already been observed that a relationship exists between 
GHQ and seizure frequency.
Table 4
Relationship between Employment, GHQ and Seizure
Frequency.
_ _ _ _________________ ^
! |EMPLOYED! UNEMPLOYED iRESULT OF EPILEPSY!
i___________________________ i______________ t_____________________ i_________________________________ {
! Mean GHQ ! 4.47 j 5.29 ! 10.50 !
i  i _ _i_____________________ i__________________________________<
i--------------------------- 1-------------- 1------------  i •
'Mean Seiz.Freq. i 15.59 ! 8.43 ! 13.33 !
! per month. ! ! ! I
F = 6.50 (d.f. 2, 104) P < 0.01 
F = 4.34 (d.f. 2,104) P < 0.01
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Ex am in at ion of cell means shows that patients in category 
3, those who have lost their jobs as a result of their 
epilepsy, are very much more psychologicaly disturbed (in 
terms of the GHQ) than those in the other two categories. 
Yet employed patients have slightly more seizures per 
month than those who have lost their jobs. The 
sociological implication is that actual frequency of 
seizures has nothing to do with ability to hold down a 
job. There is also an important implication for the 
treatment study. If the high GHQ score is the result of 
becoming unemployed then psychological techniques may not 
_Jxave much to offer in terms of reducing GHQ score. If 
patients are more likely to become unemployed if they are 
suffering from the type of psychological distress which 
leads to high GHQ scores then alleviating this might 
increase the probability of gaining employment.
MEDICAL AND PSYCHIATRIC MORBIDITY.
Twenty-three out of 160 patients had a medical disability 
in addition to their epilepsy which made it impossible for 
them to complete the interview and questionnaire 
schedules. In some cases this was a direct effect of the 
condition as in the case of blindness or mental handicap. 
In other cases their condition made interpretation of 
results impossible. Examples are a patient with a very 
high score on the GHQ who was concerned about his recently 
diagnosed Parkinson’s disease and a patient with poorly
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control led diabetes who could not distinguish seizures 
from hypoglycaemic attacks. It was decided that such 
patients should be excluded from the treatment study 
because of the risk of extraneous factors confounding 
outcome evaluation.
Eleven patients out of 160 were undergoing psychiatric 
treatment, 3 of these had significant scores on the FSSI 
'psychotic' scales and so did 2 others not attending a 
psychiatrist. Eight of these 13 were classified as poorly 
controlled by themselves and by the neurologist who 
reviewed them. It was decided to exclude patients who were 
undergoing psychiatric treatment; there are too few of 
them to allow them to -be studied as an identifiable 
sub-group, but enough of them to confound results when 
evaluating psychological treatments which might have some 
overlap with psychiatric treatment.
5. SUMMARY AND CONCLUSIONS
The field study has demonstrated that in the target 
population — attenders at neurology out-patient clinics - 
there is a sufficiently high proportion of patients with 
chronically poorly controlled seizures to make a treatment
study methodologically possible and worthwhile.
An examination of some of the characteristics of this
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population has shown that about half of them have 
significant scores on the GHQ 30. The implication of this 
is that many might benefit from psychological treatments 
of anxiety and depression. There is a significant 
relationship between GHQ score and seizure frequency but 
it is too small to offer much hope that treating anxiety 
and depression will have much impact on seizure control.
About two thirds of the sample experience some warning of 
a seizure and about two thirds know of factors tending to 
'trigger" seizures. This indicates that it will be 
possible to evaluate methods which rely on these factors, 
but the fact that they are equally distributed across the 
range of seizure frequency suggests that they carry no 
natural advantage for seizure control.
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1. TREATMENT SELECTION.
A review of the literature shows that there is quite a 
variety of possible treatments which can loosely be termed 
'psychological'. There is sufficient evidence that 
psychological intervention can be effective in seizure 
reduction for this to be undisputed. Whal: is less certain 
is how wide is the application of these methods.
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Systematic comparison of treatments has not been carried, 
out and so potentially any one or any combination of 
several might be an equally good choice. The preliminary 
study has given some further indication of what would be 
appropriate and practically possible in an out-patient 
population.
Theoretical Considerations.
One treatment which is promising in terms of its potential 
for an out patient adult population is one which teaches 
subjects to avoid seizures or to interrupt or abort them. 
The preliminary study shows that 62.9% of patients 
experience an 'aura' or some warning of an attack; that 
rather fewer (15.2%) think that they can sometimes 
suppress seizures; and that 65.7% think that they know of 
some factor or factors which provoke seizures. In the 
preliminary study sample the presence of these factors 
does not necessarily lead to better seizure control.(see 
section on results of preliminary study) It is 
hypothesised, however, that these factors might form a 
potential natural resource. It is only a minority of 
patients who believe that they can exert some control over 
their attacks and none in the sample used for the 
preliminary study had ever tried to make use of these 
factors in a systematic way. Some exhibited almost 
superstitious behaviour in attempts to avoid seizures but
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these attempts tended to be short lived and not logically 
organised. A treatment which uses the techniques of 
behavioural analysis to identify factors which provoke 
seizures, and evaluates various interruption strategies in 
a systematic, experimentally based way might be able to 
make use of this "natural resource".
During pilot experiments with psychological methods it was 
observed that some patients who do not spontaneously 
report seizure warnings or triggers may develop them or 
become aware of them with psychological intervention. 
J^uras' are part of the seizure itself, and may be 
sometimes very short, but in pilot experiments some 
patients reported that auras became longer with attempts 
to interrupt them. These observations suggest that it is 
worth trying interruption and avoidance strategies with 
all patients.
Results of the preliminary study show that a large 
proportion of the target population is suffering from 
significant psychological distress, usually in the form of 
anxiety and depression. Most patients believe that stress 
or anxiety increases their seizure frequency. There is a 
significant correlation between seizure frequency and GHQ 
score in the target population. The problem of 
establishing causality has been discussed in a previous 
section, and it was noted that the shared variance between 
seizure frequency and GHQ was only 11%, but treatments
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aimed at reducing anxiety and depression are obviously 
desirable for two reasons. Firstly patients will benefit 
from reduction in psychological symptomatology even 
without improved seizure control, and secondly if the 
result of treatment is improved seizure control, then we 
have sound experimental evidence that anxiety can have an 
adverse effect on seizure control, even though that effect 
may be small.
During data collection for the preliminary study it was 
observed that a large proportion of patients over the 
whole range of control felt that they had been given 
inadequate information about the nature of epilepsy. It is 
possible, although no actual evidence is available to 
support the notion, that education and the dispelling of 
certain misconceptions about the nature of the disorder, 
(e.g. that it leads to inevitable deterioration) might 
have a therapeutic effect.
Practical Considerations.
Information from the preliminary study indicated a number 
of practical considerations which should be taken into 
account in treatment selection. Most people with epilepsy 
live at home; and some never attend specialist clinics.
The ones that do so are likely to be patients with the 
more difficult problem, either because there is some other
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complieating factor, or because their seizures have proved 
difficult to control. It is this latter group which is the 
prime target of this study. Since they are an out-patient 
group, out-patient treatments will be the cheapest and 
most practical. Thus treatments should be to a large 
extent self-administered to reduce numbers of treatment 
sessions, and viable with or without the support of a 
relative. Intensive behavioural modification programmes or 
biofeedback programmes are therefore not a practical 
option.
— iT-fere number of attendances should be as few as possible, 
because firstly, as shown in the preliminary study, a 
proportion of patients are working and their work 
situation may be already rather precarious; secondly some 
can only leave the house if accompanied by a relative, and 
thirdly the geographical area covered by specialist 
clinics is large and so some patients in the target 
population will have to travel considerable distances.
The preliminary study revealed that the number of patients 
who might potentially benefit from treatment is large. If 
tx-eatment methods are kept as simple as possible then once 
evaluated they need not necessarily be administered by 
clinical psychologists. It may be possible simply to 
standardise advice, information and instructions which are 
already given as part of routine clinic practice so that 
no extra input would be required. Diversification of
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therapists would allow larger numbers of patients to be 
offered ’psychological' intervention. The disadvantage of 
minimal intervention out-patient treatments is , of 
course, that they rely heavily on patient motivation and 
belief in the techniques suggested. If the treatment 
appears bizarre, or if the patient has a long history of 
expectation of a pharmacological "cure" then maintaining 
compliance will require considerable expertise on the part 
of the therapist. Where the success of a treatment stands 
or falls on the therapist’s ability to sell it, there is a 
risk that success rate will diminish with diversification 
_of therapists. Future research should examine the 
effectiveness of treatments when carried out by a range of 
therapists from different professional backgrounds, but at 
the present time the aim is only to evaluate effectiveness 
of treatments administered by one psychologist. The 
disadvantage is that it will be difficult to control for 
so called "therapist variables." Treatment success, if 
there is success, may be dependent on some unmeasurable 
selling ability of the therapist carrying out the present 
study.
The main practical considerations, therefore, are that 
treatments should be simple, relatively short, and consist 
essentially of information and techniques that patients 
can learn and apply for themselves.
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2. TREATMENT PROCEDURE
In the light of the above considerations the following two 
treatments were employed in the study, each being 
independent of the other. Three blind raters observed a 
total of ten treatment sessions between them and 
identified correctly which treatment was being used in 
each case.
Treatment A: Education. Avoidance and Interruption.
This treatment required a detailed account from the 
patient, and where possible a relative, of any 
physiological or environmental factor which he/she thought 
might provoke seizures, either immediately and directly, 
or indirectly. The most commonly mentioned factors were 
tiredness, lack of sleep, too much sleep, alcohol abuse, 
hunger and hot rooms. Most patients also mentioned 
psychological factors at this stage, but great care was 
taken not to comment on, or to allow discussion about 
these. Instead a practical discussion was held which dealt 
with changes in life style which would enable the patient 
to avoid these physiological or environmental provocative 
factors.
The patient and someone who had observed some of the 
patient's typical seizures were asked to provide a
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description of them, with particular emphasis on 
sensations and movements in the initial stages of the 
attack. The patient was then advised to try to carry out 
some activity counter to the normal initial stages of the 
attack. If patients had tried this sort of strategy 
before, they were encouraged to make a further more 
systematic attempt, as described below. Many patients felt 
that their previous efforts had been "silly" because they 
tended to believe that seizures were something which "just 
happened". They were discouraged from this view and were 
given examples of patients in whom such techniques had 
been successful. The nature of epilepsy and seizure 
proneness was explained to them. Patients were encouraged 
to ask questions and these were answered factually.
In the case of seizures beginning with some limb or body 
movement, the patient was advised to prevent or to counter 
this movement.
In the case of seizures beginning with a hallucinatory 
sensation the patient was advised to "flood" the relevant 
sensory system with some real stimulus. Olfactory 
hallucinations, for example, can sometimes be countered by 
sniffing some strong perfume.
In the case of seizures beginning with some forced thought 
pattern the patient was advised to impose some 
semi-automatic cognitive activity, such as counting in
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threes or reciting poetry.
In the case of seizures beginning with an epigastric 
sensation, or some undescribable "funny feeling", the 
patient was advised to take in a deep breath and let the 
air out very slowly, relaxing as much as possible.
Relatives were asked to remind the patient about the 
proposed strategy, particularly when they observed that 
the patient was about to have a seizure. If it was clear 
by the next treatment session that the strategy was not 
jworking then some modification was suggested.
It will be observed that Treatment A. is essentially three 
treatments, one educational; one concerned with avoidance 
of provocative factors; and one with interruption 
strategies. The disadvantage of this is that it will be 
impossible to evaluate the three aspects independently.
The advantage is that it will allow random allocation of 
patients to Treatment A without consideration of the form 
of their epilepsy. The field study showed that some 
patients with poorly controlled seizures know of no 
provocative factors, and that some have absolutely no 
warning of an attack. All treatment aspects have one 
essential feature in common; they encourage the patient to 
have a sense of self control over his seizures. They cease 
to be ' something which happens to me', and become 
'something which I do'. Treatment A, if seen in this
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light, can be evaluated as a discrete treatment. If 
effective, then evaluation of the component parts can be 
carried out.
Treatment B: Alleviation of Psychological Disorder.
This treatment required a detailed account of the 
psychological and practical problems in the patient's life 
at the time of interview. The preliminary study showed the 
high incidence of symptoms of anxiety and depression. It 
_ y,jas also observed that problems generally fell into three 
categories. Firstly anxiety about leaving a safe place or 
being in company, secondly depression due to loss of 
sucial functioning, and thirdly stress within the family 
as a result of disagreement about how much independence 
the patient should have.
Anxiety.
In the case of phobic-like anxiety, Treatment B sessions 
were used to give advice about anxiety management through 
graded exposure. This was appropriate in 27 of the 40 
patients who were given Treatment B. All these patients 
were fearful about the probability of having a seizure in 
a public place, and they had a history of avoidance of 
specific places where they had had a seizure in the past. 
In all cases there was a tendency to over-rate greatly the
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probabi 1 ity of having a seizure, and evidence "that the 
fear of one place had generalised to include other similar 
places. There was a wide range in degree of disability 
caused by this phenomenon, varying from being completely 
housebound to needing to be accompanied in certain places 
only, such as supermarkets and buses.
It was pointed out to patients that they were 
overestimating the probability of having a seizure. All 
patients agreed that they were probably more handicapped 
than they needed to be as a result of their epilepsy. All 
patients agreed that even if they did have a seizure in a 
public place the consequences were not so dangerous or so 
unpleasant as to make it not worth attempting to overcome 
their fear. Although there was no discussion of any aspect 
of the patient's epilepsy in this treatment, targets were 
based on what would be reasonable and safe for that 
patient to achieve.
Treatment was based on four steps in all cases.
i) Identification of panic symptoms and explanations about 
the physiological and psychological nature of anxiety.
ii) Construction of a hierarchy graded from the least 
feared situation to the most feared.
iii) Setting of targets so that exposure to each of the 
feared situations should take place and progress be
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maintained up the hierarchy.
iv) Evaluation of progress and repetition of previous 
explanations and instructions were given at each session 
after the first.
Depression
All 40 patients given Treatment B complained of at least 
some symptoms of depression, such as tearfulness and 
feeling that life was not worth living. Some patients had 
some biological symptoms, such as sleep and appetite 
disturbance. No patient was severely clinically depressed 
at the time of initial assessment. The main cause 
identified for feelings of worthlessness, helplessness and 
sadness was loss of some aspect of social functioning. In 
many cases this was secondary to the kind of anxiety 
problem described above. In other cases it was due to job 
loss or loss of some activity such as driving. Many people 
felt that they were totally isolated by their epilepsy.
Treatment was based on 3 steps in all cases.
i) Re-evaluating permanently lost functions to make them 
appear less important.
ii) Re-assessing the probability of regaining some 
functions.
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iii) Finding new sources of reinforcement. Information was 
given about Employment Rehabilitation Centres and the 
Epilepsy Association of Scotland (In the latter case 
patients were deterred from making contact until the end 
of the treatment study. The E.A.S gives information which 
duplicates that used in Treatment A. and which would 
interfere with treatment evaluation. )
"Contract" Therapy
-^fsxents or spouses of patients were interviewed as part of 
assessment procedure unless the patient lived alone. 
Disagreement about the management of the patient’s 
problems and disabilities was very common. It is possible 
to categorise this disagreement in two directions; one 
where the patient felt that he should more independent and 
that he was over-protected and "suffocated", and the other 
where the relative felt that the patient was too dependent 
and inactive. Treatment was based on simple contract 
therapy aimed at increasing the level of patient/relative 
agreement and communication.
There were 3 steps.
i) The relative and patient independently and with the 
help of the therapist made a list of activities which the 
patient should perform independently, activities with 
which he required supervision or help and activities which
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he should not do at all. An example of a typical pair of 
lists is given in the appendix.
ii) The two lists were compared and bargaining undertaken 
under the guidance of the therapist to obtain 
reconciliation on as many points as possible. This 
resulted in a 'contract' containing a list of agreed 
activities and the circumstances under which they should 
be performed, (see appendix B for example) Both parties 
were advised not to discuss or argue over the remaining 
irreconcilable points.
iii) In each subsequent session both parties were 
congratulated on those aspects of the contract that they 
had been able to keep and further discussion and advice 
given about the remainder.
It will be observed that Treatment B, like Treatment A, 
has multiple elements. It is not, as might appear, three 
separate treatments because the majority of patients 
required two or more of the above procedures. They were 
administered concurrently so that each patient had the 
same amount of therapist time. It would be theoretically 
possible to construct three groups of patients each 
requiring only one of the above sub—treatments. This would 
require a much larger sample, because it is rare to find a 
patient whose psychological problems are sufficiently
-99-
clear-cut for one and one only of the above to be 
appropriate. Since it is rare there would not be much 
advantage in evaluating each procedure separately. The 
point here is to provide a general procedure which will 
cover almost all problems and with a central common 
feature of identifying the cause or causes of 
psychological distress and applying a problem solving 
approach to it.
.JL. PATIENT SELECTION.
It has already been stated that the target population for 
this study is patients with epilepsy attending specialist 
out-patient clinics. Since the aim is to evaluate 
treatments with a potentially wide application then 
patient selection criteria should be kept as minimal as 
possible. The following were considered the minimum 
possible to make the study practicable and to avoid 
confounding effects.
Methodological Considerations.
There must be evidence that seizure frequency is 
relatively constant so that 1 improvement’ can not be 
accounted for solely in terms of natural fluctuation.
There can be no change in drug treatment during any stage 
of baseline or treatment. Drug or drug dosage changes 
during follow—up may be tolerated provided that there is 
no change in seizure frequency for three weeks subsequent 
to the change. Patients whose seizure frequency changes 
during follow-up, after manipulation of anticonvulsant 
drugs must either be excluded, or data used only up until 
the time of that manipulation.
•Practical Considerations.
Patients must agree that their seizure control is poor. If 
they are happy with their degree of control then treatment 
which relies on self-motivation is not a practical option.
Patients must have at least two seizures per week at the 
start of treatment otherwise the follow-up period required 
to evaluate treatment effect would need to be 
impracticably long.
Patients must have adequate cognitive ability to benefit 
from the treatments in question. They must be able to 
express themselves well enough for the therapist to gather 
the necessary information and they must be able to 
comprehend instructions. It is essential that they should 
be able to keep accurate records of seizure frequency.
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Patients should be complying with drug therapy before and 
during the study. Frequent serum concentration monitoring 
during the study is not a practical option, but 
anticonvulsant blood levels should be shown to be within 
the therapeutic range before baseline.
4. EXPERIMENTAL DESIGN
There are two possible experimental designs which can be 
— used, to evaluate treatment effects. In one, subjects are 
allocated randomly to either a treatment condition or to a 
'control' condition for a period of time. At the end of 
this time the two groups are compared. In the case of the 
alternative design, there is a baseline phase, a treatment 
phase and a follow-up phase, each with sufficient 
observation points for statistical analysis, and pre- and 
post- treatment comparisons are made. In the first a 
'between subjects' comparison is made, and in the second a 
'within subjects' comparison is made. The second type of 
design has five distinct advantages over the first.
i) It eliminates the between subjects variance caused by 
having two independent samples, one for a control group 
and one for a treatment group. If the samples are matched, 
then such variance is minimised, but a 'within subjects 
design ensures that there is no error due to individual
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differences because the 'control' group becomes the 
treatment group after baseline.
ii) A baseline must be long enough to ensure that it is 
stationary but it does not have to be as long as the 
treatment part of the experiment. Data from a control 
group would have to be collected over a period as long as 
treatment. By shortening the length of time during which 
control information is collected, error variance due to 
chance interventions is reduced.
— i-'iri) A "no treatment" control group in this study would 
have to keep an accurate weekly seizure record for the 
same length of time as the treatment and follow-up phases 
were taking place in the other group (i.e. 36 weeks). A 
proportion would certainly fail to do this unless frequent 
encouragement was given. If a proportion "drops out" of 
the control group not only would more subjects be 
required, but also results become rather difficult to 
interpret. If, on the other hand, frequent encouragement 
to keep records is given, the "no treatment group becomes 
much less a "no treatment" group than treated patients 
during baseline.
iv) It would be very difficult to ask a psychologically 
distressed patient with poor seizure control to co-operate 
with an experiment for 36 weeks without offering any 
treatment. It would be impossible to ask such a patient
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not to seek any other kind of psychological counselling 
from G.Ps, social workers or other agency during that 
period. Many treatment studies use a "waiting list" 
control group to overcome this problem. In order to ensure 
that enough patients have enough seizures to make 
treatment evaluation possible, this study will have to run 
for several months. Several months is too long for a 
waiting list in this group of patients.
v) Using the same patients as a baseline "control" group 
and then as a treatment group is very economical in terms 
-of numbers of subjects required.
Treatments should be totally independent of each other. 
They should be administered either to two independent 
matched samples or to the same sample over two separate 
time periods. Normally, in the latter case, a wash-out 
period would be allowed, but these treatments are 
educational and cannot be unlearned.
It was decided to adopt a 'within subjects’ design, 
bearing in mind the following points in determining its 
precise form.
i) It is intended that the overall effectivenes should be 
measured, and that the relative effectiveness of each 
treatment should be compared.
ii) Any subject with significant psychological disorder
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could in theory benefit from both treatments. Therefore 
the combined effectiveness should be evaluated.
iii) Subjects without significant psychological disorder 
cannot benefit from Treatment B.
Figure 2. shows the experimental design which, in the view 
of the author, is the most economical in terms of size of 
sample and therapist time, the most productive in terms of 
information gained; and which obeys all the above 
principles. In essence it is a cross-over design. Patients 
will be selected consecutively from the parent population 
and those with psychological disorder randomly allocated 
to Group 2 or 3.
5. OUTCOME MEASURES
i) Seizure Variables
WSR. The primary purpose of this treatment experiment
is to measure the effect of certain psychological 
treatments on seizure frequency. The main dependent 
variable, therefore, is weekly seizure rate (WSR). 
Subjects were given daily diary forms and filled in the 
times at which their seizures occurred. The forms were 
collected at each visit and a weekly count made.
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Seizure_Durati o n Patients’ relatives were asked to 
record seizure duration, but this proved too inaccurate 
for use as an outcome measure. Most relatives simply 
estimated time and frequently there was disagreement 
between two observers. In many cases the exact beginning 
and end of seizures could not be determined due to ’auras’ 
or periods of post-ictal confusion. It would be impossible 
for patients with no relatives to record seizure duration.
Control Ratings. Patients were asked to rate the
'•rcontrol of their epilepsy on a three point scale, as in 
the field study. Only patients who rated their control as 
poor were included in the treatment study. Control ratings 
were also used as an outcome measure. At the end of 
follow-up patients were asked to rate control of their 
epilepsy on the same three point scale. In the field study 
neurologists rated seizure control on the same scale. 
Neurologists’ ratings were not used as an outcome measure 
because it was assumed that their rating would be based 
simply on seizure frequency and patient’s degree of 
satisfaction with control. Both these factors are measured 
(i and ii) and so no additional information would be 
obtained.
- 106 -
ii) Psychological Variables.
In previous chapters it has been noted that there is more 
to the management of epilepsy than seizure control. 
Psychological disturbance is common in epilepsy and may 
require treatment in its own right. This study cannot be 
complete without some measurement of the effect of 
intervention on psychological state.
It has also been noted, both in the literature review and 
in the field study, that anxiety and depression are the 
most commonly reported psychological complaints. Some 
objective measure of anxiety and depression symptom 
constellations is necessary. Degree of psychological 
disorder must be assessed before treatment in order to 
decide to which treatment condition patients should be 
assigned: patients with no measurable psychological 
disorder cannot be given Treatment B. It is also important 
to assess degree of psychological disorder post treatment. 
The theoretical basis for selecting Treatment B was to see 
what effect alleviating psychological pathology has on 
seizure frequency. Change in psychological pathology must, 
therefore, be measured as well as change in seizure 
frequency.
GHQ This questionnaire provides quickly and cheaply a 
single measure of non-psychotic psychological distress. It 
was selected because it has been shown to be a reliable 
research tool for separating groups into ’case and
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'non-case'. Subjects scoring above a cut-off point are 
deemed to have significant psychological disorder (42). 
This is exactly what is required in this study to 
determine whether or not patients should receive Treatment 
B. The questionnaire was also used as an outcome measure 
to provide a single measure of post-treatment 
psychological disturbance. The GHQ 60 was rejected 
because despite its length (60 items) it has negligible 
advantages over the thirty item version the GHQ 30. The 
GHQ 28 allows distinction between various types of 
disorder, but since anxiety and depression measures were 
-be -be used in any case, this is not an advantage.
Goldberg (42) recommends 4/5 as a threshold score for 
"just significant clinical disturbance."
S.TA1 The State-Trait Anxiety Inventory was devised by 
Spielberger, Gorsuch and Lushene, and extensive 
reliability studies have been carried out (144). The scale 
provides two measures of anxiety; 'State' anxiety is 
assessed in terms of score on a 20 item questionnaire 
concerned with the patient's feelings at the time of 
completing it; 'Trait' anxiety is assessed by means of a 
similar questionnaire, except that in this case the 
patient is asked to record how he generally feels. Both 
questionnaires are easily intelligible and can be 
completed quickly. Many anxiety schedules contain items 
concerning the physiological manifestations of anxiety,
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such as dizziness, palpitations and tingling. In this 
sample such items could be confounded with sensations 
associated with seizures. The STAI contains no such items. 
The advantage of using a scale which distinguishes between 
trait and state anxiety is that treatment effect can be 
measured more precisely. Trait anxiety, which is in a 
sense a personality measure, would be expected to remain 
relatively stable, while state anxiety would be expected 
to change with treatment. The trait anxiety scale 
therefore serves as a control against which treatment 
effect can be measured.
Spielberger (144) has derived college student norms for 
the STAI; the 50th percentile score is 39 for 'state' 
anxiety and 38 for 'trait' anxiety. He also gives normal 
data for psychiatric patients; the 50th percentile score 
for this group is 48 for 'state' anxiety and 47 for 
'trait' anxiety.
ZUNG There are a number of self administered depression 
inventories available, all widely used and all with many 
documented reliability and validity studies. The most 
popular research tools appear to be the Hamilton rating 
scale (145), Beck's depression inventory (146), and the 
Zung self rating scale (147). In reviewing these scales 
Carroll (148) points out that the Hamilton scale is 
largely concerned with behavioural and somatic 
manifestations of depression, the Beck s scale is more
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concerned with psychological and cognitive features, but 
the Zung scale contains a broad sample of features. The 
inclusion of somatic items may be a disadvantage for this 
study since, for example, excessive tiredness may be a 
symptom of depression and drug toxicity. However Gabrys 
and Peters (149) show the discriminative reliability of 
the Zung compared to other scales in separating 
pathologically negative attitude from realistic response 
to difficulties. This is an important distinction in a 
population of patients facing overwhelming difficulties as 
a result of their epilepsy, where the aim is to measure 
^depression independently from healthy response to such 
difficulties.
Zung (147) compared a group of depressed patients with a 
normal control group on his scale. The mean score for the 
control group was 26 and for the depressed group before 
treatment was 62.
ACTIVITIES In addition to scales rating affect or degree 
of psychological disturbance it is necessary to obtain 
some measure of the functional and behavioural effect of 
epilepsy and the associated disorders on life style. An 
independent sample (N = 20), from the same parent 
population as the field study was asked to list activities 
that they would like be able to carry out but felt unable 
to as a direct result of their epilepsy. The nine most 
commonly mentioned activities were presented to the
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experimental subjects and they were asked to tick the ones 
which they felt restricted in or barred from. Although the 
resultant 'score' must be interpreted with caution since 
the scale is not an interval scale, it does provide some 
indication as to degree of effect on life-style of the 
disorder. It also provides a valuable outcome measure 
since it gives an indication of the extent to which 
behaviour and/or attitude changes as a result of 
psychological intervention.
INDEPENDENCE Patients were categorised as 'independent'
"if they did not require assistance during or after their 
seizures, and if they kept their own seizure frequency 
records. An assessment of independence was considered 
necessary for two reasons. Firstly it is necessary to 
identify patients who are dependent on relatives to the 
extent where treatment would be impossible without 
involving them. Secondly increased independence may be a 
consequence of successful treatment, and as in the case of 
the 'Activities' scale it provides an indication of 
behaviour or attitude change as a result of treatment.
These measures and scales, together with the standardised 
instructions for patients entering the study, and the list 
of questions collecting demographic information, are given 
in Appendix C.
6. PROCEDURE
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Assessment
Patients attending out-patient neurology clinics in two 
geographical areas of Glasgow were assessed with a view to 
including them in the treatment study. The days on which 
patient selection was made were randomly determined and on 
those days consecutive patients with a diagnosis of 
epilepsy were interviewed. The diagnosis, as in the Field 
Study, was made by a consultant neurologist and was based 
bh EEG and clinical evidence. The patient was asked to 
rate seizure control as 'inadequate'; 'inadequate but has 
improved in the last two months'; or 'adequate.' All 
patients who rated their seizure control as 'inadequate' 
completed the GHQ 30, the Zung Depression Inventory, the 
STAI, the 'Activities' check list, the 'Independence' 
rating, and the Seizure questionnaire, (see Appendix C).
Records were obtained from the patient, the case file, and 
if possible a relative, of seizure frequency over the 
previous two to three months. Some patients did not have 
written records but were able to assert with assurance 
that they knew their weekly seizure rate. Patients without 
written records, and with no relative who was able to keep 
£in account of seizure frequency, and who were uncertain of 
the frequency were excluded. In this population such cases 
were rare (about 2%). Most patients had some kind of
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record going back to their last clinic visit. Some had 
records which had been immaculately kept for many years.
After this assessment procedure patients were admitted to 
the study if they met the criteria described in the 
section headed "Patient Selection".i.e.
i) They had rated their seizure control as ’inadequate'.
ii) They had had an average of at least two seizures per 
week for at least the last two months.
iii) They were able to complete the questionnaires and 
rating scales without undue help. (It was assumend that if 
they were able to do this then they did not have cognitive 
deficits severe enough to prevent them from benefiting 
from treatment).
Treatment
All patients whose score was 5 or above on the GHQ were 
randomly assigned to Groups 2 or 3. Those whose score was 
less than 5 were assigned to Group 1. (see Figure 2).
After this procedure Group 1 had 26 subjects, Group 2 had 
22 subjects and Group 3 had 23 subjects.
The experimental design was then followed as in Figure 2.
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Further exclusions were made according to the criteria 
previously described:
i) Patients whose seizure frequency appeared to be 
decreasing during the six week baseline.
ii) Patients whose anticonvulsant medication was altered 
during baseline or treatment. If medication was altered 
during the follow-up phase patients were only excluded if 
an alteration in weekly seizure rate (WSR) - in either 
direction - occurred during the three weeks after the
— change in medication.
Final groups for data analysis were as follows:
Group 1. 19 subjects
Group 2. 21 subjects
Group 3. 19 subjects
Basic descriptors of the sample are given in Table 5.
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Table 5.
DgfflQ^^hic_.Charact^rjstigs_Qf_Treatment Study Sample.
11111
Group 1 Group 2 Group 3
! Age
i
27.9 13.0 32.8 12.1 34.4 11.1
j Sex
i
8m Ilf 9m 12f 8m Ilf
i
{ Marital Status
i
4m 15s 10m 11s 10m 9 s
i
j Yrs. Since 
J Diagnosis
i
15.4 10.4 20.3 13.3 17.9 11.1
i
J Seizure Type
iiiii
10 Partial 
7 Mixed 
2 Unknown
8 Partial 
11 Mixed 
2 Unknown
8 Partial 
11 Mixed
Evaluation of Outcome
A record of WSR was kept throughout the 42 weeks of the 
trial. The rating scales and questionnaires providing the 
other outcome measures described in the previous section 
were re-administered at the end of the follow-up period.
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£H£EXEE_£
TR£ATMENT_SIUDYi_EVALUATION OF TREATMENT EFFECTS.
1. OVERALL TREATMENT EFFECT
2. GROUP DIFFERENCES
3. TREATMENT DIFFERENCES
4. OTHER OUTCOME MEASURES
In data analysis it is useful to begin with the least 
sophisticated method, to consider the implications of the 
results and then to progress systematically to more 
sophisticated methods, posing questions about the meaning 
of the data and answering them at each stage. All this can 
be done within the framework of the hypotheses which form 
the basis of the study. Results and discussion follow this 
plan in each of the subsequent sections.
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1. OVERALL TREATMENT EFFECT.
A. IS THERE ANY IMPROVEMENT IN SEIZURE FREQUENCY?
The first question which must be addressed is whether or 
not there is any evidence that psychological intervention 
has an effect on weekly seizure rate (WSR). The simplest 
way to do this is to see if WSR is lower at the end of 
— treatment than it is at the beginning.
Figure 3. shows mean WSR in each of the 42 weeks of the 
study, for each of the three groups. There appears to be a 
generally downward trend. This is a rather inconvenient 
way of examining the data because of the large number of 
data points and the variance between them causing a 
zig-zagging effect.
Figure 4. summarises Figure 3. by plotting mean WSR at the 
beginning and end of baseline, first treatment, second 
treatment, and follow up. It appears that WSR has fallen 
during the time periods where treatment was administered. 
WSR at the end of follow-up appears to be lower than 
during baseline. The simplest test to see if mean WSR at 
the end of the study is lower than at the beginning is a 
paired sample t — test. The assumptions required for the
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use of this test are met.(150). These are firstly that the 
responses (in this case WSR) should constitute random 
samples from the distribution of all such responses, 
secondly that they are taken from a normal distribution 
and thirdly that the variance of both sets of responses is 
equivalent. Normality of distribution of mean WSR in each 
of the time periods can be assumed - the degree of 
skewness is acceptable in a sample of this size.
A paired sample t - test comparing baseline mean WSR with 
mean WSR for the second follow-up period shows a highly 
— -s4gn.ificant difference.
t = 6.27 p < 0.001
However until it has been established that improvement 
occurred during treatment, and only during treatment, it 
may not be concluded that the improvement is a result of 
treatment. Further analysis to this end is carried out in 
sub-sections B and C.
Another way of presenting overall treatment effect is 
illustrated in Figure 5. WSR change scores are obtained by 
the following operation; Mean Baseline WSR — Mean last six 
weeks Follow up WSR/ Mean Baseline WSR X 100. A frequency 
plot of numbers of patients against percent change in W.~>R 
is shown. Final WSRs and Control ratings are plotted on
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the same figure but these aspects are discussed in section
4. of this chapter. It will be seen that about 50% of the 
sample improve by 50%.
B. WHEN DOES IMPROVEMENT BEGIN?
Firstly it is necessary to rule out the possibility that 
patients had begun to improve before treatment began. If 
this was the case then the decrease could simply be a 
continuation of a pre-treatment trend.
The fact of being included in an experimental trial, the 
assessment procedure and the encouragement to keep a daily 
seizure record might, separately or in combination, have 
caused a reduction in WSR before the treatment phases 
began. Demonstrating a stable baseline not only proves 
that patients had not in general begun to improve before 
treatment but also indicates that improvement was not 
simply attributable to a placebo effect.
Figure 3. shows mean WSR for each of the six weeks of the 
baseline for each of the three treatment groups. It is 
necessary to establish that baseline was stable for each 
of the three groups independently because at a later stage 
treatment outcome will be evaluated separately in each of 
the three groups. Each must have a stable baseline before 
any conclusions about treatment effect may be drawn.
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Oneway analysis of variance allows comparison of mean 
seizure frequency for week one with mean seizure frequency 
for week six; that is from the beginning to the end of 
baseline. The Statistical Package for Social Sciences X 
version of this test, {SPSSX (151)} also allows 
comparisons of ranges and gives tests of homogeneity of 
variance. Results showed no differences between means, 
ranges or variance between beginning and end of baseline 
for any of the three treatment groups. It was concluded 
that the six week baseline period was stable for each of 
the three groups.
It might be remotely possible that improvement follows a 
step-wise course so that although baseline is stable it 
was preceded by a higher WSR and will be succeeded by a 
lower WSR irrespective of treatment. The diagram shows 
this theoretical pattern.
1-2 Pre-baseline !
i
2-3 Baseline
3-4 Post-baseline
WSR
1 2 3 4
It was considered that a baseline of six weeks was long 
enough to make this extremely unlikely.
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As a further safeguard patient records during the two 
months prior to the start of baseline were examined. It 
will be recalled that patients were not accepted for the 
study unless they had such records showing an average WSR 
of at least two during this period and showing no pre 
baseline downward trend.
It was concluded that the six week baseline period was 
representative of the previous two month pre-intervention 
period.
C. WHEN DOES IMPROVEMENT END?
Another possibility which must be considered is that once 
improvement began it continued in a linear fashion during 
the follow-up periods and possibly beyond them. Further 
paired sample t - tests would allow some conclusions to be 
drawn about the course of improvement but simply comparing 
pairs of means for each of the phases has drawbacks. These 
have been itemised by Norusis (151) Firstly each t - test 
would not be independent because the same means would be 
used in overlapping combinations. There is consequently a 
risk of type 1 error; that is calling too many differences 
significant. Secondly a single test of the hypothesis that 
there is no change over the whole period of investigation
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would not be available.
The best available statistical tool for examining changes 
over time, with particular reference to change in slope 
following an intervention, is time series analysis. This 
technique would allow:
i) the use of all 42 observation points.
ii) naturally occurring cyclical changes in seizure 
frequency to be "ironed out" of the data, and measurement 
of any residual overall change.
iii) comparison of the slope during treatment with the 
slope during follow-up.
iv) investigation of trends towards continued improvement 
or relapse during follow-up.
v) comparison of the change in slope occurring after 
treatment A. with the change in slope occurring after 
treatment B.
The Box-Jenkins approach is the most commonly used time 
series model (153), but this requires at least fifty and 
preferably one hundred observations. This study has only 
42 observation points. Follow-up could have been continued 
for long enough to make up the required number of 
observation points, but for reasons which will become
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apparent this would not have been useful. Simonton's 
approach is more suitable to the present design (154). It 
requires a minimum of 5 observations on at least 20 cases. 
It is essentially a generalised least squares regression 
analysis and allows measurement of the effect of an 
intervention on the time series. Unfortunately the data 
fail to meet one of the criteria for the use of this 
method. It must be assumed that all within-case errors 
follow a first-order autoregressive scheme. In these data 
too many observations are too close to zero and to each 
other for this to be true.
The next best appropriate statistical tool is repeated 
measures analysis of variance. It will:
i) allow a test of the hypothesis that change in WSR 
continues through follow-up.
ii) allow a test of linearity of change.
iii) It overcomes the problems inherent in simply doing 
multiple univariate tests.
Unfortunately it will not make as efficient use of the
data as time series analysis, and so the use of additional
/
methods will be required to test all the relevant 
hypotheses.
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Repeated measures analysis of variance was carried out 
using MANOVA from the Statistical Package for Social 
Sciences X version (151).
MANOVA allows a single test of the hypothesis that there 
is no overall change in WSR. It has already been seen that 
a t-test comparing mean baseline WSR with mean follow-up 
WSR is significant, and so unless there is a massive 
zig-zagging effect between baseline and follow-up the 
ri^tGlusion of intermediate mean WSRs should not make much 
difference. As predicted the ’ F' value is highly 
significant and so the null hypothesis may be rejected 
with confidence.
F (d.f. 5, 58) = 88.91 p < 0.001
The next step is to test the null hypothesis that 
differences in mean WSR between successive pairs of time 
periods is 0. In this way a picture can be formed of where 
changes occurred.
Let ' Change 1’ be the difference in mean WSR between 
Baseline and the first treatment phase, 'Change 2 the 
difference betwen the first and second treatment phases, 
'Change 3' between second treatment and immediate
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post-treatment six week period, "Change 4" between 
immediate post-treatment six week period and first follow 
-up six weeks and "Change 5" difference between first and 
second follow-up period.
Baseline Treatment 1 Treatment 2 Post-Treatment
Change 1 Change 2 Change 3 Change 4
Follow-up 1 Follow-up 2 
Change 5.
l^afefle 6 shows the F values and results of univariate 
significance tests for each of the "Change" variables.
Table 6.
F values and Significance levels for Differences between 
WSR between each of Six Six Week Periods.
F- Value (d.f 1, 56)
i
i
Significance i
i
! Change 1 32. 18 <0.000 !
t
! Change 2 39. 90 <0.000
1
! Change 3 21. 70 <0.000 ! 1
! Change 4 3. 01 0.082 ! 1
! Change 5 2. 28 0.136 !1
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A significant change occurred between each time period 
except between the immediate post-treatment period and the 
two follow-up periods. It should be noted that the 
observed significance levels for individual values are not 
adjusted for the fact that several comparisons are being 
made. Strictly the assumptions needed for the use of 
multiple univariate tests are not met. These require that 
the variances of transformed variables are equal and that 
their covariances are 0. Bartlett"s test of sphericity is 
significant, showing that this is not the case. The 
univariate tests do, however, serve as guides to the most 
-^aportant changes. MANOVA also carries out multivariate 
tests of significance. Pillais", Hotelling’s, Wilk’s and 
Roy’s tests were all significant.
F = 10.90, p < 0.000
MANOVA can be used to provide further information about 
the shape of change in WSR. To test the hypothesis that 
fall in mean WSR is linear across the time periods where 
change occurs orthogonal polynomial contrasts can be used. 
Results show that there is a linear fall over the two 
treatment phases, but that it ceases to be linear after 
them. An idealised graph of change in WSR, based on this 
information is presented in the diagram.
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0-1 Baseline
1-2 Treatment 1.
2-3 Treatment 2.
3-4 Post-treatment.
4-5 Follow-up 1. WSR
5-6 Follow-up 2.
0 1 2 3 4 5 6
It is concluded that most of the change in WSR occurred 
during the treatment phases of the experiment, that change 
continued through the immediate post- treatment period 
hut did not continue through follow-up.
The fact that change in WSR levels off during follow-up so 
that there is no significant further change is 
justification for not continuing follow-up for a longer 
period. Given that this population has a chronic problem 
unsuccessfully controlled, in some cases for many years, 
it must be realistically expected that there will be some 
relapse eventually. Annual follow-up for some years is 
desirable to identify and possibly to counter relapse 
factors, but that is not within the scope of this study.
2. GROUP DIFFERENCES.
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Groups 2 and 3 are random samples from the same population 
of patients with significant psychopathology. Group 1 is a 
sample from a different population: those that have no 
significant psychological disorder. Results of analysis of 
variance show that there is no difference between the 
groups at the start of treatment in terms of age or years 
since diagnosis. Chi-squared tests show no difference 
between them in sex, marital status, independence, type of 
epilepsy, and whether or not they claimed to have warnings 
of seizures or to know of factors triggering seizures. 
Analysis of variance showed no significant differences 
between Groups 2 and 3 in terms of the measures of 
psychopatho1ogy.
Any hypotheses about differences in treatment response 
between the groups will depend on how important we 
consider psychopathology to be in maintaining a high 
seizure frequency. If it is a very significant factor then 
the following hypotheses would be generated:
i) Group 1 will have a significantly lower baseline WSR 
than Groups 2 and 3.
ii) Groups 2 and 3 will have a larger decrease in WSR 
overall. (This follows because if psychological disorder 
is a factor causing a large proportion of patients 
seizures then alleviating it will remove that large 
proportion, assuming for the moment that it is
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alleviated).
If psychopathology is totally unimportant in maintaining 
seizure frequency, then no difference in treatment 
outcome, measured in terms of WSR, would be expected.
Evidence from the preliminary study suggests that 
psychopathological factors are neither very significant 
nor completely insignificant. It has been shown that there 
is a significant correlation between GHQ and seizure 
frequency (Pearson’s r = 0.343 in the preliminary study), 
— but it has been noted that a causal relationship in either 
direction cannot be inferred with any degree of certainty. 
Even if it is assumed that the factors underlying GHQ 
cause seizures, they would have to be eliminated 
completely to bring about a modest (around 11%) reduction 
in frequency.
Figure 4. shows mean WSR at the beginning and end of each 
phase for each of the three Groups. It will be observed 
that the pattern of change for groups 2 and 3 is similar, 
but that group 1 follows a slightly different pattern. The 
next logical step is to apply statistical methods to 
specify more precisely any differences.
A. IS THERE A DIFFERENCE IN BASELINE WSR BETWEEN THE 
GROUPS?
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A. IS THERE A DIFFERENCE IN BASELINE WSR BETWEEN THE 
GROUPS?
Oneway analysis of variance was used to measure the 
significance of differences between the groups at 
baseline. Group 1 does have a lower baseline WSR, but the 
F ratio does not approach significance.
F (d.f. 2,56) = 0.616 p = 0.544
Neither were there significant differences between the 
ranges or variances of the three groups.
Thus hypothesis i) remains unsupported; it would appear 
from these data that psychological disorder is not related 
to increased seizure frequency. This finding is contrary 
to expectation given the significance of the correlation 
between GHQ and WSR, and although the small size of that 
correlation may account in part for these seemingly 
diverse findings there is a better explanation. When the 
procedure for patient selection is recalled, it becomes 
apparent that comparison of baseline WSR between Group 1 
and Groups 2 and 3 is not a good experiment to test the 
hypothesis that WSR is related to GHQ score. Patients were 
only selected for Group 1 if their seizure frequency was 
in excess of two per week and if their GHQ score was 5 or 
less. The probability of finding such a patient in the 
parent population was about half the probability of 
finding a patient for Groups 2 or 3. Thus in testing 
hypothesis i) all patients with a seizure frequency of
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less than two per week and who are rated as well 
controlled are omitted. It is not surprising, therefore, 
that the result is not significant. Examination of the 
correlation between WSR and GHQ in the parent population 
is a much better method of examining the relationship.
B. IS THERE AN OVERALL DIFFERENCE IN TREATMENT EFFECT 
BETWEEN THE GROUPS?
Multivariate analysis of variance (MANOVA) was repeated 
^"IXSlng the three treatment groups as a factor. There was no 
significant group effect on baseline to follow-up change 
in WSR. Thus in terms of overall treatment response each 
group did as well as the other two groups.
At first sight these findings appear to provide firm 
support for the general hypothesis that psychological 
disorder, measured in terms of GHQ, is not important in 
determining treatment outcome, and by implication is not 
important in maintaining seizure frequency. It must be 
remembered, however, that Group 1 had only one treatment 
and therefore half the number of treatment sessions. Thus 
Group 1 did as well with one treatment as Groups 2 and 3 
did with two. In one sense Group 1 was more successful.
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C. IS THERE A DIFFERENCE BETWEEN THE GROUPS AT ANY STAGE 
OF TREATMENT OR FOLLOW-UP?
Exam in at ion of Figures 3 and 4 shows that the pattern of 
improvement is slightly different for each of the groups. 
MANOVA allows the significance of these differences to be 
tested at each phase of treatment. Table 7 shows results 
in the same form as in Table 6, but in this case the group
by WSR change interaction is being tested.
Table_7^_
F Values and Significance Levels for Group Effect on WSR
Change Between each of Six Six Week Periods.
11
1t F- Value (d.f 1, 56)
1\
Significance !
i1
j Change 1 0. 39 0.674 !i1
! Change 2 4.01 0.023* |i
i
1 Change 3 0.86 0.425 i
i
! Change 4 1. 18 0.318 !i
i
! Change 5
ii
0.08 0.918 !i
. ... i
Results show that there is a significant difference 
between the Groups after one treatment, but not at any 
other time.
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Examination of Figure 4 shows that this difference is 
caused by Group 1 which appears to have greater change in 
WSR during the first treatment phase. During follow-up 
this difference evens out. Either of the models described 
below could explain why Group 1 appear to have done better 
after one treatment.
What is less clear is why the difference is not 
maintained. The most probable explanation is the number of 
treatment sessions. Group 1 has fewer; possibly if it had 
had more the difference would have been maintained.
D. TWO MODELS WHICH COULD EXPLAIN WHY GROUP 1 DOES AS WELL 
WITH ONE TREATMENT AS GROUPS 2 AND 3 DO WITH TWO.
i) This result is in keeping with what is known about 
treatment response in general. It is generally accepted 
that patients with significant anxiety or depression tend 
to respond less well to a variety of medical and surgical 
treatments and that excessive anxiety interferes with 
learning. If we conclude that the total response of Groups 
2 and 3 is only as good as Group 1 when their 
psychopathology has been treated then a new treatment 
mechanism could be suggested to fit the results so far. So 
far the model under consideration has been.
Let us suppose that psychopathology does not directly 
maintain a high seizure frequency but prevents patients 
benefiting maximally from Treatment A.
If this was so then in Group 1. Treatment A acts directly-
Treatment B might work by reducing psychopathology so that 
A can be effective. At this stage we have very little 
evidence to support this model, but examination of 
treatment order effects and the effect of degree of 
psychopathology on treatment, should allow the model 
either to be refuted or supported further. The former is 
undertaken in the next section and the latter in Chapter
Treatment A.
IV)
but in Groups 2 and 3 psychopathology interferes:
Treatment A
7.
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ii) There is an alternative explanation for the relatively 
rapid improvement shown by Group 1 patients. If, as 
discussed in a previous section, seizures in any 
individual are caused by n factors, then elimination of 
any of these factors would be expected to reduce seizure 
frequency. In the experimental sample all groups have the 
same baseline seizure frequency, X. The two treatments, A 
and B, aim to "eliminate’ two different types of factor,
'"Mi and Bn. It is assumed that because Group 1 has no 
significant psychopathology that Bn = 0 in their case. The 
total number of seizures at baseline is some function of 
the number of factors. For Group 1;
X = f(An + Cn)
where C represents the unknown factors. For Groups 2 and 
3;
X = f (An + Bn + Cn).
It is not unreasonable to assume that the distribution of 
values for ’C ’ is the same in all three groups. If X and C 
have the same values in both equations then A must be 
smaller for Groups 2 and 3. Therefore Treatment A, even if 
equally effective in eliminating An in all groups, would
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have a smaller effect on X in Groups 2 and 3. Again 
examination of differences in treatment effects will allow 
further evaluation of these speculations. The only 
conclusion that can be drawn at the end of this section is 
that two treatments are as effective in reducing WSR in 
Groups 2 and 3 as one treatment is in Group 1.
3. TREATMENT DIFFERENCES.
A. ARE TWO TREATMENTS BETTER THAN ONE?
Results presented in Table 6 and discussed in section 1. 
of this chapter show that there is a further significant 
decrease in WSR during the second treatment in both 
groups. However this finding does not allow the conclusion 
that two treatments are better than one because it is 
possible that there might be a continued improvement after 
the first treatment without the addition of a second. 
Evidence for the existence of a carry-over effect is 
discussed below. If it can be demonstrated that such an 
effect does not exist then it may be concluded that two 
treatments are better than one.
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B. IS ONE TREATMENT MORE EFFECTIVE THAN THE OTHER?
Is a treatment different when it is administered first 
rather than second?
It has already been demonstrated that there is no 
difference in overall outcome between Groups 2 and 3. 
Administering Treatments A then B is exactly as effective 
as administering B then A. However the total change during
A across both Groups might be different from the total
change during Treatment B.
Mean % change for both groups during:
Treatment A = 29.8% S.D. 56.8
Treatment B = 22.0% S.D. 57.7
A test of the difference between these means shows no 
significant difference. It is concluded that there is no 
difference in effectiveness between Treatments A and B.
C. IS THE EFFECT OF ADMINISTERING A TREATMENT FIRST 
DIFFERENT FROM ADMINISTERING IT SECOND?
Treatments are essentially educational and cannot be 
withdrawn once they have been administered. There may be 
some carry—over effect so that a treatment continues to
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cause a change in slope in WSR for some time after its 
final treatment session. The change in slope during the 
second treatment, therefore, may be caused by the 
summation of both treatment effects. However treatments 
were administered in a different order in Groups 2 and 3 
and so this possibility can be investigated statistically. 
If there is a significant carry-over effect then it would 
be expected that the treatments would have a different 
apparent effect when they were administered second than 
when they were administered first; graphs representing 
change in WSR would tend to look like this:
1-2 Baseline
2-3 Treatment 1
3-4 Treatment 2
WSR
1 2  3 4
The carry-over effect could be measured by subtracting the 
effect of a treatment when it was administered first from 
its effect when it was administered second.
If, on the other hand, there is no significant carry-over 
effect then change during the treatments should be the 
same regardless of whether they are administered first or 
second.
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1-2 Baseline
2-3 Treatment 1
3-4 Treatment 2
WSR
1 2  3 4
Examination of Figure 4. shows that there is an apparent 
upward jump in WSR during the second treatment phase. 
Comparison with Figure 3 shows that this is a little 
misleading and is a result of the wide zig-zagging effect 
during that phase. Mean WSR at week 15 has been marked 
with an X to clarify this. If a 'best fit' line was drawn 
through the second treatment phase of Group 2 then the 
slopes during Treatments all appear rather similar 
regardless of whether the Treatment is A or B or whether 
it is administered first or second. A comparison of mean % 
change during A when it was administered first with mean % 
change when it was administered second shows no 
significant difference. A comparison of mean % change 
during B when it was administered first with mean % change 
when it was administered second also shows no significant 
difference.
These negative results suggest that there is no
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significant carry-over effect thus allowing the following 
conclusion that it is very probable that two treatments 
are more effective than one treatment.
D. IMPLICATIONS OF THE RESULTS OF COMPARISONS BETWEEN 
TREATMENTS.
Figure 5 shows that there is a wide range of reponse to 
treatment. In a population with such large individual 
differences in treatment response it would be unwise to 
draw any firm conclusions about how treatment works. It is 
possible to make generalisations about the likely 
mechanism of action but even in this relatively small 
sample there must be a proportion of patients for whom the 
generalisation is not true.
In section 2., which discussed group differences, a model 
was proposed in which the mechanism of action of Treatment 
B was that it removed factors preventing subjects from 
benefiting from Treatment A. If this is so then Treatment 
A should have a much smaller effect when it is 
administered first than when it is administered second. It 
might also be expected that the combined effect of A then 
B is less good than B then A. Results of data analysis do 
not support this. In the case of the second model proposed 
in the previous section, there is no particular reason why 
order should be important. The data tend to support this
second model.
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If treatments are equally effective the possibility that 
they are really the same treatment must be considered. 
Perhaps factors that the treatments had in common were 
more important than things which distinguished them. The 
checks that were made to ensure that the two treatments 
focused on independent aspects of the patients' condition 
are described in the section headed 'Procedure', but both 
treatments had two obvious common factors; the therapist 
and therapist time. If therapist time and attention is the 
"‘effective ingredient then it would reasonably be expected 
that Group 1 would do less well since they have fewer 
treatment sessions. It has been demonstrated that they do 
not. An even more convincing argument is that treatment 
effect is maintained over a six month follow-up period 
without further therapist attention. This certainly 
suggests that patients have acquired some skill during 
treatment which is resistant to decay. An alternative 
hypothesis is that the common ingredient in both treatment 
packages is an improved sense of self-control. This might 
well be a result of a treatment directed at psychological 
disturbance, or of one directed at seizure control. An 
examination of the other outcome measures should give some 
indication of the likelihood of this hypothesis. These 
measures are discussed in the next section.
Another possible explanation for the similarity in effect
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of both treatments could be that both brought about an 
improvement in drug compliance, and that this was the key 
component leading to treatment success. In Chapter 5 in 
the section dealing with subject selection it was reported 
that each subject's case records were examined for 
evidence of non-compliance and that all subjects in the 
study had had serum concentration of their AEDs measured 
and found to be at optimal levels within 3 months of the 
start of psychological intervention. This is a relatively 
crude check on compliance and it is quite possible that 
some patients were more consistent in taking their 
medication during treatment than before it. However it is 
extremely unlikely that this effect is large enough to 
account for treatment success in a significant number of 
cases. Although no formal assessment was made, several 
patients claimed that they had reduced their medication on 
their own initiative by the end of follow up as a result 
of improvement in seizure frequency. On balance it seems 
that changes in drug compliance could not account for the 
similarity in effectiveness of the two treatments and 
could not alter significantly the conclusions of the 
study.
Yet another possible explanation for the similarity in 
treatment effects is that both treatments simply 
eliminated pseudo-epileptic seizures and that the attacks 
left at the end of treatment are the remaining genuine 
epileptic seizures. The main evidence against this
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possibility is the size of the treatment effect. The 
highest estimate of the proportion of non-epileptic 
seizures amongst the population of people with epilepsy is 
26% (see Chapter 2 section 7. ) In this sample the mean 
improvement in seizure frequency is nearer 50%. Fenton 
(90) recommends lengthy and complex treatment for 
pseudo-seizures and it seems unlikely that the short, 
simple treatments used here would be effective against 
them.
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4. OTHER OUTCOME MEASURES.
A. IS THERE ANY EVIDENCE OF CLINICAL IMPROVEMENT OTHER 
THAN FALL IN WSR?
In previous sections results which show evidence of a 
statistically highly significant treatment effect have 
been presented. Statistical effects, however, are not 
always of much importance to the patient. If the degree of 
improvement is insufficient to make a difference to the 
'patient's quality of life then the real benefits of 
treatment may be negligible.
The first, most simple question to be asked is whether 
patients'" perception of seizure control changes when 
absolute frequency has changed. Patients were asked to 
rate how well their seizures were controlled on a three 
point scale before treatment (see Chapter 5), and only 
those patients who rated their control as poor were 
included in the study. Patients rated their seizure 
control on the same scale at the end of follow-up. 
(Patients were also asked if they felt more in control of 
their seizures; it will be seen that this is a quite 
different question and is dealt with at the end of this 
section.) Figure 5 shows the relationship between amount 
of improvement in WSR from baseline to follow up, mean WSR 
at
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the end of follow up. It will be seen that patients who 
changed their control ratings from poor to good were those 
who improved the most.
Table 8. shows pre- and post- treatment scores on all 
outcome measures apart from seizure frequency. Once again 
paired sample t-tests are the most powerful, sensitive 
appropriate statistical method of comparing pre- and 
post-treatment means on measures which can be assumed to 
have a normal distribution. The 'Activities' scale is not 
'tlth"interval scale and is not normally distributed and so 
although means are quoted, a Mann-Whitney U test was 
carried out and the significance level refers to this 
result.
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Table 8..
ost--Treatment Mean Scores on Outcome Measures
for each Group
1
! GROUP 1. 
i n=19
i
Pre-Treat.
Mean
Post-Treat.
Mean
11
Significance of! 
Comparison !
! GHQ
i 3. 26 3. 05 N. S. |
J STAI (state)
i 39. 47 39. 68 N.S.
; STAI (trait) 
1 40. 00 38. 68 N.S. j
ZUNG
i 25. 37 24. 58 N.S. i
j ’ACTIVITIES’
i
3. 16 2. 58 0.004
i
! GROUP 2. 
! n=21i
Pre-Treat.
Mean
Post-Treat.
Mean
ii
Significance of 1 
Comparison J
I
! GHQ
i 12. 81
7. 05 o .ooi  i
i
! STAI (state) 1 59. 91
50. 62 0.001 | i
! STAI (trait)
i
53. 48 48. 05 0.018 j 1
! ZUNGi
35. 67 30. 05 0.001 !1
! ’ACTIVITIES’i
3. 38 2.71 0.016 !1
... i
i
I GROUP 3. 
n = 19
Pre-Treat.
Mean
Post-Treat.
Mean
11
Significance of! 
Comparison !
i
GHQ 16. 05 8. 47 0.001 ! 11
! STAI (state) 62. 16 53. 05 0 . 0 0 1 1
J STAI (trait) 56. 00 51. 84 0.023 !i
ZUNG 40. 32 32. 74 0.001 I1
! ’ACTIVITIES’i
2. 74 2. 37 0.015 !1
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It is concluded, that in terms of the measures of anxiety 
and depression used, Groups 2 and 3 become significantly 
less anxious and depressed as a result of treatment.
Group 1 was not expected to become less anxious or 
depressed because its scores on the rating scales were 
normal at the start of the experiment.
Table 8. shows that there was a significant reduction in 
the number of work related and social activities that
T^at'ients felt restricted in or barred from as a result of
their epilepsy. ’Independence’ was also rated pre- and 
post- treatment. Eleven patients in Group 1, ten in Group 
2 and eight in Group 3 were ’independent’ before 
treatment. Fourteen patients in Group 1, twelve in Group 2 
and eleven in Group 3 were ’independent’ after treatment.
The change in the ’Activities’ scale and the small
increase in number of ’independent’ patients suggests that 
there may be a behavioural change as well as a change in 
symptom reporting.
It will be noted that in terms of STAI scores ’Trait’ 
anxiety has fallen as well as ’State’ anxiety. Test- 
retest reliability studies have been carried out for the 
scales (144) and show that test - retest correlation 
ranges from 0.73 to 0.86. for ’Trait anxiety. Parrino 
(155) used the scales on a psychiatric population before
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and after treatment for phobic anxiety. He found a 
significant reduction in ’State’ anxiety, but ’Trait’ 
anxiety remained unchanged. It appears then that contrary 
to expectation based on previous evidence, patients in 
this sample have changed their view of how anxious they 
generally feel. This is likely to be result of the long 
time period between administrations of the test. If 
patients have been feeling less anxious for some time then 
they will respond differently to the question "how do you 
generally feel" than if their improvement has been recent.
In addition to the standardised questionnaires patients 
were asked if they felt more or less in control of their 
seizures and psychological problems at the end of 
treatment that they did at the beginning. (This is a 
different question from asking for a rating of how well 
seizures are controlled, since it deals with sense of 
self-control and is therefore active rather than passive.) 
The question was apparently not very meaningful since all 
but two patients said that they felt more in control of 
their disorder. These two patients had shown an 
improvement in WSR of 29% and 37% respectively. Patients 
who showed relatively little treatment effect still 
reponded affirmatively. This serves to illustrate the 
value of standardised rating scales since they are less 
open to bias caused by patients wishing to give the 
"correct” answer.
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B. IS THE CLINICAL IMPROVEMENT SUFFICIENT TO MAKE 
TREATMENT COST-EFFECTIVE?
Table 8 reveals that Groups 2 and 3 are drawn from a 
highly anxious and depressed population. Normal data for 
these scales are presented in the section headed 'OUTCOME 
MEASURES' Chapter 5. It will also be observed that at the 
end of the study subjects are still highly anxious and 
slightly depressed compared to 'normal' subjects even 
"although there has been a significant improvement. Most 
are still unemployed and most still feel restricted in or 
barred from at least 2 activities. Only 8 subjects who 
were unable to cope alone with their seizures before 
treatment were able to cope after treatment. Despite the 
gains of treatment at the end of the study there are still 
26 patients with a seizure frequency in excess of 2 per 
week and 24 patients with a GHQ score in the 'caseness' 
range. Nineteen patients have both these characteristics. 
Thus almost half the sample, in the light of the arguments 
in favour of psychological intervention presented in the 
Introduction, still require psychological intervention. 
There are two possible alternative explanations of this 
result; more treatment sessions may be required to help 
some patients or there may be some patients for whom these 
treatments are not effective.
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Ihe fact that some patients may still require treatment at 
the end of the study gives only an overall indication of 
treatment cost-effectiveness. The question of whether an 
individual patient's decrease in seizure frequency 
represents a clinically significant improvement remains 
open. It appears that psychopathology has been reduced and 
that there are some behavioural manifestations of the 
improvement. If the same patients are improving on all 
these measures then it is reasonable to conclude that 
treatment causes a clinically significant effect. If some 
patients are improving on one measure and some on another 
the gain, and by implication the cost-effectiveness of 
treatment, is less apparent. An attempt to relate patient 
characteristics to outcome may help to clarify this; such 
an attempt is made in the following chapter.
C. THE IMPLICATION FOR THE RELATIONSHIP BETWEEN WSR AND 
PSYCHOPATHOLOGY.
The conclusion above that anxiety and depression in Groups 
2 an 3 improves with treatment does not specify which 
treatment. It may be that the two groups become less 
anxious and depressed as a direct result of Treatment B. 
The improvement in psychological state may also be due to 
the indirect effect of a reduction in seizures. It may be 
due simply to the effect of being included in the study.
It is not possible to disentangle these alternatives with
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any degree of certainty. Scores on the rating scales 
obtained between treatments might have been helpful, but 
they were not administered at this point. Enough is known 
about patients' response to psychological treatment in 
general for this lack of information to be relatively 
unimportant. It can safely be assumed that any new 
treatment, or even being placed on a waiting list, would 
have some effect in reducing patients' GHQ scores, etc. It 
can also be assumed that a treatment specifically aimed at 
anxiety and depression will be more effective in 
alleviating them than one not aimed at anxiety and
depression. It can be accepted that Treatment B was an
important agent, although almost certainly not the only 
agent, in reducing psychological symptoms. It has already 
been demonstrated that WSR falls during Treatment B. Taken 
together this evidence provides support for the 
hypothesis that alleviating psychological disorder can 
decrease seizure frequency.
It is concluded that since WSR and scores on measures of 
psychopathology fall during Treatment B there is in all 
probability a mechanism by which alleviating psychological 
disorder decreases seizure frequency.
The evidence that Treatment B, the treatment aimed at 
alleviating patients' psychological problems, succeeds in
doing this and causes a reduction in WSR, has been
discussed. If alleviating psychological distress brings
-151-
about a reduction in seizure frequency then it can be 
inferred that psychological distress can raise seizure 
f requency.
If it can be shown that there is a mathematically 
functional relationship between change in psychopathology 
measures and change in WSR then this provides further 
support for the hypothesised relationship between WSR and 
psychological distress, although a spurious relationship 
is still a logical possibility.
Table 9. shows Pearson’s correlation coefficients between 
change in WSR and change in psychopathology measures. 
"Change" in both instances is pre-treatment score -
post-treatment score/ pre-treatment score.
Table_9
Correlations Between Change in Psychopathology Measures
and Change in WSR.
i i i i i ~ i t i! GHQ (ch)
i j ;
|STAIS (ch)ISTAIT (ch)!
i
ZUNG (ch)!
i
! WSR (change)j! .2406 ! .2116 ! .1594 ! .1499 !
i
i i
i n - 1 i P - ii i ( ___________ i
. 067 ' .095 ! .163 ! 
! ! <
. 178
1
None of these correlations is significant, although the
—  1 P 1 r‘1 ■J £. ~
correlation between WSR (ch) and GHQ (ch) approaches 
significance. An explanation for these negative results 
may be found in the nature of the treatments. The WSR (ch) 
variable is a measure of total change from before the 
first treatment until after the second. One of the 
treatments, Treatment A, is not concerned with 
psychopathology. It would not be expected, therefore, that 
there should be a significant relationship between change 
in psychopathology and change in WSR during Treatment A.
If, instead of using total change over both treatments, we 
examine total change during Treatment A and during 
Treatment B separately, results may take on a different 
appearance.
Table 10 shows Pearson’s correlations between pre - post 
psychopathology measures and pre - post WSR change during 
Treatment A and during Treatment B.
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Table 10.
Co gelations, between change in WSR and change in 
P s ^ hjppa th ol,ogy__measures_for_Treatment A and Treatment B.
11
11
GHQ (ch) STAIS (ch) STAIT (ch) ZUNG (ch)
IT.A WSR (ch) 
*
. 1067 . 0646 . 0009 . 1138
1
! P =
i
. 318 . 346 . 498 . 242
!T.B WSR (ch) 
1
. 4138 . 3980 . 2008 . 2993
I
! . P = 1
. 004 . 005 . 107 . 030
It will be seen that the correlations between WSR change 
and psychopathology change during Treatment A are 
negligible while the correlations between WSR change and 
psychopathology change during Treatment B are significant 
except in the case of trait anxiety (STAIT), which it will 
be recalled changes the least with treatment.
These results indicate that there is a mathematically 
functional relationship between change in psychopathology 
measures and change in WSR.
The implications of this section can be summarised as 
follows: Treatment B has been shown to alleviate 
psychological distress. It is inferred that alleviating 
psychological distress causes a reduction in seizure
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frequency, and that the amount of reduction is related to 
the amount of change recorded in the anxiety and 
depression rating scales.
THE—CONCEPT OF SEVRRT'fV
1. BASELINE SEIZURE FREQUENCY
2. PRE-TREATMENT PSYCHOPATHOLOGY
3. TIME SINCE DIAGNOSIS
4. RESTRICTED ACTIVITIES
5. CONCLUSIONS AND IMPLICATIONS
Until this point results have been discussed as though 
variance in treatment response was unimportant. In fact 
there is considerable variance in treatment response; some 
patients have no seizures during six months of follow-up, 
while others have slightly more than at baseline. This 
chapter, and the subsequent three chapters, are concerned 
with variables, and groups of variables, which might 
explain why some patients benefit more from treatment than 
others.
The concept of severity has been discussed previously, it
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will ke reca-ll6d that it was concluded that the concept 
includes several factors and cannot be considered as a 
single entity. In a general way it may be expected that, 
in common with many psychological treatment studies, 
pre—treatment * severity* might have an adverse effect on 
treatment response. If each of the components of 
* severity* is examined independently, however, it will 
seen that such an hypothesis would be an 
over-simplification.
1."SEVERITY" IN TERMS OF BASELINE SEIZURE FREQUENCY
There is no particular reason why a high baseline seizure 
frequency should be associated with relatively poor 
outcome. It might be suggested that very poor seizure 
control at baseline was an indication of the extent to 
which previous treatments had failed, but all previous 
treatments were pharmacological and so previous 
therapeutic failure is not likely to reduce the 
probability of present therapeutic success.
There are reasons why a high baseline seizure frequency 
might be associated with better treatment response.
Firstly, in the case of Treatment A, the more frequent the 
seizures the greater the opportunity for practising and 
perfecting techniques of seizure interruption. Secondly, 
it may be that cases where pharmacological methods have
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been the least effective are those cases where 
psychological methods will be the most effective. This 
might well be true, for example, in the case of a patient 
with a high proportion of pseudo-epileptic seizures. It 
might equally be true of a patient in whom psychological 
factors were a significant, powerful seizure potentiator.
Using a paired sample t-test, mean baseline seizure 
frequency for the 20 patients whose WSR decreased by 59% 
or more between baseline and the end of follow-up, (the 
best third) was compared with mean baseline seizure 
frequency for the 20 patients whose WSR decreased by 26% 
or less, (the worst third).
The result did not approach significance. In terms of 
these data, baseline seizure frequency appears to be 
irrelevant to treatment outcome. This does not exclude the 
possibility, however, that in some individual cases a high 
baseline frequency might confer an advantage, as suggested 
above.
2. "SEVERITY" IN TERMS OF PRE-TREATMENT SCORES ON 
PSYCHOPATHOLOGY SCALES.
Pre—treatment scores on the four psychopathology scales, 
(GHQ, STAIS, STAIT, ZUNG) are given in Table 6. Group 1 
patients, by definition, have a normal GHQ score, and
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insignificant levels of anxiety and depression measured in 
terms of the other scales. Groups 2 and 3 are 
significantly anxious and depressed in terms of these 
scales. Differences in outcome between the Groups have 
been discussed in Chapter 4 section b. At this point we 
are concerned with the effect of * severity* of 
pre-treatment psychopathology on final outcome in terms of 
weekly seizure rate. The effect on treatment response may 
not be the same for both treatments; it is necessary to 
examine the effect on Treatment A and Treatment B 
separately.
A) Anxiety and depression might interfere with ability to 
learn the techniques presented in Treatment A. If so the 
more psychologically distressed patients will benefit less 
from Treatment A.
When treatment order effect was the topic of discussion 
the above hypothesis was considered. At that point in the 
argument it was suggested that Treatment A administered 
first would be less effective than Treatment A 
administered second. If anxiety and depression truly 
interfere with response to Treatment A then when these 
symptoms have been alleviated by Treatment B, A should 
have a greater probability of working. It was demonstrated 
that Treatment A was equally effective whether 
administered first or second. However, at that stage the 
effect of severity was not considered. The most severely
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anxious and. depressed patients might indeed fail to 
respond to Treatment A. If so, there will be an inverse 
relationship between pre-treatment scores on 
psychopathology scales and change in WSR during Treatment 
A.
Table 11 shows Pearson’s correlation coefficients between 
change in WSR during both treatments {T. A WSR (ch) and T.B 
WSR (ch)} and pre-treatment scores on the psychopathology 
scale.
Table 11
Correlations between change in WSR during Treatment A and 
Treatment B and pre-treatment psychopathology measures.
~ GHQ STAIS STAIT ZUNG
T. A WSR (ch) . 1558 . 2205 . 1290 . 1535
P = . 168 . 086 . 214 . 172
T.B WSR (ch) . 0603 -.0979 -.0444 -.4758*
P = . 356 . 274 .393 . 001*
There is no inverse relationship between change in seizure 
frequency during Treatment A. and pre—treatment scores on 
the psychopathology scales. In fact the correlations are 
all positive and, in the case of state anxiety, (STAIS) 
approaching significance. The hypothesis that anxiety and 
depression may interfere with Treatment A is not
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con firmed. There may be a very weak trend towards the 
converse; that patients with higher initial levels do 
slightly better.
B) It might be expected that patients whose anxiety and/or 
depression is severe will not benefit from a treatment as 
short and simple as Treatment B. If Treatment B is not 
effective in alleviating psychological disturbance in the 
more chronic or complex cases then it will not be 
effective in reducing seizure frequency in these cases.
This hypothesis must be dealt with in two stages. The 
first stage is to test whether high pre-treatment 
psychopathology scores are a poor prognostic sign for 
treatment outcome in terms of reduction in
psychopathology. The second stage is to test whether they 
are a poor prognostic sign for outcome in terms of 
reduction in seizure frequency.
Table 12 gives Pearson’s correlations between 
pre—treatment measure of psychopathology (GHQ etc. ) and 
change in measures of psychopathology {GHQ (ch) etc. } 
Change scores were pre-treatment score - post—treatment 
score/ pre-treatment score.
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Table 12
Co£r&latiQQ5_between pre-
psychopathologv
GHQ STAIS STAIT ZUNG
GHQ (ch) . 7139
STAIS (ch) . 5496
STAIT (ch) .5960
ZUNG (ch) .7337
P  < 0.0001 in each case.
It is clear from these results that in terms of amount of 
change in score on these measures the higher the initial 
level the greater the improvement. It may be possible that 
those patients who began the treatment trial with the 
highest anxiety/depression levels were those who ended the 
trial with the lowest levels. In order to test this the 
sample was divided into two groups; ’high’ scorers and 
’low’ scorers on each of the psychopathology measures. The 
two groups were then compared in terms of final score on 
the same measure, using paired sample t-tests. There were 
no significant differences; it appears that the same end 
point is reached whatever the initial level. In terms of 
outcome on the psychopathology scales initial high levels 
are neither a bad prognostic sign, nor a good one.
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The results displayed in Table 11 show that change in WSR 
during Treatment B is inversely related to initial ZUNG 
score. It becomes clear that although overall ZUNG scores 
improve with treatment (see Table 8), the higher the 
initial score the poorer the treatment response, not in 
terms of change on the ZUNG scale, but in terms of 
improvement in seizure frequency. This finding tends to 
weaken the evidence for a causal relationship between 
depression and seizure frequency. If depressed patients do 
less well in terms of improvement in WSR, despite a very 
substantial improvement in their depression, then it is 
unlikely that depression is maintaining a high seizure 
frequency. This conclusion has important implications 
which are discussed at the end of this section. 
Correlation, although useful as an indicator of what 
factors might be associated with good or poor treatment 
response, is rather a imprecise test. One or two isolated 
results outlying the rest of the data can produce a 
seemingly highly significant result. A further test would 
be to compare a group of relatively low scorers on the 
pre-treatment Zung scale with a group of relatively high 
scorers. If the correlation is truly indicative of an 
important effect then the low scorers will have a 
significantly greater treatment reponse than the high 
scorers. A t—test is appropriate given that Zung scores 
and WSR change scores may be considered to be normally 
distributed.
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lable 13
Comparison m  Outcome ing aboyp th?
50th_£££cenfcile_and_those Scoring Below on the ZUNG
Depress ion Scale.
Mean % Change in WSR
Pre-Treatment Zung score above 31 34
Pre-Treatment Zung score below 31 46
t = 3.21 p < 0.002
3. •'SEVERITY” IN TERMS OF TIME SINCE DIAGNOSIS.
Time since diagnosis is essentially a measure of 
chronicity. Experience in the use of psychological 
therapies would lead one to suppose that the longer a 
patient has had a problem, the more different clinicians 
he has seen, and the more different treatments he has 
tried the less likely he is to do well. However it must be 
remembered that none of these patients has had any formal 
psychological therapy before and so there is no particular 
reason to suppose that the usual rule will apply.
The variable 'Time Since Diagnosis' is not normally 
distributed: the range is from 0 to 30 years with a median 
of 3 years. Non—parametric statistics are the most 
appropriate in this case.
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Results show a Spearman's correlation coefficient of -.23, 
P — 0.04, between change in WSR and time since diagnosis. 
The scattergram showed wide scatter and there was no 
suggestion of clusters of patients with a long history and 
poor outcome or short history and good outcome.
As a further test the sample was divided into two groups, 
those with a history of longer than 3 years and those with 
a history of 3 years or less. Mean baseline WSR and mean 
total change in WSR were compared for the two groups 
'chronic' and 'not chronic'. Differences between the 
groups did not approach significance. It is apparent, 
therefore, that if chronicity is a poor prognostic sign it 
is a very weak one.
4. "SEVERITY" IN TERMS OF RESTRICTED ACTIVITIES.
Another possible indicator of severity is functional 
impact of the disorder. In this study the measure of 
functional impact is the number of normal activities that 
the patient feels restricted in or barred from as a result 
of his epilepsy. Patients' attitude to their disability 
tends to vary greatly from one individual to another. Some 
with a relatively low seizure frequency (for this sample) 
were housebound and dependent. Others refused to give up 
any activity; several patients in the study with a seizure 
frequency in excess of two per week were still driving a 
car on a regular basis.
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The Activities' variable is a 9 point ordinal scale, with 
a pre—treatment mode score of 3. The sample was divided 
into two groups, those scoring above 3, (18 subjects) and 
those scoring below 3 (15 subjects.) A t - test showed no 
difference in baseline WSR or total change in WSR between 
the groups. Pre-treatment disability level, measured in 
this way, is not related to outcome.
5. CONCLUSIONS AND IMPLICATIONS.
In conclusion, only one aspect of pre-treatment 'severity' 
is a predictor of treatment outcome in terms of seizure 
frequency. An initially high score on the Zung scale 
appears to be associated with less reduction in seizure 
frequency during Treatment B. , even although Treatment B 
appears to be effective in reducing score on the Zung 
scale. If depression were actively increasing seizure 
frequency then alleviating it should decrease seizure 
frequency. The fact that it does not suggests that there 
is no causal relationship in the direction shown below:
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Depression — —--------  ^ Seizure Frequency.
Neither can there be a significant causal relationship in 
the opposite direction:
Seizure Frequency ----- > Depression.
If there were then it seems mOst unlikely that depression 
could be effectively treated while seizure frequency 
remained relatively unchanged.
How, then, can the relationship between pre-treatment Zung 
score and amount of reduction in WSR be explained? It is 
proposed that some unknown factor causes both depression 
and seizures to be resistant to the effects of 
psychological treatment.
Factor X.
Seizure Frequency Depression
This factor would be a predictor of poor treatment 
response and therefore of practical and theoretical 
importance. Variables which may by their presence, or by 
their absence, predict treatment response are examined in 
the subsequent chapter. It may be possible to show that 
one of these is related to both seizure frequency and to 
depression.
FACTOR£_PQTENTMLLI_ADyANTAGEOUS FOR TREATMENT.
1. AURAS
2. FACTORS WHICH PROVOKE SEIZURES
3. INDEPENDENCE
This section examines factors which might be considered 
advantageous for treatment. If they are then they may be 
predictors of treatment response, or even pre-requisites 
for a successful reduction in seizure frequency.
At the end of the previous section, under 'Conclusions and 
Implications', a question was raised concerning the 
relationship between seizure frequency and score on the 
Zung depression scale. It appears that a pre-treatment 
high Zung score is associated with less improvement in 
seizure frequency. Since Zung score falls significantly 
with treatment it seems unlikely that there could be a 
direct relationship between the two variables. Some other 
factor might link seizure frequency and depression and 
explain these results. It is proposed that the lack of one
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or other of the factors discussed in this section might be 
related to depression and might also be related to poor 
treatment response. Each factor will be examined with this 
in view.
1. AURAS
An 'aura' is generally defined as some sensory experience 
or alteration in consciousness which precedes a seizure.
In the case of temporal lobe seizures the aura is 
frequently some vivid sensory hallucination, although in 
other cases the feeling is indescribable. Patients who do 
not have temporal lobe epilepsy not infrequently 
experience some indication that they are about to have a 
seizure. Strictly the 'auras' associated with temporal 
lobe epilepsy are part of the seizure itself. Probably the 
feeling of an impending seizure in other forms of epilepsy 
also represents electrical changes preceding the actual 
burst of activity which constitutes the seizure itself.
For the purpose of this discussion any kind of seizure 
warning will be termed an aura.
a) Auras in Relation to Treatment Response.
In this sample 42 patients experience an aura or some form 
of warning that they are about to have a seizure, and 17
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do not. In this case the hypothesis is clear. Treatment A 
almost requires subjects to have sufficient notice of a 
seizure to carry out some form of interruption technique. 
It is predicted, therefore, that patients with an aura 
better during Treatment A than those without. 
There is no particular reason to assume that the presence 
of an aura will have any influence on susceptibility to 
Treatment B.
Table 13 shows mean % changes in WSR from baseline to 
final follow - up for subjects who experience an aura and 
those who do not. There was no significant difference in 
'baseline seizure frequency between these two groups, and 
the distribution of % change in WSR was approximately 
normal.
Table 13
Difference in Treatment Response Between Subjects with 
Aura and Those Without.
! Subjects with 'Aura' 
! n = 42
Mean % change in WSR 
49. 77
JSubjects without 'Aura' 
n = 17
Mean % change in WSR 
16. 39
t = 2.49______ p = 0.02
If the above hypothesis holds it would be expected that 
almost all this difference between the two groups occurs
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during Treatment A. A comparison between change during 
treatment A and change during Treatment B can only be made 
for Groups 2 and 3 (n = 40). Within these groups there are 
only 9 subjects who do not experience an aura. This sets 
limits on statistical analysis and probably explains why 
mean change during Treatment A during Treatment B shows no
significant difference between patients with aura and
those without.
Table 14
Difference in Response to Treatments A and B Between
Subjects with Aura and Those Without.
Change with T.A. Change with T.B.
Subjects with Aura 
n = 29 30.48% 20.37%
Subjects without Aura 
n = 9 27.78% 27.38%
The advantage of using this structure for the data is that 
Treatment effects are measured across Treatment groups.
For example, some subjects with an aura were in Group 2 
and had Treatment A first, some were in Group 3 and had 
Treatment A second. It has been shown that treatment order 
has no effect and so it is permissible to ignore grouping 
by Treatment condition. If Group had to be included in the 
model at this stage numbers in each cell would be very 
small. There were, for example, only 3 patients in
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Treatment Group 2 who had no aura. When 'No aura' patients 
from Group 2 are added to the 'No aura' patients from 
Group 3, there are 9 of them. The disadvantage is that it 
is not possible to use analysis of variance when the data 
are in this form because assumptions are violated. This 
means that the source of any differences cannot be 
detected statistically. Chi-squared, however, using the 
method describrd by Meddis (155), is applicable and the 
source of any significant differences can be identified by 
a process of elimiation since it is already known that the 
effectiveness of each Treatment is similar (see Chapter
6). Any differences, therefore, must be attributable to 
the effect of the variable 'Aura' or to an interaction 
between 'Aura' and treatment type. The same arguments 
apply when considering the other two factors of interest, 
knowledge of'Provocative' factors and 'Independence'.
A chi-squared test was carried out, comparing the cell 
means with their expected value if Traetment A and 
Treatment B had exactly the same effect and if presence or 
absence of an aura was irrelevant. In this hypothetical 
case the cell means would all have the same value, 26.6%, 
the overall mean change. The chi-squared value was not 
significant. It was demonstrated in Chapter 6 that both 
treatments have the same effect and so if the chi—squared 
value had been significant it would have been safe to 
assume that the differences were attributable to the 
effect of having, or not having, an aura. Within the aura
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group, there is a 10% greater change during A than during 
B. This difference is in the expected direction. The trend 
supports the hypothesis that experiencing some form of 
warning before a seizure confers an advantage for 
Treatment A. It is certainly possible that with a larger 
sample size it would be possible to demonstrate this 
statistically.
b) Auras in Relation to Depression and Seizure Frequency.
The model proposed at the end of the previous section 
suggests that there could be some unknown factor linking
depression to seizure frequency. The next step is to
consider whether presence or absence of an aura could be 
this missing factor. If it is then either its presence or 
its absence should be associated with high scores on the 
Zung scale and relatively small change in seizure
frequency. It has already been shown that patients who do
not experience a warning before a seizure tend to do worse 
with treatment. Is there any particular reason to 
hypothesise that they might also be more depressed before 
treatment? This is a theoretically complex issue in which 
two possibilities must be considered before forming that 
hypothesis. It might be expected that patients with 
frequent seizures which occurred without any warning would 
be more likely to suffer from "learned helplessness" and 
as a consequence to have high Zung scores. However the
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type of seizure may influence the psychological 
symptomatology. An aura is a warning of a seizure only 
from the patient's point of view; in reality it is a part 
the seizure itself and the type of aura is determined 
by the location of the seizure activity. Not infrequently 
(in this sample approximately 40%) an important component 
of the aura is a sense of fear or impending disaster. No 
doubt in some cases this is a psychological response to 
the imminence of an unpleasant event. In other cases it 
may be a product of limbic lobe seizure activity. In 
either case the frequent experience of this unpleasant 
emotion may elevate the patient's score on the Zung scale. 
The obvious prediction is that in some cases the absence 
of an aura would lead to depression while in those cases 
where the aura itself is emotionally unpleasant there 
might also be a tendency to depression. Ideally it should 
be possible to sub-divide the sample into those who 
experience no aura, those whose aura is mainly affectual 
in type, and those whose aura consists of some other 
phenomenon, such as some sensory hallucination. The three 
groups could then be compared in terras of Zung score. This 
sub—division is not a practical option because patients 
find it extremely difficult to describe the beginning of a 
seizure; by the time all patients who were unable to say 
with certainty whether or not unpleasant emotion was a 
significant component of their aura had been excluded, the 
sample size would be too small for analysis. The 
sub-division, therefore, remains two-way and the
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hypothesis, if it can be called a hypothesis, is simply 
that either presence or absence of auras may be associated 
with raised Zung scores.
Table 15 shows the results of a comparison between the two 
groups, those with an aura and those without, in terms of 
pre-treatment Zung score.
Table 15
Differences in Pre-Treatment Zung score Retwefin Sub.iects 
with 'Aura* and those Without.
ZUNG
With Aura 34. 48
Without Aura 49. 56
t = 4. 45 p < 0.001
This result suggests that patients who do not have any 
warning of an impending seizure are on the whole more 
depressed. They also tend to do less well with treatment 
overall. It is therefore possible that the following 
relationship exists:
No Aura
Depression Less Change in WSR
High Zung score would not, in this case, be a predictor of
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poor ‘treatment outcome, and the correlation shown in Table 
10 would be spurious. The absence of an aura would be, 
however, both a predictor of treatment outcome and of Zung 
score.
2. FACTORS WHICH PROVOKE SEIZURES.
Most patients have theories about conditions, 
circumstances or events which tend to increase the 
probabilty of having a seizure. No doubt in some cases the 
‘theories are very valid; in other cases they may be 
self-fulfilling prophecies, and in others simply an effort 
after meaning without any true relationship to reality. In 
this sample 35 patients reported that they knew of some 
factor or factors which tended to increase the probability 
of having a seizure. The remaining 24 knew of no such 
factors. The incidence of different factors was similar to 
that of the preliminary study, with the majority of 
patients reporting that stress, tension or anxiety 
'caused' seizures.
a) Provocative Factors in Relationship to Treatment 
Response.
These factors may not be of much direct use for seizure 
interruption techniques since they are generally a much
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longer term phenomenon than auras. The stress or tension 
referred to by patients tends to be a product of some 
circumstance or set of circumstances. They believe that 
seizures follow a period of increased stress, or tiredness 
or hunger or whatever the provocative factor might be. It 
will be seen that Treatment A deals only with interrupting 
events, sensations etc. which immediately precede the 
seizure or which are part of the ictal event itself, not 
with background provocative factors. If the distinction 
was absolutely clear then it would be predicted that 
knowledge of provocative factors would confer no special 
advantage for Treatment A. If the provocative factors are 
background psychological problems then they may form a 
basis for Treatment B to be effective.
There may, however, be some difficulty in determining what 
is an aura and what is a provocative factor in some cases. 
Case no. 27 reported that she thought that she was more 
likely to have a seizure after she had been arguing with 
her husband. She also reported that she experienced a 
feeling of unbearable rage and frustration immediately 
before the onset of a seizure. Cause and effect, and 
consequently suppositions about the mechanism of 
treatment, become very mixed in this sort of case. Does 
quarrelling leading to a particularly intense feeling of 
rage activate an electrically unstable part of this 
patient's brain and trigger a seizure? Or do the 
electrical changes preceding a seizure cause the patient
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to become irritable and quarrelsome? If the first is true 
then a form of Treatment B focusing on improving the 
management of the relationship to avoid conflicts might be 
effective. If the second is true then teaching the patient 
to inhibit or counteract the sensations associated with 
rage in a form of Treatment A may be effective. In cases 
such as this where it is not clear whether the so called 
provocative factor is a * trigger' or an aura it is not 
possible to predict whether it will be a predictor of 
success for Treatment A or for Treatment B.
Table 16 shows the relationship between overall treatment 
response and provocative factors.
Table 16.
Difference in Treatment Response between Patients who
report Provocative 
Factors and Patients who do not.
11
! Provocative Factors
i
i
! Mean % change in WSR
! N = 35 ti 46. 76
1
! No Provocative Factors
i
! Mean % change in WSR
i n = 24
ii
i
i
i
t__
30. 51
t = 1.36______ £ll_taill_E_0^Q9
As in the case when the sample was divided according to 
presence or absence of an aura, there was no significant 
difference between the groups in terms of baseline seizure 
frequency, and the distributions of % change approximated
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to normal.
The result shows that there may be a slight tendency for 
patients who can identify so-called 'provocative" factors 
to do better, but that the difference is not significant. 
Given the trend, it is worth sub-dividing response during 
the two treatments to see whether there is a difference 
between the groups on one treatment only. Table 17 shows 
the results of this. It should be noted that the total 
subject number is smaller than in the above table because 
only two thirds of the sample have both treatments.
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Iablfl.12
— In Response to Treatments A and B between 
Patignts_who Report Proyp^a-^jv^ Factors and Patients who
do not.
Change with T.A. Change with T.B.
Provocative Factors 
n = 22 19.89% 25.85%
No Provocative Factors 
n = 16 45.10% 16.76%
X =  27. 83 P < 0 . 001.
A Chi-squared test was carried out, comparing the cell 
means with their expected value if Treatment A and 
Treatment B had exactly the same effect and if presence or 
absence of provocative factors was irrelevant. In this 
hypothetical case the cell means would all have the same 
value, 26.8%, the overall mean change. (Note that this 
value is 0.2% different than the expected value quoted 
when discussing the effect of 'aura’ on Treatment due to 
the effect of rounding values off to two decimal places.) 
The chi—squared value is significant and so it may be 
concluded that knowledge of provocative factors does 
influence treatment outcome. It can be assumed that the 
differences in the cells in the above Table are 
attributable to an interaction between Provocative factors 
and Treatment, since it has been shown in Chapter 6 that
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both Treatments have an equal effect, and in Table 16 "that 
if patients knowing of provocative factors are simply 
compared with those who do not, the difference is not 
significant. It appears, then, that the 'No Provocative 
Factors' group do better with Treatment A. This finding 
can probably be explained by the fact that a large 
proportion of patients feel that stress, anxiety etc. 
provoke seizures. Treatment B deals specifically with 
anxiety while Treatment A ignores it. Comparing the STAI 
scores of the 'Provocative factors' group with the scores 
of the 'No Provocative factors' group, provides further 
Support for this hypothesis. Data for this comparison are 
presented in Table 18.
Table 18
STAI Scores for Patients who Report Provocative Factors 
and Patients who do not.
11
«1 STAI (state) STAI (trait)
1
{ Provocative Factors 
! n = 35
46. 37 44.63
1
|No Provocative Factors 
j n = 24
ii
61. 62 53. 98
= 2.52 p < 0. 01 
t(trait) = 1. 72 ._p._=-JL-Q£
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b) Provocative Factors in Relation to Depression and 
Seizure Frequency.
Any hypothesis relating knowledge of provocative factors 
to depression would be rather weak. On the one hand, as in 
the case of auras, it might be predicted that having no 
idea of any factor which increased seizure probability, 
might lead to "learned helplessness". On the other hand 
knowing of such factors but being unable to avoid them 
might be more depressing. In any case there is an 
'iss^sociation between anxiety and depression and anxiety and 
'Provocative factors' and so there is a risk that an 
apparent association between depression and 'Provocative 
factors' would be spurious. While it might be possible to 
form a rational hypothesis about any one individual's 
level of depression if something was known of that 
individual's circumstances and seizure type, 
generalisations over the whole sample are unlikely to 
meaningful. However, a t-test comparing mean Zung score 
for patients who know of provocative factors with Zung 
score for those who do not was carried out. The result was 
not significant. It may be assumed, therefore, that 
1 Provocative factors do not explain the relationship 
between depression and seizure frequency.
3. INDEPENDENCE
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An 'Independent' patient in this study is one who neither 
requires nor gets assistance from anyone during his 
seizures or immediately following them, and keeps he own 
seizure record. The reasons for including this variable 
and defining it in this particular way are discussed in 
Chapter 5. In this sample 27 patients are 'Independent' 
and 32 are not. Eight patients who were not independent at 
the beginning of treatment became independent. All of 
these 8 had more than a 50% reduction in WSR. Since the 
?llTXffiber who changed their independence is small this 
variable will be considered as a constant variable.
a) Independence in Relation to Treatment Response.
The 'common sense' hypothesis is that independent patients 
will be more likely to benefit from self administered 
treatments. These rely very heavily on self-motivation, 
and input and supervision by the therapist are minimal. It 
is unlikely that patients who are unable keep their own 
seizure frequency records would do as well with this type 
of treatment as 'independent' patients. This may be 
because they are less intelligent, have a greater 
incidence of cerebral impairment, or because they are 
unused to self—regulation. Table 19 shows mean % changes 
from baseline to follow-up for independent patients and 
non-independent patients. As in the case of the other two
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factors discussed, there is no significant difference 
between Independent* and * Non—Independent* patients in 
terms of baseline seizure frequency.
Table 19
Difference in Treatment Response Between Independent 
Sub.iects and Non-Independent Subjects.
Independent (27) Mean % change in WSR 52.96.
Non-independent (32) Mean % change in WSR 29.35.
t = 2. 06 p - 0. 04
This difference, although significant and in the predicted 
direction, is not as large as might be expected when the 
fact that treatments require a high degree of 
self-motivaton is considered. Possibly the reason for this 
is that the influence of a spouse or relative has not been 
taken into consideration. Non-independent patients, by 
definition, require support and supervision. It is likely 
that a spouse or relative will also be active in 
supporting and encouraging the patient in Treatment A and 
B. Indeed in both treatments relatives are actually 
encouraged to participate. Treatment A, however, is the 
more specific] it does not involve tackling psychological 
problems which are sometimes long-standing and rather 
diffuse. Experience in administering the treatments led to 
the observation that non-independent patients and their
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relatives could grasp the principles of Treatment A and 
co-operate in applying them in much the same way as they 
co-operate with administring drug-treatments. It was 
rather more difficult to gain the co-operation of 
non-independent patients for Treatment B. They perceived 
this as having nothing to do with their epilepsy and on 
the whole were more unhappy with the therapist*s avoidance 
of discussing their seizures during Treatment B. It is 
predicted, therefore, that non-independent patients will 
have a smaller change in seizure frequency during 
Treatment B than during Treatment A, and that this will 
^Xplain a large part of the difference between the 
Independent and Non-Indepedent groups shown in Table 19.
llQCi6Per)dgbt *— Subjects and * Non-Independent .} Sub-iects.
11
111 Change with T.A. Change with T.B.
J Independent Subjects 
! n = 19
i
27.86% 35.73%
JNon-Indpendent Subj. 
! n = 19
i
31.83% 10.32%
-JLk. 1Z^14___ pio^ooi
A chi-squared test, comparing the cell means with their 
expected value if neither treatment nor independence 
influenced outcome, that is, the overall mean 26.7%, was 
significant. As predicted non-independent patient's poor 
response to Treatment B appears to be responsible for this 
difference.
b) Independence in Relation to Depression and Seizure 
Frequency.
In considering any possible relationship between 
independence and depression the implications of 
non—independence must be considered. It is likely that a 
patient who requires assistance during his seizures has 
seizures which are in some sense more severe . In this 
sample generalised seizures are relatively rare, but a 
tendency to fall or to wander off during an attack or to 
carry out some bizarre automatism, is more common, (see
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section dealing with type of epilepsy in Chapter 9). In 
the case of this group of patients any depression would 
not necessarily be due to lack of independence per se, but 
to the distressing nature of the attacks. If, however, it 
were possible to separate patients into two groups by some 
objective criterion into those who require supervision and 
those who do not, it would be seen that the correspondence 
with Independence was inexact. Many patients who get 
assisstance during a seizure may not require it in terms 
of the hypothetical objective criterion. Similarly some 
patients who have a tendency to fall and injure themselves 
during a seizure declare that they are quite independent. 
There may, therefore, be a sub-group of patients who are 
depressed as a direct result of non-independence. A 
discussion of the theoretical issues linking lack of 
independence with depression is beyond the scope of this 
study but since patients have little knowledge of what 
actually happens during their seizures many find the 
solicitations of a caring relative uneccesary and 
frustrating. Others simply become helpless and dependent. 
Either frustration or dependence could produce depression 
in the sense in which it is measured on the Zung scale.
There is one other possibility that must be mentioned 
before forming a definite hypothesis. What of the patients 
who are Independent because they have no-one to look after 
them and who feel this as a depressing lack? Among the 40 
patients who scored above the criterion on the GHQ and who
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were consequently assessed in detail with respect to their 
psychological background, only 2 appeared to be depressed 
as a result of unwanted Independence. This possibility can 
therefore be ignored where the purpose is simply to make a 
generalisation about a possible link between 
non-Independence and depression.
The diagram may serve to clarify this relatively complex 
discussion.
It will be seen that the argument leads to a prediction 
that non-Independence will be associated with higher 
scores on the Zung scale than Independence. Table 21 shows 
the results of a comparison between the two groups, 
Independent and non-independent, in terms of pre—treatment 
Zung score.
's.E.v/e.p.rrV of S£i2of*.€.*,
fJoM - lNDtP£Mfc£MC_e C>EPP-£4.SVOkI
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Iable_ai
Dj£ferensgs_in Pre-Tr^ ati-pent Zung score Between
Independent and Non-
ZUNG
Independent (20) 33. 40
Non-Independent (20) 42. 35
t.= 2.38 p(l tail) = 0.012
Thus it has been demonstrated that non-independent 
patients tend to do less well with Treatment B and that 
they tend to be more depressed. Non-Independence may, as 
well as lack of an aura, explain the anomalous results 
concerning the relationship between depression and 
treatment outcome. The inter-relation between these 
variables is becoming complex; discriminate analysis will 
be used to determine their influence on treatment outcome 
when they are considered together rather than seperately. 
Before carrying this out, however, the potential 
predictive value of the remaining * demographic * variables 
must be evaluated.
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CMEIEE_9
DEMOGRAPHIC. VARIABLES AS
1. AGE
2. SEX
3. MARITAL STATUS
4. TYPE OF EPILEPSY
These variables require only brief consideration because 
they are of no particular relevance to any treatment 
mechanism theory. They may, however, have an incidental 
effect on treatment response, and before selecting the 
best combination of variables for predicting outcome it is 
important to exclude the possibility that any one of the 
variables which might be termed 'demographic’ is having a 
significant effect.
1. AGE
The age range of the treatment sample is 16 to 60 with a
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mean of 31.9 years and a standard deviation of 12.2 years. 
Thus the whole of the adult population is represented with 
the exclusion of the elderly. Within this range certain 
changes in responsiveness to treatment might be expected. 
Older patients might possibly be a little more rigid and 
less inclined to accept the suggestion that a 
physiological event, such as a seizure, might come under 
psychological control. The fact of having a longer history 
of seizures might disincline them to this point of view.
If this were the only age related factor then it would be 
hypothesised that the patients whose WSR decreased most 
--during treatment were younger. However age is closely 
related to some of the other variables (independence, for 
example) which might act in the opposite direction, making 
this hypothesis rather facile. In fact a groups comparison 
t-test showed no significant difference in mean age 
between the patients whose WSR reduced by 59% or more (the 
"best" third) and those whose WSR reduced by 26% or less 
(the "worst” third). Neither was there a significant 
correlation between age and percent improvement in WSR.
2. SEX
In this sample there were 26 males and 35 females evenly 
distributed amongst the three groups. It might just be 
possible that sex could have an effect on outcome through 
an interaction with the sex of the therapist. It is widely
-191-
accepted that, therapist variables can influence treatment 
success and that the sex of the therapist is more or less 
influential depending on the type of therapy. In some 
cases a male therapist is perceived as being more 
competent, particularly by male patients, and in other 
cases a female therapist is perceived by female patients 
as being easier to talk to. It might therefore be 
hypothesised that female patients will respond best to 
treatment, perhaps particularly in Treatment B where 
discussion of personal matters is necessary. A Chi-squared 
test shows that there is no difference between the 
^proportion of males in each of the two outcome groups as 
defined above.
3. MARITAL STATUS
The preliminary study showed an interesting relationship 
between marital status and GHQ; that is that married 
patients tended to have higher GHQ scores. The following 
relationships might be postulated:
Married > GHQ > WSR. However the weakness in these 
relationships has already been demonstrated and it seems 
very unlikely that this mechanism exists to any 
significant degree. Even if it did, the effect on WSR 
would be constant so that it would not necessarily 
influence change in WSR in either direction. Before 
rejecting marital status as irrelevant it is necessary to
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cons ider the usefulness of a spouse as a co-therapist. In 
treatment A a relative, frequently a spouse was given 
instructions to help the patient interrupt his seizures 
and to remind him what he was supposed to do. It might 
therefore be expected that treatment A would work better 
if the patient were married. In fact 'Independence' is a 
more relevant variable in this context since only patients 
who were not 'independent' would have a relative on hand 
to give advice during seizures. Many married patients were 
independent in this respect and many unmarried were not. 
The hypothesis, then, is that marital status will not 
^affect treatment outcome. Results of data analysis confirm 
this; there is no difference between mean change in WSR 
between married patients and unmarried patients. A 
chi-squared test comparing number of married patients in 
each of the two categories of improvement also showed no 
difference.
4. TYPE OF EPILEPSY
It is well known that seizures of a centrencephalic origin 
can be more readily controlled by pharmacological means 
than seizures with a focal origin. Secondary 
generalisation of partial seizures can usually be 
prevented effectively by drugs. The primary implication of 
this for the present study is that since the sample by 
definition is poorly controlled, most patients will have
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some form of partial epilepsy. This is indeed the case: 
reference to Table 5. will show that 26 patients have 
partial seizures only, 29 have partial seizures with 
occasional secondary generalisations, and that in 4 cases 
it was not possible to define the seizure type. No 
patients had primary generalised epilepsy. Essentially, in 
terms of the definitions used, 'type of epilepsy' divides 
patients into only two groups; one with and one without 
occasional secondary generalised seizures. If these 
seizures had occurred frequently then it would have been 
possible to see if psychological treatments were more 
^effective against one type than another in any given 
patient. Unfortunately from the point of view, of the 29 
patients who had generalised seizures the highest 
frequency was 1 per month and the mean frequency 1 in six 
months. This is too low to compare teatment effectiveness 
within subjects. The two groups can be compared in terms 
of mean % change in WSR, in case there is some inherent 
difference between them; results showed no significant 
difference in mean % change in WSR between the groups.
The most important question to be considered is whether 
psychological treatment is simply eliminating 
non—epileptic seizures. Possibly, despite the criteria of 
patient selection, the sample contains two groups, those 
with epileptic seizures and those with pseudo—epileptic 
seizures, this division cutting across the division 
discussed above. If there were two distinct groups with
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treatment being effective against non-epileptic seizures 
only, then one would expect the distribution of the 
variable % change in WSR to be more binomial than normal. 
Figure 5 demonstrates that this is not the case.
An alternative possibility is that all patients have 
epileptic seizures but that a large proportion have 
pseudo-epileptic seizures as well. Figures as high as 26% 
have been cited in the literature (94). Treatment could be 
effective only against these non-epileptic seizures and 
still result in the same distribution of treatment 
^success. Although some proportion of the seizures 
eliminated by treatment may be non-epileptic there are a 
number of reasons why this is not a satisfactory 
explanation for the whole treatment effect. If the 
treatments in the study are only effective against 
pseudo-epileptic seizures then in order to create the 
size of treatment response - a 50% improvement in 50% of 
cases - we must assume that most of the sample were having 
mostly pseudo-epileptic seizures at the start of 
treatment. It can be imagined that secondary gain may 
maintain a high seizure frequency in some individuals but 
it seems unlikely that this could occur in over half of a 
randomly selected sample given that the highest estimate 
in the literature is 26%. In any case neither treatment 
aims to eliminate secondary gain: Treatment B may do so 
indirectly, but Treatment A not at all. Fenton (90) 
suggests that the treatment of pseudo-epileptic seizures
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is complex, should be carried out in a in-patient setting 
and requires follow-up over several years. It seems 
unlikely that the short simple treatments employed in this 
study could be effective against non-epileptic seizures. 
Given these arguments it is reasonable to accept that 
psychological treatments eliminate genuine epileptic 
seizures. They may eliminate non-epileptic seizures as 
well, but they are not specifically directed against these 
any more than are pharmacological treatments.
^EtT'may be concluded that neither age, sex, marital status, 
or type of epilepsy are predictors of treatment reponse 
and that they may safely be ignored in further data 
analysis.
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£HAEXER_1Q
COMBINING PREDICTORS.
The previous three chapters in this section have 
identified some factors which are associated with 
treatment success or relative lack of success. These are 
pre-treatment score on the Zung scale, presence or absence 
of auras, presence or absence of 'provocative' factors and 
* independence'. Although these factors show a significant 
relationship with % change in WSR, individually they are 
not of much pratical use in predicting treatment outcome; 
they explain a relatively small proportion of the variance 
in % change in WSR. As discussed in Chapter 8 the apparent 
relationship between an initially high Zung score and poor 
reponse to Treatment B is in any case probably spurious. 
There is evidence that the apparent advantage of lack of 
provocative factors is simply a result of the fact that 
there is a strong association between knowledge of 
provocative factors and anxiety. However it is worth 
examining the possibility that some combination of 
variables is a useful predictor of outcome. This 
combination should include the three individually 
significant variables. It might also include 'Provocative 
factors', which failed to reach significance but which for 
theoretical reasons could be relevant.
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The most sensitive and efficient statistical tool for this 
type of problem is discriminant analysis. The concept 
underlying discriminant analysis is fairly simple. Linear 
combinations of independent variables — that is the 
possible predictor variables - are formed and serve as the 
basis for classifying cases into one of two groups, in 
this case good outcome and poor outcome. For the linear 
discriminant function to be 'optimal' that is, to provide 
a classification rule that minimises the probability of 
misclassification, certain assumptions about the data must 
be^met. Each group must be a sample from a multivariate 
normal population. SPSSX's "DISCRIMINANT" package carries 
out Box's M test, which is based on the determinants of 
the group covariance matrices. The significance 
probability is based on an F transformation. A small 
probability would require rejection of the null hypothesis 
that the covariance matrices are equal. The test is also 
sensitive to departures from multivariate normality so 
that it tends to call covariance matrices unequal if the 
normality assumpton is violated. In each of the 
discriminant analyses which follow a Box's M test was 
carried out and in each case the significance level was 
rather borderline, that is between 0.05 and 0.06. The most 
likely reason is that some of the independent "predictor 
variables" are not near enough to normal. A further 
problem is that some of the variables (Independence, Aura, 
Provocative factors) are dichotomous. Gilbert (156),
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however, concludes that, most evidence suggests that linear 
discriminant function performs quite well with dichotomous 
variables. Mixtures of dichotomous and continuous 
variables are less promising. It is apparent that the data 
are not absolutely ideal for the use of discriminant 
analysis, but it was decided that since the method has so 
much to offer it would be used, but that the significance 
of results would be regarded with some degree of caution.
Discriminant analysis can separate cases into two groups 
by^-calculating one discriminant function which maximises 
the ratio of between- to within- groups sums of squares.
If there are more than two groups, one less discriminant 
function than the number of groups, is calculated. A two 
group division seems the most appropriate; the results 
fall more naturally into two groups, poor and good 
outcome, than three - poor, moderate and good. The 
division was made along the 50% line so that one group 
contained 32 subjects who had had less than 50% 
improvement in WSR and another which contained 27 subjects 
who had had a 50% or more improvement in WSR.
Discriminant analysis was carried out using eight 
variables: all four pre-treatment scores on the 
psychopathology measures, score on the Activities scale, 
Independence, presence or absence of auras and knowledge 
of factors increasing seizure probability. A stepwise
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variable selection procedure was used, with the criterion 
for variable selection being to minimise Wilks' lambda. 
Wilks' lambda is the ratio of within groups sum of squares 
to total sum of squares. The closer that lambda is to 0 
the greater the proportion of total variability 
attributable to differences between the means of the 
groups. The variables entered after 4 steps are 
'Independence', 'aura' and the pre-treatment Zung and 
State anxiety scores. The remaining variables did not 
reach criterion for entry after four steps. Table 21 gives 
Wilks' lambda values after each of the variables has been 
-centered. The order of the variables is according to the 
size of their effect, from largest to smallest.
Table 21
Variables used to discriminate between two outcome 
categories: change in WSR above 50% and below 50%.
VARIABLE WILKS' LAMBDA SIGNIFICANCE
1. Independence 0. 899 0.014
2. Aura 0. 859 0.014
3. Pre- ZUNG 0. 829 0.015
4. Pre- STAIS 0. 791 0.012
The classification results, using discriminant function 
scores based on the above variables, show that 68.7% of 
patients with "good" outcome are classified correctly, and
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that 74.1% of poor" outcome patients are classified 
correctly.
Returning to the mean score on the four key variables it 
is seen that being independent and experiencing a warning 
of a seizure are good prognostic signs and that high state 
anxiety and a high depression score are bad prognostic 
signs. The point of discriminant analysis is, of course, 
that these variables are only of use in predicting outcome 
when taken together. In fact given the 60 - 70% hit rate 
it will not be practical to exclude patients from
^treatment by their score on the discriminant function;
there would be too many false classifications. The results 
do, however, tend to support part of the original 
hypotheses: 'Independent' patients do indeed do better and
so do patients experiencing auras. Highly anxious and 
depressed patients do not do well; the implication is that 
they might need more intensive prolonged treatment to 
bring their symptoms under control.
The definitions of "good" and "poor" so far have been 
completely arbitrary. It is not usual to define an
improvement of less than 50% as a poor outcome. The whole
procedure was repeated using subjects towards the ends of 
the distribution shown in Figure 5. The new groups were 
"good" with 19 subjects who improved by 59% or more and 
"Poor" with 18 subjects who improved by 26% or less. It 
was considered that these were the minimum sized groups
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for analysis. Again four variables had a sufficient F-to 
enter in the stepwise analysis and are displayed in Table 
22.
Table 22
Variables used to discriminate hpf-.wppi^ t-.un rm-hr>nrpp>
categories.: change in WSR above 56% and change in WSR
below 26%
VARIABLE WILKS' LAMBDA SIGNIFICANCE
1. Aura 0. 823 0. 009
“2. Pre-Zung 0. 715 0. 003
3. Pre-STAIS 0.671 0. 004
4. Activities 0. 636 0. 006
It will be seen that 'Independence' is no longer 
important, but that score on the activities scale is.
Using these function scores the classification rate is 
83.3% "Good" outcome patients correctly classified and 
78.9% "Poor" outcome correctly classified. The result is 
much better than in the first analysis; the final lambda 
after four steps is down to 0.631, showing that a 
relatively larger proportion of the variance is 
attributable to group differences. In practical terms this 
means that a patient who does not consider himself to be 
banned from more than two activities, who experiences some 
warning of a seizure and who has a State anxiety score of
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less than 54 and a Zung depression score of less than 28 
is very likely to improve by at least 50% with treatment. 
It should be noted that a State anxiety score of 54 is 
almost 2 standard deviations above college student norms 
and so the treatment can obviously cope with relatively 
high anxiety levels. The inverse of these factors predicts 
a poor outcome and so in reality a depressed, restricted 
patient who never knows from one minute to the next when 
he might have a seizure is not likely to benefit from 
treatment. Those falling between these categories may or 
may not benefit.
These predictor variables are not in any way surprising; 
they could have been assumed without any complex 
statistical analysis. Discriminant analysis has not added 
significantly to the information obtained by examining 
each variable independently. However the classification 
rates show that these variables, taken in combination, are 
reliable indicators of treatment success and failure, 
albeit only in the top and bottom third of outcome range. 
Chapters 7, 8 and 9 examined the theoretical aspects of 
the effects of these variables on outcome. Discriminant 
analysis has given an indication of their quantitative 
effect.
-203-
QME1EE_11
LIMITATIQM^_gQNgLUSIQNS AND FINAL EVALUATION.
1. LIMITATIONS
2. CONCLUSIONS
3. FINAL EVALUATION
1. LIMITATIONS.
Inevitably in a clinical study of this kind there are 
problems in making precise definitions of samples and 
experimental treatments. Although all subjects in the 
study had some form of partial seizure, there was a great 
deal of individual variation in seizure type and in type 
of psychological difficulty. As a result of this 
treatments were defined within rather broad limits to 
cater for the variance in type of problem treated.
Seizure frequency may appear to be a precise, objective 
outcome measure since it may be thought that either the 
subject has a seizure or he does not. Error must be
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expect-ed, however, in any experiment where the main 
outcome measure is based on subjects' self-report and not 
on direct observation. There may be a tendency to under 
report seizures to please the therapist, and although 
where possible relatives were involved in seizure 
reporting, sometimes subjects kept their own records and 
it must be expected that some seizures would be forgotten. 
In some cases the relative or patient may not be sure 
whether a seizure has occurred or not. One of the 
unmeasured effects of treatment was that patients often 
reported that seizures had become shorter and less 
itffr&tise. This evidence in itself might lead to less 
accurate recording, and also throws into question the 
validity of seizure frequency, rather than duration or 
severity as an outcome measure. The other outcome measures 
were standardised questionnaires and so may be assumed to 
be reliable. The question must be asked, however, to what 
extent is a score on an anxiety questionnaire a valid 
measure of the subjects 'real-life' fears and sources of 
stress, and to what extent does an improvement in score 
represent an improvement in ability to cope with stress?
Some other limitations have been discussed elsewhere. It 
has been noted that the exact proportion of 
pseudo-epileptic seizures in this sample is unknown. 
Although it is most unlikely that the whole treatment 
effect is due to the elimination of pseudoseizures, the 
uncertainty imposes limitations on inferences about
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treatment mechanisms. Unless pseudoseizures can be 
completely eliminated from the equation it is not possible 
to measure the importance of psychological disturbance in 
maintaining epileptic seizures.
Another major limitation is that all treatments were 
carried out by a single therapist. Precautions were taken 
to ensure that this did not bias the results; none of the 
outcome measure required the therapist to make any 
judgement, but a single therapist study does impose limits 
on treatment evaluation. Certainly the therapist's ability 
to "sell" the treatment and to engage the subject's 
co-operation must be an essential ingredient to treatment 
success. It is at least possible that there would be 
considerable inter-therapist variability in this and that 
the same study carried out by a different therapist may 
have led to more or less successful results. Only in a 
study using a number of therapists would it be possible to 
measure this effect.
The failure to control for, or remove these unwanted 
factors is probably inevitable in this type of clinical 
experiment. It might have been possible to design a more 
tightly controlled experiment in a laboratory' setting. 
The present study, however, was designed from a clinical 
rather than an experimental perspective. It was not 
intended to provide a definitive answer to the question of 
how psychological variables affect seizures, but to
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provide a definitive answer to the question of whether or 
not psychological intervention is of any practical use in 
the management of epilepsy. To be of practical use 
treatments must be applicable to a clinical population in 
a clinical setting. Generality is more desirable than 
precision in makink an initial assessment of the 
usefulness of treatment. However, within these limitations 
it has been possible to design and execute a controlled 
study evaluating two distinct treatments separately and 
together, and to draw a series of conclusions.
2. CONCLUSIONS.
Conclusions have been drawn throughout the study but have 
been derived from the discussion immediately preceding 
them and there has been little attempt to make major 
generalisations. In this section all previous conclusions 
are summarised and the arguments which led to them briefly 
reiterated. (Some compression is unavoidable in 
summarising complex arguments and where appropriate the 
reader is referred to the relevant sections may be 
necessary.)
In the first three chapters of this study a review of the 
literature showed that pharmocalogical management of 
epilepsy is not adequate for a significant proportion of 
patients, either because it fails to control seizures, or
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because an exclusively pharmacological approach has no 
impact on the many psychological and psycho-social 
problems of epilepsy. A review of studies using 
non-pharmacological methods of seizure control suggests 
that some techniques may be effective but that more, and 
properly controlled, studies with larger numbers of 
subjects are necessary to evaluate the usefulness of such 
methods.
In chapter 4 a study of the characteristics of a 
population of patients with epilepsy attending out-patient 
Neurology clinics formed the practical and theoretical 
basis for treatment selection and for the design of the 
treatment study described in chapter 5.
Chapters 6 - 1 0  presented the results of the treatment 
study. There was a significant decrease in seizure 
frequency during the experiment. This occurred during the 
treatment phases and not during baseline or follow-up. 
Seizure frequency did not increase significantly during 
the six month follow-up period. About 50% of patients had 
a 50% decrease in seizure frequency.
Group 1, the group with no significant psychopathology, 
did as well with one treatment as Groups 2 and 3 did with 
two treatments. Two models are proposed which could 
explain this finding. One suggests that Treatment A, which 
teaches interruption strategies, can only be effective
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after Treatment B has alleviated psychological 
disturbance. This model is rejected on the grounds that 
Group 2, who had Treatment A then B, did not do better 
than Group 3 who had Treatment B then A. The other model 
is presented algebraically and suggests that Treatment A 
brings about a smaller effect in Groups 2 and 3 than in 
Group 1 because the seizure-precipitating factors against 
which it is effective, form a smaller proportion of the 
total number of such factors in Groups 2 and 3 than in 
Group 1.
Within Groups 2 and 3 both treatments are equally 
effective and there is no significant order effect. This 
raises the possibility that in some sense they are the 
same treatment. It is unlikely that the improvement is 
simply a placebo effect since it occurs only during active 
treatment and is maintained during follow-up. It is 
suggested that their common factor is reduction in 
passivity and improved sense of self-control.
In addition to the improvement in seizure frequency,
Groups 2 and 3 showed highly significant improvements in 
measures of anxiety and depression and all three groups 
showed a reduction in the number of work related and 
social activities they felt barred from as a result of 
their epilepsy. It is noted, however, that at the end of 
treatment the overall mean weekly seizure rate is still 
above 2 and that scores on anxiety and depression scales
remain above "normal."
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Significant correlations were shown between amount of 
change in seizure frequency during Treatment B and amount 
of change in scores on the anxiety and depression scales. 
An inference is drawn that alleviating psychological 
distress causes a reduction in seizure frequency.
High pre-treatment scores on the Zung depression scale are 
associated with less reduction in seizure frequency during 
Treatment B, even although Zung score falls during 
£r¥atment. It is suggested that some unknown factor must 
cause both depression and seizures to be resistant to the 
effects of psychological treatment. Further evaluation of 
the data indicates that this factor is likely to be the 
lack of any warning of an impending seizure, since 
patients without auras are both more depressed and have a 
smaller improvement in seizure frequency. Lack of 
"independence" is also associated with a poorer outcome 
and with higher pre-treatment depression scores.
Discriminant analysis showed that the best predictors of a 
good treatment outcome in terms of fall in seizure 
frequency, were presence of some form of warning of a 
seizure, a pre—treatment state anxiety (STAI) score of 
less than 54, a pre-treatment Zung depression score of 
less than 28 and not more than 2 activities the patient 
considers himself barred from. However, discriminant
-210 -
scores based on these variables correctly classified only 
83.3% of patients and should probably not be used to 
exclude patients from treatment.
3. FINAL EVALUATION.
Putting these various conclusions together it can be seen 
that both the literature review and the field study show 
that there is a need for some form of intervention in the 
management of epilepsy, which improves seizure control in 
patients refractory to pharmacological treatments, and for 
some form of intervention which alleviates non-psychotic 
psychological disturbance. The treatment study shows that 
intervention with brief, simple psychological treatments 
can achieve both of these ends. A treatment based on 
interruption techniques and seizure avoidance brings about 
a highly significant improvement in seizure control in 
patients without psychological disturbance and a slightly 
less significant improvement in patients with 
psychological disturbance. A treatment aimed specifically 
at alleviation of psychological disturbance is effective 
in doing this and in improving seizure control. The 
results of the study lead to some speculations, and 
implications for future research, concerning treatment 
mechanisms.
Treatment A.
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The major principle of Treatment A is that subjects are 
encouraged to believe that they can carry out some 
activity which can avert seizures. The crucial question is 
whether they can in fact interrupt seizures or whether the 
increase in confidence which is a consequence of the 
treatment is in itself therapeutic.
In some cases, during the course of treatment sessions, it 
was possible to observe the onset of a seizure, perhaps 
signalled only by loss of contact with the therapist, 
^rfolrlowed by the recommended "interruption" strategy, 
followed by a return to normal responsiveness. Unless the 
patient is imagining that seizure activity has begun it 
seems clear that he has really learned to supress it with 
his physical or cognitive strategy. It might well be 
possible to confirm this with EEG studies. Ounstead Lee 
and Hutt (106) reported one case where they were able to 
alert a child to the fact that his EEG was beginning to 
show seizure activity. They "punished" this with a noxious 
stimulus and the child learned to supress the clinical 
manifestation of the attack. Although the EEG bio-feedback 
literature is extensive (Chapter 3 section 2), most work 
is concerned with the effect on overall seizure frequency 
of learning to increase duation or amplitude of certain 
cerebral rhythms. To date Efron"s 1957 study (130) is the 
only one showing EEG confirmation of a subject"s ability 
to abort seizures. Efron provides an explanation for the
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phenomenon and this is described in Chapter 3. It is also 
noted that his explanation of a "build up of cortical 
inhibiton" ahead of the path of the seizure, seems rather 
simplistic. However without more detailed studies of 
subjects who are able to abort seizures this explanation 
is the best available. The mechanism by which an 
individual can learn voluntary control of autonomic 
functions such as heart rate is not understood. It is not 
therefore surprising that the concept of conscious control 
over neuro-electric activity is still very much in the 
borderland between science and science fiction. The actual 
evidence from this study shows only that patients tend to 
improve if they are encouraged to believe that they can 
learn self-control over their seizures. The experimenter's 
observations and Efron's study suggest that in some cases 
seizure activity is genuinely aborted. This must be shown 
to be possible using sophisticated recording techniques 
before satisfactory, testable hypotheses can be produced.
Treatment. £L_
Psychopathology was measured in terms of standardised 
anxiety and depression questionnaires. In this sample 
these appeared to be particularly valid measures since 
scores were so much higher than normal data (see Chapter 6 
Section 4). A major aim of the study was to test the 
hypothesis that psychological distress can maintain a high
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seizure frequency. In the literature review it was 
reported that such a link has been discussed in a general 
way (116), but not demonstrated experimentally. It might 
be theoretically possible, in a laboratory setting, to 
stress poorly controlled epileptic patients, to record EEG 
changes, and to see if clinical seizures could be 
provoked. There would be many methodological, practical 
and ethical objections to such an experiment on human 
subjects, but the use of an animal model would overcome 
these objections. Large numbers of studies investigating 
the properties of convulsant and anticonvulsant agents in 
animal models are reported in the literature, but there 
does not appear to have been any attempt to identify a 
mechanism by which fear or experimentally produced stress 
might lower seizure threshold. It has been observed, for 
example, that cats kindled in the ventral tegmental area 
show behavioural manifestations of fear (156), but such 
observations do not support the notion that fear can 
actually increase seizure probability. As recently as 1986 
Delgado-Escueta et al. (157) noted that "We still have no 
animal model which truly mimics complex partial epilepsies 
in humans, and the closest experimental version of 
psychomotor epilepsies in animals is the kindling 
phenomenon." Perhaps it is this lack which has prevented 
appropriate investigation of the role of fear, since it is 
in these forms of the disorder where fear seems the most 
likely to be a significant factor. The present 
investigation has been designed to test the negative
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corrollary of the hypothesis that fear or anxiety can 
increase seizure probability; that alleviating symptoms of 
anxiety, and possibly of depression, brings about a 
reduction in seizure frequency. This is a most 
satisfactory option; it can be carried out in a clinical 
rather than a laboratory setting and so valid clinical 
generalisations can be made, yet provided the outcome 
measures are reliable and valid it is a methodologically 
sound experiment.
Careful analysis of results has shown that although scores 
on the depression scale fall during treatment, a 
pre-treatment high score is associated with significantly 
less improvement in seizure frequency. It was concluded, 
therefore, that there was unlikely to be a causal 
relationship between depression and seizure frequency in 
either direction. (Chapter 7 section 2.)
Symtoms of anxiety and depression tended to occur together 
and their treatment was not distinct; both were included 
in the "B" treatment package. This is not an ideal 
situation for identifying likely treatment mechanisms, but 
fortunately, due to the elimination of depression as a 
likely source of poor seizure control it appears that 
anxiety may be a significant factor. This is a 
generalisation since there may be patients who have 
frequent seizures and who suffer from anxiety, yet who do 
not benefit from anxiety reduction. In this study it was 
not possible to identify such a sub-group, but its
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existence is certainly a theoretical possibility. The STAI 
and the GHQ show clearly that anxiety falls during 
treatment, seizure frequency falls during the same 
treatment, and that there is a correlation between the 
amounts of change. Since the treatment is designed 
specifically to alleviate anxiety it may be concluded that 
doing so directly brings about the improvement in seizure 
control. Thus there is some support for the hypothesis 
that anxiety, but probably not depression, can maintain a 
high seizure frequency.
In the foregoing discussion "anxiety” has been defined 
entirely in terms of the instruments for measuring it used 
in this study. The instruments have been selected because 
they have been shown to be reliable and valid (144), but 
it is known that subjective anxiety, the physiological 
changes associated with anxiety and the behavioural 
accompaniments of anxiety are imperfectly correlated
(158). If, as has been suggested, anxiety can in some way 
cause or maintain seizures, it would be most useful to 
know which aspect of anxiety is most responsible in order 
to formulate a hypothesis about how precisely this occurs. 
There are a number of possible theories. Firstly the link 
might be explained in purely psychological terms. Suppose, 
perhaps as a result of leading questions during a clinical 
interview, perhaps as a result of discussions with other 
patients, a patient comes to expect to have a seizure if 
he feels what he recognises as "anxiety". In this case it
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might not be the anxiety but the expectation that 
triggered the attack. If this were the case then we must 
assume that either a conscious cognition - expectation — 
can interfere with seizure inhibition, or that patients 
who believe in the anxiety/seizure link are having a high 
proportion of pseudo-epileptic seizures. To date there is 
no experimental evidence that expectation alone can 
produce genuine epileptic seizures although there is 
evidence that certain types of cognitive activity can do 
so (15). The possibilty that the elimination of 
pseudo-epileptic seizures accounts for the treatment 
effect in this study has been discussed and it has been 
pointed out that the magnitude of the effect makes this 
most unlikely. (Chapter 9).
Secondly the link between anxiety and seizure frequency 
might be explained in learning theory terms. It might be 
speculated that there is a form of reflex epilepsy where 
anxiety, or one of its physiological components, was the 
"sensory" trigger as in the reading epilepsy or 
musicogenic epilepsy described by Forster (113, 114). It
has been noted (Chapter 3 section 1) that although reflex 
epilepsies may sometimes respond to desensitisation it is 
not at all clear whether the stimulus is conditioned or 
unconditioned. If conditioned then presumably a chance 
association between the stimulus and a seizure can 
increase the probability of a seizure occurring at the 
next presentation of the stimulus. This does not
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necessarily suggest that there must be some cognitive 
mediation since it is possible to condition an increase in 
heart rate to the sound of a bell in utero and to 
produce many types of behavioural and physological change 
in response to a conditioned stimulus in relatively 
primitive animals. Perhaps, then, anxiety is a conditioned 
stimulus which in individuals with low seizure thresholds 
might produce seizures as a conditioned "response". If so, 
the precise neurophysiological mechanism may be similar 
to that of other learning phenomena. Recent research has 
shown evidence that the essential conditioned stimulus 
pathway involves mossy fiber projections and the essential 
unconditioned stimulus pathway involves climbing fibre 
projections to the cerebellum. Ablation of these pathways 
prevents acquisition of certain conditioned resposes
(159). At the cellular level it has been shown that 
learning may be mediated by alterations in membrane 
permeability (160). Certain predictions about how the CS - 
CR link between anxiety and seizures would behave should 
it exist, can be made. It should be possible to extinguish 
it by desensitisation. Forster (114) has shown that this 
is possible. In the present study desensitisaton was used 
not to break the link between anxiety and seizures, but 
between anxiety and whatever it was causing the anxiety.
In most cases the anxiety provoking factor was leaving a 
safe environment.
As pointed out above, the purpose of this treatment was to
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test. the hypothesis that reducing anxiety would reduce 
seizure frequency. It has been shown that it did, but a 
closer look at the theory that seizures could be a 
conditioned response to anxiety reveals that this could 
have happened in two ways.
If the type of desensitisation programme that Forster used 
(114) was attempted, then the patient would be 
systematically exposed to levels of anxiety just below the 
threshold at which seizures were produced, and gradually 
increasing until the patient was able tolerate levels 
wfiTcB previously triggered seizures. This is relatively 
simple with a sensory stimulus but a little more 
complicated with such a nebulous set of sensations and 
cognitions as anxiety. However this may be exactly what is 
happening during Treatment B. The patient constructs a 
hierarchy of situations to do with being away from a safe 
environment and is exposed to them working from the least 
noxious to the most noxious. This might not only serve to 
break the link between the anxiety provoking situations 
and the panicky response, but by repeatedly causing the 
subject to experience anxiety just below the level 
necessary to produce a seizure, succeed also in breaking 
that link. Treatment B, therefore, may produce its effect 
partly by ensuring that the patient copes more effectively 
with leaving the house and so is anxious for less of the 
time, and had less opportunity for having a seizure, but 
also indirectly by ensuring that higher and higher levels
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of anxiety can be tolerated without seizure potentiation
Treatment B.-------------
Leaving the house -> Anxiety Seizures
Thirdly there may be some more direct link between 
anxiety, or some aspect of it, and seizures. The change in 
neurological state which occurs when a patient is highly 
aroused and anxious may interfere with seizure inhibition 
or may facilitate seizure propogation, or both. The 
evidence that certain so-called "idling" cerebral rhythms 
can increase seizure inhibition has been discussed 
(Chapter 3 section 2). The EEG tends to become more 
desynchronised during anxiety, with less alpha and more 
beta rhythm (161), and this may interfere with 'SMR'. 
Certainly a patient who is trained to produce SMR at will 
cannot do so at the same time as feeling anxious (117). 
Anxiety, therefore, may bring about its effect by 
disrupting inhibitory processes. EEG records only 
symbolise the underlying neuro-electric processes and so 
to envisage the direct action of anxiety on seizure 
inhibition in these crude terms is unsatisfactory. Certain 
neurochemical studies tend to lead towards the opposite 
conclusion: that anxiety may actually prevent seizure 
propagation. Stress raises circulating levels, and brain
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levels of adrenaline and noradrenaline, but recent 
experimental evidences suggest that noradrenaline inhibits 
seizure activity and may be termed “an endogenous 
anticonvulsant.” (162). There is also evidence from 
genetic studies of epileptic mice that epileptic strains 
may be deficient in noradrenaline. The picture is yet 
further complicated by pharmacological studies showing 
that although the benzodiazepines most effective in 
controlling anxiety are rather weak anticonvulsants,(e.g. 
diazepam), carbamazepine appears to have potential as an 
antianxiety agent. It has also been shown that there is a 
lbngf list of convulsant agents which can also produce 
panic attacks (163). Finally, the fact that some forms of 
temporal lobe epilepsy and anxiety share a common 
anatomical substrate in the limbic system is suggestive.
It might be speculated that patients with an anxiety 
disorder could ’kindle’ temporal lobe seizures as a result 
of persistant limbic activity. It will be seen that there 
is much scope for collaborative work between basic 
neuroscientists to unravel these various strands of 
evidence. A direct neurochemical link between seizures and 
anxiety remains an attractive, but as yet unproven, 
possibility.
The three theories outlined above which attempt to explain 
the link between anxiety and seizure frequency are not 
mutually exclusive. They represent three view-points, one 
cognitive (expectation), one from the perspective of
learning theory, and one from a neurobiological
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perspective. This study has provided evidence that a link 
between anxiety and seizure frequency is likely. Further 
studies, using more varied anxiety measures such as 
galvanic skin response and behavioural observations, could 
pin-point more precisely the sequence of internal and 
external events which links anxiety and seizures. 
Telemetric recording of EEG, GSR and heart rate might be 
invaluable in determining in an individual case whether 
anxiety was a consequence of seizure onset, part of the 
seizure itself, or a cause of seizures.
Whether or not these treatments are cost-effective remains 
a matter of opinion. On the one hand it has been shown 
that a statistically highly significant effect can be 
produced with short, simple treatments and maintained for 
six months. Patients have fewer seizures after treatment 
than before, they feel less anxious, less depressed and 
less socially restricted. On the other hand the majority 
of patients are in no sense ’cured’ by the treatment. They 
remain more psychologically distressed than a normal 
population and most are still having frequent seizures. 
Factors predicting treatment success are not sufficiently 
reliable for use at an individual level. Certainly 
psychological intervention appears useful in this 
experiment but it would be unwise to make major claims 
about it without making two further tests. Firstly, longer
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term follow-up should be carried out and if ther© is a 
tendency to relapse after six months the ©ffeet ©f 
occasional ’maintenance’ treatment sessions should be 
evaluated. Secondly, the experiment should be repeated 
with several different therapists, possibly froffi a variety 
of professional backgrounds. If treatment effeot ©an be 
maintained indefinitely and is generally effective over a 
wide range of therapists and patient groups, then a good 
case could be made for including psychological treatments 
routinely in the out-patient management of epilepsy*
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AEPEimiX-j^
STMMBDISED-INTERVIEW SCHEDULE FOR PATIENTS TAKING PART
IN PRELIMINARY STUDY
1. SUBJECT NO: 2.DATE:
3.NAME: 4.ADDRESS:
5.AGE: 6. D.O.B. 7. SEX:
8. MARITAL STATUS:
(Code 1: married/co-habiting Code 2: single Code 3: 
Other)
9. EMPLOYMENT STATUS:
(Code 1: Employed/student Code 2: Unemployed as a direct 
result
of epilepsy Code 3: Unemployed for reason other than 2.) 
IOT^'MEDICAL HISTORY:
Have you attended any hospital clinics in the past year 
apart from this one?
11. If so for what reason?
12. Have you ever had any treatment from a psychologist or 
a psychiatrist?
13. Give reason and approximate dates.
SEIZURE INFORMATION:
14. Type:
(Code 1 = Generalised Seizures, 2 = Partial Seizures, 3 = 
Mixed 1 and 2
4 = 'Absences' 5 = Unknown.)
15. Frequency per Month: Patient's Record =
Patient's Estimate =
Relative's Estimate =
Case Note Estimate =
16. How old were you when you had your first seizure?
17. How old were you when the diagnosis of epilepsy was 
made?
Control Rating:
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18. Do you feel that the control of your epilepsy on your 
present treatment is
Good (Code 1)
Moderate (2)
Poor (3)
Patient's rating of control =
If the patient rates control as '3' ask
19. How long since your epilepsy was well controlled ?
‘20. Neurologist's rating of control =
Record from case records
21. no. of clinic visits in last six months =
22. no. of changes in medication last six months =
23rT^Can you tell when you are going to have a seizure?
24.How?
(Description of auras, warnings etc.)
25.Do you know of anything which brings on your seizures 
or anything or circumstance which makes you more likely to 
have a seizure?
(Description)
26. Do you ever feel that you can put off a seizure or stop 
one from happening?
27. GHQ 30 score =
28. FSSI score A =
B =
C =
D =
E =
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APPENDIX B.
S amp 1 e— 129/teri.a.1— from J contract therapy* aspect, of
Treatment B
A. Patient"s list. ( In this case 28 year old male.)
Independent: Going to shops
Taking medication
Cooking
Going to pub
Supervision needed : Going to hospital (for out-patient
appointments.)
Shouldn't do: Drive
Drink too much
B. Relative's list. ( In this case mother)
Independent: Taking dog for walks.
Going to shops for food
Supervision needed: Cooking
Using the lawn mower 
Taking medication 
Some shopping (i.e.clothes) 
Attending for hospital appointments
Shouldn't do: Drink alcohol 
Drive
Use electric hedge trimmer
C) Revised list agreed by both parties.
Independent: Going out for walks 
All shopping 
Cooking 
Going to pub
Supervision needed: Attending for hospital appointments
Taking medication (patient has poor 
memory)
Using the lawn mower (but mother 
should watch from the house, not 
hover anxiously in garden).
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Shouldn't do: Use hedge trimmer
Drink more than one pint beer per night. 
Drive
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AEEEMEIX_£^
1^SIM£ARDI5£3LJ[NIEBVIEH_SCHEDULE FOR PATIENTS TAKING PART
IN TREATMENT STUDY.
1. SUBJECT NO : 2.DATE:
3. NAME: 4.ADDRESS:
5.AGE: 6. D.O.B. 7. SEX:
8. MARITAL STATUS:
(Code 1: married/co-habiting Code 2: single Code 3: 
Other)
9. EMPLOYMENT STATUS:
(Code 1: Employed/student Code 2: Unemployed as a direct 
result of epilepsy Code 3: Unemployed for reason other 
;s£han 2. )
SEIZURE INFORMATION:
10. Type:
(Code 1 = Generalised Seizures, 2 = Partial Seizures, 3 = 
Mixed 1 and 2 4 =  'Absences' 5 = Unknown.)
11. Frequency per Week: Patient's Record =
Patient's Estimate =
Relative's Estimate =
Case Note Estimate =
12. How old were you when you had your first seizure?
13. How old were you when the diagnosis of epilepsy was
made?
14a. Can you describe one of your usual seizures? 
(Patient)
b. How long do they usually last?
15a. Can you describe one of his/her usual seizure? 
(Relative)
b. How long do they usually last?
16. Can you tell when you are going to have a seizure?
17. How?
(Description of auras, warnings etc.)
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18. Do you know of anything which brings on your seizures 
or anything or any circumstance which makes you more 
likely to have a seizure?
(Description)
19. Do you ever feel that you can put off a seizure or 
stop one from happening?
20a. Do you need any help during or after a seizure? 
(Patient) 
b. (Relative)
21. Do you always take your medication exactly as 
prescribed?
Forget occasionally 
Forget often
Almost always take less than prescribed
Record from case records
no. of clinic visits in last six months =
23. no. of changes in medication last six months
24. Present medication.
QUESTIONNAIRES:
25. GHQ 30 score =
26. STAI(State) score =
27. STAI(Trait) score =
28. ZUNG score =
29. Activities Check list.
14 to 21 and Questionnaires 25 to 29 were repeated at the 
end of six months follow up.
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APPENDIX C.
 ACTIVITIES CHECKLIST FOR TREATMENT STUDY PATIENTS.
Tick any of the following activities which you would like 
to be able to do but cannot do at all, or cannot do as 
often as you would like, because you have epilepsy.
1. Driving a motor vehicle.
2. Operating machinery and appliances, (machinery at work, 
or domestic appliances such as motor mowers, electric 
irons, cookers etc.
3. Drinking alcohol.
4. Making friends/ socialising.
5. Going out alone.
6. Using public transport alone.
7. Going away for a holiday.
8. Career or job which definitely excludes people with 
epilepsy.
9. Any sport.
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* Weeks during which patient was seen by the therapist. 
+ During follow up reviews were used simply to collect 
seizure records.
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